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With the increasing number of novel mutations being discovered by whole genome and 
whole exome sequencing, functional studies are increasingly required to determine 
whether specific mutations are responsible for the disease phenotypes. Drosophila, with 
its vast set of genetic and molecular tools as well as robust behavioural assays, is an 
ideal model for functional characterisation. 
Coenzyme Q biosynthesis is highly conserved from yeast to humans and involves a 
number of genes in the enzymatic pathway including COQ8A. The role of COQ8A in 
CoQ biosynthesis is not clear. However, mutations in COQ8A have been associated 
with autosomal recessive cerebellar ataxia, which is characterised by gait ataxia, 
cerebellar degeneration and CoQ10 deficiency. This project aimed to characterise the 
phenotypes resulting from the reduction of coq8 expression (the Drosophila homologue 
of COQ8A) to develop a model of coq8 deficiency that could be used to characterise 
COQ8A mutations functionally. 
RNAi knockdown of coq8 resulted in severe developmental delay, larval lethality, 
locomotor impairment, a decrease in ATP production, as well as developmental deficits 
and neurodegeneration in the Drosophila eye. Reintroduction of wild-type Drosophila 
coq8 partially rescued the larval lethality, restored locomotor function and also 
primarily rescued the necrotic phenotype in the eye. This model could, therefore, be 
used to determine whether a specific mutation impaired function, such that it would not 
rescue the deficiency. As a proof-of-principle, two mutant variants of coq8, I295P and 
L520*, which were modelled on the human COQ8A mutations L277P and 
c.1506+1G>A (which results in a truncated protein) did not rescue the coq8 deficiency, 
indicating that they disrupted normal coq8 function. However, the reintroduction of 
human COQ8A did not restore function but instead exacerbated the necrotic and 
neurodegenerative phenotype in the eye suggesting that it may be impairing the 
mitochondrial function of wild-type coq8.  
Drosophila provides the means to characterise disease-causing genetic mutations 
functionally. Here we have developed a model that can be used to study the role of coq8 
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1.1 Autosomal recessive cerebellar ataxia 
Autosomal recessive cerebellar ataxias (ARCAs) are a heterogeneous group of rare 
inherited neurological disorders that affect the cerebellum and/or the spinal cord 
(Lagier-Tourenne et al., 2008; Palau & Espinós, 2006). Early-onset often occurs before 
20 years of age and can include cerebellar ataxia, neurological defects, alteration to 
sensorimotor function, cognitive abnormalities, intellectual disability, uncoordinated 
gait and coenzyme Q (CoQ) deficiency (Anheim , Tranchant , & Koenig 2012; Fogel & 
Perlman, 2007). Affected individuals present in childhood with uncoordinated gait and 
cerebellar ataxia that progressively gets worse with age. The effect of CoQ deficiency 
can be highly heterogeneous including impairments in muscle, kidney and central 
nervous system (CNS) function (Luna-Sánchez et al., 2017). In some instances, CoQ 
deficiency is one of the more treatable effects of ARCA but has had varied responses to 
external supplementation of CoQ (Horvath et al., 2012; Jacobsen et al., 2017; Liu et al., 
2014). 
1.2 Coenzyme Q 
Coenzyme Q (CoQ) is an essential component of metabolic function in all eukaryotes. It 
is a lipophilic molecule composed of a quinone head group and a polyisoprenoid tail, 
which embeds itself in the mitochondrial membrane (Doimo et al., 2014; Tauche, 
Krause-Buchholz, & Rödel, 2008; Tran & Clarke, 2007). The isoprenoid head group is 
responsible for the redox reactions involving quinone, semiquinone and hydroquinone 
(Dutton et al., 2000). The length of the isoprenoid tail is species dependent and most 
commonly contains ten repeating isoprenoid units in humans (CoQ10), nine isoprenoid 
units in C. elegans (CoQ9), eight isoprenoid units in E. coli (CoQ8), and six in yeast 
(CoQ6) (Fernández-Ayala, Jiménez-Gancedo, Guerra, & Navas, 2014). CoQ10 functions 
in adenosine triphosphate (ATP) production (Fernández-Ayala et al., 2014), 
biosynthesis of pyrimidines, modulation of apoptosis (Doimo et al., 2014), acts as an 
antioxidant (López-Lluch, Rodríguez-Aguilera, Santos-Ocana, & Navas, 2010) and as 
an electron transporter from complex I and complex II to complex III in the 
mitochondrial respiratory chain (MRC) (Crane, Hatefi, Lester, & Widmer, 1957; 
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Lagier-Tourenne et al., 2008; Turunen, Olsson, & Dallner, 2004). CoQ10 levels 
throughout the body are consistent with the dependence of the tissue for mitochondrial 
respiration (Lester & Crane, 1959). 
 
Table 1.1 Table of the genes required for CoQ biosynthesis. They are highly conserved across a number 
of higher organisms and are integral in roles such as cellular signalling, and CoQ biosynthesis. Gene 
names were obtained from https://www.yeastgenome.org/, http://flybase.org/ and 
https://www.ncbi.nlm.nih.gov/  
S. cerevisiae D. melanogaster Human 




COQ2 CG9613  COQ2 
COQ3 CG9249 COQ3 
COQ4 CG32172 COQ4 
COQ5 CG2453 COQ5 
COQ6 CG7277 COQ6A 
COQ6B 
COQ7 CG14437 COQ7 
COQ8 CG32649 (coq8) COQ8A 
COQ8B 
COQ9 CG30493 COQ9 
COQ10 CG9410 COQ10A  
COQ10B 
 
The biosynthesis of CoQ is orchestrated by a number of enzymes and occurs in different 
subcellular mitochondrial compartments (Doimo et al., 2014). The synthesis of the 
isoprenoid tail takes place in the cytosol in higher eukaryotes (Doimo et al., 2014) and 
is essential for the stability of the Q complex (He, Xie, Allan, Tran, & Clarke, 2014) 
which is a multi-enzyme complex containing biosynthetic enzymes and is integral for 
the biosynthesis of CoQ (Bentinger, Tekle, & Dallner, 2010; Casarin et al., 2008; He et 
al., 2014). In humans, 13 genes that are involved in the biosynthesis of CoQ (Table 1.1) 
each corresponding to a different step in the enzymatic pathway (Doimo et al., 2014). In 
yeast, COQ4, COQ6, COQ7 and COQ9 are thought to play an essential role in the 
formation of the Q complex (He et al., 2014). Mutations to any of the CoQ genes can 





1.3 CoQ deficiency 
CoQ deficiency is characterised as a decrease in CoQ10 levels in tissues and/or cells in 
the body and is observed in a clinically and genetically heterogeneous group of ataxias 
that can affect vital organs, the central and peripheral nervous systems (Casarin et al., 
2008; Luna-Sánchez et al., 2017). Primary CoQ10 deficiency occurs when there are 
mutations in the genes that make up the Q complex responsible for CoQ biosynthesis 
(Casarin et al., 2008) whereas secondary CoQ deficiency occurs when mutations are in 
genes not directly associated with CoQ10 biosynthesis (Doimo et al., 2014). 
Confirmation of CoQ deficiency is most reliably determined via CoQ levels in a muscle 
biopsy (Rahman, Clarke, & Hirano, 2012). CoQ deficiency has a strong association 
with mitochondrial dysfunction (Grant, Saldanha, & Gould, 2010), an increase in 
reactive oxygen species (ROS) (Barca et al., 2016), stroke-like lesions (Horvath et al., 
2012), caspase activation, neuronal apoptosis (Grant et al., 2010) and has been linked to 
malfunctions in the biosynthesis of CoQ.  
1.4 COQ8A 
Coenzyme Q8A (COQ8A previously known as ADCK3 and CABC1) encodes a highly 
conserved putative kinase that is involved in the regulation of CoQ biosynthesis (Barca 
et al., 2016; He et al., 2014; Mollet et al., 2008). Phylogenetic analysis identified 
COQ8A as an atypical kinase that is part of the UbiB protein kinase-like (PKL) family 
(He et al., 2014; Stefely et al., 2015). The UbiB family are found primarily in the 
mitochondria of eukaryotes (Pagliarini et al., 2008). 
 
Figure 1.1 Schematic representation of COQ8A, indicating structural domains.  




UbiB kinases are highly conserved from archaea to eukaryotes, but in E.coli ubiB 
(homolog of human COQ8A) is essential for the biosynthesis of CoQ10 (Poon et al., 
2000) and carry several trademark features that make them unique (Stefely et al., 2015). 
These characteristics include an N lobe insert, an N-terminal extension containing a 
unique and invariant KxGQ motif, a non-canonical A-rich loop, and an ExD motif in 
the N lobe insert, an altered catalytic loop, a mitochondrial targeting sequence (MTS), 
an atypical active site and a selectivity for binding adenosine diphosphate (ADP) 
(Figure 1.1) (Stefely et al., 2015). 
The KxGQ motif is integral for the proper function of COQ8A in the biosynthesis of 
CoQ and is highly conserved from yeast to humans (Figure 1.2). Mutations to the 
KxGQ motif results in a mutant phenotype in yeast and the inability for yeast to produce 
mitochondrial CoQ (Stefely et al., 2015). 
 
 
The secondary structure of the N-terminal extension and the N lobe fold into a series of 
β sheets and α helices while the C lobe folds into α helices and β strands (Stefely et al., 
2015). This secondary structure of the N-terminal extension occludes the substrate 
binding pocket by placing the KxGQ motif into the active site and ultimately preventing 
substrate binding (Stefely et al., 2015). This is an unusual feature of COQ8A as most 
PKL families will fold away from the substrate binding pocket as opposed to into it, 
where the KxGQ motif acts as an autoinhibitory domain (Stefely et al., 2015). The 
Figure 1.2 Conservation of the KxGQ motif. 
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inhibition of protein kinase activity in COQ8A is essential for the biosynthesis of CoQ 
(Stefely et al., 2015). 
A QKE triad is also present and contains a salt bridge from the highly conserved K276 
and Q397 residues of the KxGQ motif to the E405 residue of the ExD motif (Stefely et 
al., 2015). The QKE triad folds and prevents substrate binding near the A-rich loop 
which ultimately prevents kinase activity in the protein kinase domain (Stefely et al., 
2015). The KxGQ domain and the QKE triad work as inhibitory mechanisms to prevent 
protein kinase activity and are what make COQ8A unique from other members of the 
UbiB family. 
COQ8A localises to the mitochondrial cristae via an N-terminal MTS which is cleaved 
upon entry into the mitochondria (Cullen et al., 2016; Stefely et al., 2015). N-terminal 
FLAG-tagged COQ8A failed to colocalise to mitochondria when using MitoTracker® 
suggesting that the N-terminal of COQ8A is cleaved before entry (Cullen et al., 2016). 
COQ8A was FLAG-tagged at either the N-terminal or the C-terminal. Colocalisation 
was absent in the N-terminal FLAG-tagged COQ8A but present in the C-terminal 
FLAG-tagged COQ8A (Cullen et al., 2016). This suggested that the N-terminal of 
COQ8A was cleaved before entry into the mitochondria with this idea being supported 
by the cleavage of 162 amino acids in mature COQ8A (Stefely et al., 2015). 
The MTS is located on proteins that are destined to function in mitochondria. These 
MTS are generally located on the N-terminal of the protein and often form amphiphilic 
helices (von Heijne, 1986). While MTS vary in sequence, dependent on function, the 
sequence itself seems to be 20 amino acids in length. Websites currently exist which aid 
in determining the presence of MTS in proteins. These websites are listed in Table 4.3. 
While the role of COQ8A is mostly unknown, studies have tried to unravel the mystery 
surrounding COQ8A function (Cullen et al., 2016). It has been suggested that COQ8A 
may function in a regulatory capacity in the CoQ biosynthetic pathway by interacting 
with COQ3, COQ5, COQ7 and COQ9 (Cullen et al., 2016). While the exact function is 
unknown, in the absence of COQ8A it was noted that some of the CoQ proteins were 
unphosphorylated (Fernández-Ayala et al., 2014) suggesting that COQ8A may function 
in a regulatory capacity to stabilise or form the Q complex (Cullen et al., 2016; Stefely 
et al., 2016; Stefely et al., 2015). 
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1.5 COQ8A mutations 
CoQ deficiency and cerebellar ataxia are often a result of COQ8A mutations in humans 
(Barca et al., 2016). Mutations in COQ8A can result in numerous disease phenotypes 
ranging from mild to extremely catastrophic (Horvath et al., 2012; Lagier-Tourenne et 
al., 2008). Clinical presentation can include infantile-onset cerebellar atrophy as 
determined by magnetic resonance imaging (MRI), seizures, complex ataxia-
myoclonus, tremors, CoQ deficiency, slurred speech and uncoordinated gait (Barca et 
al., 2016; Horvath et al., 2012; Jacobsen et al., 2016 ; Liu et al., 2014; Stefely et al., 
2015). A list of mutations and their associated phenotypes are listed in Table 1.2 with a 
schematic illustrating the mutations and their locations along the protein (Figure 1.3). 
The chemical analysis identified a decrease in the activity of complexes I+III and 
complexes II+III in the MRC (Liu et al., 2014) but is not always a consistent indicator 
of mutations to COQ8A.  
 
 
With the increase in whole exome and genome sequencing, many COQ8A mutations 
are being identified (Bao et al., 2014; Horvath et al., 2012; Jacobsen et al., 2017; Mollet 
et al., 2008) and functional analysis of these mutations are necessary to determine 
whether the mutations are responsible for the disease state. Supplementation with 
Figure 1.3 Schematic representation of the mutations found in COQ8A. Mutations are listed in Table 
1.2. The mutations indicated by blue arrows were found on the 
https://www.uniprot.org/uniprot/Q8NI60#family_and_domains website. The mutations indicated by 
purple arrows were the mutations used in this project and were found by the Minds for Minds research 
network (Jacobsen et al., 2017). 
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exogenous CoQ has varied results in patients with some responding well (Barca et al., 
2016; Liu et al., 2014) and others showing no improvement at all (Horvath et al., 2012). 
 
Table 1.2 Mutations found in COQ8A. Mutations were found on the 
https://www.uniprot.org/uniprot/Q8NI60#family_and_domains website highlighting the genetic mutations 
currently identified in COQ8A. The purple rows highlight the mutations identified by Jacobsen et al. 
(2017) which have not been functionally characterised. 
Mutation Change Phenotypes Publication 
R213W Missense Arg → Trp 
Highly conserved 
residue 
Mild hypotonia, talus valgus, 
developmental delay, seizures, 
cerebellar ataxia, cerebellar atrophy, 
ptosis, vermis hypoplasia, epilepsy, 
muscle weakness, epilepsia partialis 
continua, CoQ10 deficiency stroke-like 
anomalies and hyperintensities. 
 
CoQ supplementation was not 
effective. 
(Mollet et al., 2008) 
(Horvath et al., 2012) 
R271C Missense Arg → Cys 
Loss of interaction 
with V300 and Y361 
Mild cerebellar ataxia, cerebellar 
atrophy, ptosis, CoQ10 deficiency and 
tremors. 
(Horvath et al., 2012) 
G272D Missense Gly → Asp 
Steric clash with I342 
and S340 
Exercise intolerance, CoQ deficiency, 
hyperlactatemia, cerebellar ataxia, 
cerebellar atrophy, epilepsy, 
myoclonus, a decrease in respiratory 
chain activity in muscle 
(Mollet et al., 2008) 
(Horvath et al., 2012) 
(Auré et al., 2004) 
G272V Missense Gly → Val 




Mild hypotonia, talus valgus, 
developmental delay, seizures, 
cerebellar ataxia, ptosis, vermis 
hypoplasia, epilepsia partialis 
continua, stroke-like anomalies and 
hyperintensities mild cerebellar 
atrophy, tremor, epilepsy and muscle 
weakness. 
CoQ10 supplementation was not 
effective.  
(Mollet et al., 2008) 
(Horvath et al., 2012) 
L277P Missense Leu → Pro CoQ10 deficiency, uncoordinated gait 
and cerebellar atrophy. 
(Jacobsen et al., 
2017) 
R299W Missense Arg → Trp 
Decreased stability 
Loss of interactions 
with S303 and E261 
Cerebellar ataxia, cerebellar atrophy, 
epilepsy, muscle weakness, and 
cognitive defects,  
(Stefely et al., 2015) 
(Horvath et al., 2012) 
(Hikmat et al., 2016) 
A304T Missense Ala → Thr 
Steric clash with 
P335 and A338 
Mild cerebellar ataxia, cerebellar 
atrophy, epilepsy, muscle weakness, 
ptosis, CoQ10 deficiency, tremor 
(Horvath et al., 2012) 
A304V Missense Ala → Val 
Steric clash with 
P335 and A338 
Cerebellar ataxia, cerebellar atrophy, 
spasticity, tremor, epilepsy, 
myoclonus, muscle weakness, ptosis, 
CoQ10 deficiency. 
(Horvath et al., 2012) 
K314_Q360 Deletion 
Lys314_Gln360 
Cerebellar ataxia, moderate disability, 
brisk reflexes and mild hearing loss. 
(Lagier-Tourenne et 
al., 2008) 
D420W Frameshift Asp →Trp Cerebellar ataxia, cerebellar atrophy, 
exercise intolerance, mental retardation 





Y429C Missense Try → Cys 
Decreased stability 
Loss of interaction 
with #446 and R419 
Cerebellar ataxia, cerebellar atrophy, 
spasticity, tremor, epilepsy, muscle 
weakness, mild cognitive deficient, 
depression,  
(Stefely et al., 2015) 
(Horvath et al., 2012) 
K502* Disrupts a canonical 
splice donor site in 
exon 12 
predicted to inhibit 
transcriptional 
processing 
CoQ deficiency, uncoordinated gait 
and cerebellar atrophy. 
(Jacobsen et al., 
2017) 
Y514C Missense Try → Cys 
Loss of H-bond with 
E605 backbone 
Unsteady gait, generalised tonic-clonic 
seizures, absence seizures, gait 
increasingly atactic, lost ability to walk 
by 12 years, lost speech at 14 years 
old, feeding difficulties PEG inserted, 
sleeps a lot, drowsy, severe retardation, 
progressive cerebellar atrophy, 
enlarged ventricles, thinning corpus 




(Horvath et al., 2012) 
G549S Missense Gly → Ser 
Decreased stability 
Steric clash with I542 
Slow motor development, progressive 
ataxia, muscle weakness, cognitive 
impairment, wheelchair-bound, 
horizontal nystagmus, mildly slurred 
speech, spastic tetraparesis with 
increased reflexes, bilateral dysmetria, 





(Stefely et al., 2015) 
(Horvath et al., 2012) 
E551K Missense Glu → Lys 
Decreased stability. 
Highly conserved 
change from glutamic 
acid to lysine. 
Homozygous change 
Loss of H-bond with 
T548 backbone 
Proximal muscle weakness, cerebellar 
ataxia, strabismus, tonic seizures, high 
CSF lactate, trunk hypotonia 
intellectual regression, unable to walk 
and speak after 12 years of age, stroke-
like anomalies, epilepsia partialis 
continua cerebellar atrophy, epilepsy, 
ptosis, cognitive deficiency, decrease 
in respiratory chain activity in muscle 
fibroblasts and CoQ10 deficiency.  
CoQ10 supplementation was not 
beneficial 
(Stefely et al., 2015) 
(Mollet et al., 2008) 




Childhood-onset epilepsy, progressive 
cerebellar ataxia, stroke-like episodes 
and focal epileptic activity. 
(Hikmat et al., 2016) 
Missing 584  Unsteady gait, generalised tonic-
clonic, absence seizures, gait 
increasingly atactic, lost ability to walk 
by 12 years, lost speech at 14 years 
old, feeding difficulties PEG inserted, 
sleeps a lot, drowsy, severe retardation, 
progressive cerebellar atrophy, 
enlarged ventricles, thinning corpus 
callosum, and epileptiform activity. 
(Lagier-Tourenne et 
al., 2008) 
(Horvath et al., 2012) 





Exercise intolerance, progressive 
cerebellar syndrome, cerebellar 
atrophy, CoQ deficiency and 
hyperlactatemia. 





1.6 Case study 
The Minds for Minds research network are a group of New Zealand researchers and 
clinicians who work collectively to better understand autism spectrum disorders and 
other neurodevelopmental disorders. The Minds for Minds research group assessed a 
female sibling pair who presented with cerebellar atrophy and cerebellar hypoplasia 
(Jacobsen et al., 2017). Clinically the children presented with CoQ deficiency, 
uncoordinated gait and cerebellar atrophy. Whole exome sequencing identified 
compound heterozygous inheritance of two single nucleotide polymorphisms (SNP). 
The first SNP was paternally inherited, this resulted in a non-synonymous missense 
change from Leucine to Proline (c.830T>C, p.Leu277Pro) in exon 6 (Jacobsen et al., 
2017). This amino acid is highly conserved and located in the highly conserved and 
invariant KxGQ motif at the x position (Stefely et al., 2015). The second SNP, 
maternally derived, resulted in a novel mutation that disrupts a canonical splice donor 
site in exon 12 (c.1506+1G>A) (Jacobsen et al., 2017). It has been predicted that this 
SNP will destroy the splice donor site and inhibit transcriptional processing. Neither of 
these mutations have been previously characterised, and for this reason, functional 
studies are needed to confirm that the amino acid substitutions result in impaired 
functionality. 
1.7 Drosophila as a model for functional analysis of 
human COQ8A mutations 
Drosophila, the fruit fly, has been used to study genetics for many years with the iconic 
experiment carried out by Thomas Hunt Morgan which determined the sex-linked 
inheritance of eye colour in Drosophila (Morgan & Bridges, 1916). Drosophila are 
small, inexpensive, easy to care for; they have fast generation times, produce many 
offspring, and many genetic tools that have been developed for molecular and genetic 
analysis. Advances in both molecular genetics and Drosophila genetics have led to the 
increased use of Drosophila as a model for the investigation of the molecular 
mechanism behind human genetic diseases. 
Drosophila can be used to study learning and memory (Fitzsimons & Scott, 2011), 
motor function (Rhodenizer, Martin, Bhandari, Pletcher, & Grotewiel, 2008), they can 
also be used to test the efficacy of drugs (Pandey & Nichols, 2011) and have been 
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previously used as a model to assess CoQ deficiency (Grant et al., 2010). With 75% of 
human disease-causing genes highly conserved in Drosophila (Bier, 2005) Drosophila 
provides the genetic stability to functionally characterise and probe the inner workings 
of uncharacterised human mutations. 
1.7.1 Drosophila life cycle 
The Drosophila life cycle (Figure 1.4) has four distinct stages which include the 
embryo, three larval stages, a pupal stage and finally the adult stage. When flies are 
raised at 25℃ first instar larvae emerge 24 hours after fertilisation. Each larval stage 
lasts roughly 24 hours each with the prepupa stage lasting 2-3 days before pupation 
occurs. Pupation is when morphogenesis occurs and typically lasts approximately five 
days before adults begin to emerge. During morphogenesis, the eyes, legs, antennae and 
body segments are produced. The day before the emergence of the adult fly, the wings 
and eyes become more visible, and the pupal casing darkens. During emergence 
(eclosion) adults emerge from the anterior end of the pupae. For up to eight hours after 
eclosion, female flies are sexually immature. 
Figure 1.4 The life cycle of Drosophila melanogaster. There are four 
distinctive stages in the Drosophila life cycle which include an embryo 
stage, three distinctive larval stages, a pupal stage and finally an 
adult stage. Development of Drosophila is temperature dependent and 
can be completed in 10 days at 25℃. 
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When flies are raised at 25℃ the life cycle is completed in 7-10 days, at 21℃ it takes 
10-14 days, and at 18℃ it takes 21-25 days (Suzuki, 1970). The generations times can 
be altered depending on the fly lines and driver lines used. 
1.7.2 The Drosophila brain structure 
The central brain includes the antennal lobes and the mushroom body which receive 
sensory input from the olfactory system. The optic lobes flank the central brain and 
work together to process visual input from the eyes. Drosophila contain a brain that is 
simple, yet sophisticated enough to assess memory and learning (Figure 1.5) (Bellen, 
Tong, & Tsuda, 2010). The Drosophila brain is composed of approximately 200,000 
neurons which are highly organised. The mushroom body (MB) is the bilateral structure 
which is crucial for memory formation in the fly brain (McGuire, Le, & Davis, 2001). 
The MB is composed of 2500 Kenyon cells. These are the intrinsic neurons of the brain 
which project dendrites into the calyx (Heisenberg, 1998; Yang, Armstrong, Vilinsky, 
Strausfeld, & Kaiser, 1995). The Kenyon cell axons are bundled into α/β, α’/β’ and γ 
MB lobes (Heisenberg, 1998) which project to the anterior of the brain forming a 
characteristic L-shape. The calyx functions as the primary sensory input into the 
mushroom body (Heisenberg, 1998; Zhu, Chiang, & Lee, 2003) from the antennal lobe 




Figure 1.5 Schematic representation of the Drosophila brain. Anterior view contains the mushroom 
body lobes and the antennal lobes. The optic lobes are visible from both sides of the brain. The posterior 
view shows the cell bodies of the Kenyon cells and the calyx. 
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With over 600 causative genes identified in intellectual disability disorders (Morales et 
al., 2002; van der Voet, Nijhof, Oortveld, & Schenck, 2014) a robust model system is 
necessary to enable functional characterisation of these genes. Due to the heterogeneity 
of the disease states present in intellectual disability disorders, Drosophila has been 
used to aid in our understanding of the molecular basis of human disease (Morales et al., 
2002). Drosophila has been used to functionally characterise neurological and 
neurodegenerative disorders including Fragile X syndrome (Morales et al., 2002), 
Parkinson’s disease (Pesah et al., 2004), Alzheimer’s disease (Sofola et al., 2010), 
neurodegeneration (Barone & Bohmann, 2013) and other congenital diseases (Moulton 
& Letsou, 2016). 
1.7.3 The Drosophila compound eye 
The Drosophila compound eye is an elaborate and extraordinary structure composed of 
roughly 800 ommatidia (Kumar, 2012). Each ommatidium is composed of specialised 
neurons, the photoreceptors, as well as non-neuronal cells including cone cells, primary 
pigment cells, bristle cells, tertiary pigment cells, and interommatidial cells (Freeman, 
1996; Johnson & Cagan, 2009; Kumar, 2012). To be able to construct a structure so 
grand an elaborate network of cellular interactions are necessary (Johnson & Cagan, 
2009). Any impairments in the development of the compound eye are visually evident 
as a disruption in ommatidial patterning, impaired adhesion of ommatidia and 
disruption to bristle integrity is seen. Therefore it is an excellent model to investigate 
the impact of genetic mutations on cellular interactions (Johnson & Cagan, 2009). 
During embryonic development, the optic nerve and retina are derived from the CNS 
and are therefore considered to be a part of the CNS (Johnson & Cagan, 2009). In this 
case, the retina and optic nerve can be used to assess the involvement a genetic mutation 
may have in neurodegeneration (London, Benhar, & Schwartz, 2013). 
The Drosophila eye can be used as a surrogate indicator of the effect of protein in the 
brain which is why the eye has been used to model Parkinsons (Faust et al., 2009; Pesah 
et al., 2004), Alzheimer’s disease (Sofola et al., 2010) and cellular differentiation 
(Freeman, 1996). Protocols have been established to prepare Drosophila brains and 
retina for live images to aid in the study of neuronal development, cellular function and 
neurodegeneration (Warrick et al., 1998; Williamson & Hiesinger, 2010). 
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1.8 Drosophila as a genetic toolbox 
Over the last ~30 years, many genetic tools have been developed to aid in the genetic 
and molecular analysis using Drosophila, which make Drosophila an appealing model 
for studying human disease. 
These tools include the UAS/GAL4 system which utilises the yeast-derived 
transcription factor GAL4 and the GAL4-dependent Up-stream Activating Sequence 
(UAS) which is tethered to a transgene or gene of interest (Kakidani & Ptashne, 1988). 
This system allows genes to be expressed in a cell and/or tissue-specific manner in 
Drosophila (Duffy, 2002). In conjunction with the UAS/GAL4 system, there are a vast 
library of RNA interference (RNAi) lines available from the Vienna Drosophila RNAi 
Center (VDRC, Vienna, Austria) for the knockdown of many Drosophila genes (Dietzl 
et al., 2007). Any gene can be expressed in a highly cell and/or tissue-specific manner. 
Also, genes can be switched on or off at a specific developmental stage to assess what 
impact the gene may have in Drosophila development.  
Advances in both molecular genetics and Drosophila genetics have led to the increased 
use of Drosophila as a model for neurodegeneration (Barone & Bohmann, 2013). With 
the increase in susceptibility and prevalence of neurodegenerative disorders such as 
Parkinson’s disease (Pesah et al., 2004) and Alzheimer’s disease (Sofola et al., 2010) a 
model system such as Drosophila can aid in further exploration of the pathways and 
mechanisms underpinning these disorders.  
A study by Grant et al. (2010) used Drosophila a model to functionally characterise 
mutations associated with qless, the Drosophila homologue of the human PDSS gene, 
which is the first gene in the biosynthetic pathway of CoQ10. This gene is responsible 
for the lengthening of the isoprenoid side chain that embeds in the mitochondrial 
membrane. It was identified that qless is essential for neural growth and protects 
Drosophila against mitochondrial dysfunction (Grant et al., 2010) and demonstrates that 
Drosophila can be used as a model to examine the function of genes involved in CoQ 
biosynthesis. It was also determined that dietary supplementation with CoQ10 could 
rescue the neural undergrowth. 
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1.8.1 The UAS-GAL4 System is used for cell and/or tissue-
specific expression of a transgene in Drosophila 
Targeted gene expression enables transgene expression in a cell and/or tissue-specific 
manner during any or all stages of development (Duffy, 2002). Previously used targeted 
gene expression had been limited to heat shock, which required the transgene to be 
under the control of a promoter which was activated once heated to a specific 
temperature (Ashburner & Bonner, 1979). The second method was promoter specific 
and enabled expression in a specific subset of cells in a defined region (Zuker, Mismer, 
Hardy, & Rubin, 1988) however; both options lack the finesse and high specificity 
required for an in-depth understanding of the role and function of a gene of interest. In 





Figure 1.6 Temporal and spatial expression of transgenes using the UAS/GAL4 
system in Drosophila. Virgin female flies (left) harbour a construct containing the 
cell and/or tissue-specific promoter, known as the driver, which is fused upstream of 
the yeast transcription factor GAL4. Virgin female flies are then crossed to males 
(left) which contain the GAL4-dependent upstream activating sequence (UAS) which 
is upstream of the transgene. Progeny from these crosses (bottom) contain the GAL4 
transcription factor and the GAL4-depedent upstream activating sequence. GAL4 is 




The UAS-GAL4 binary system utilises the yeast transcription factor (TF) GAL4 and the 
GAL4-dependent upstream-activating system (UAS), which enables cell and/or tissue-
specific expression of transgenes in Drosophila (Brand, 1993). In one fly line resides a 
tissue-specific promoter fused upstream of the GAL4 transcription factor and is termed 
a “GAL4 driver” (Brand, 1993). In a second fly line, the transgene is found downstream 
of the GAL4-dependent UAS which is inactive in the absence of GAL4. When these fly 
lines are crossed their progeny contain both the promoter-GAL4 and the UAS-transgene 
enabling the binding of GAL4 to UAS and ultimately the expression of the transgene. 
This system allows for targeted gene expression or silencing within Drosophila.  
The advantage of this system is the specificity of transgene expression which, in 
instances when a transgene results in a lethal phenotype this can be avoided by 
restricting expression to a specific cell and/or tissue type to further characterise the 
function and ability of the transgene. With a large number of GAL4 driver’s available, 
transgene expression can occur anywhere in Drosophila. 
1.8.2 GAL4 driver lines 
Five main GAL4 driver lines used in this study were used to drive strong ubiquitous 
expression of the transgene using da-GAL4 (Cronmiller & Cummings, 1993), weaker 
ubiquitous expression using arm-GAL4 (Akiyoshi, Kaneuch, Aigaki, & Suzuki, 2014; 
Peifer, Rauskolb, Williams, Riggleman, & Wieschaus, 1991; Riggleman, Wieschaus, & 
Schedl, 1989), pan-neuronal expression using elav-GAL4 (Campos, Rosen, Robinow, & 
White, 1987), D42-GAL4 was used to drive expression in motor neurons and glass 
multiple reporter (GMR)-GAL4 drives expression in the post-mitotic eye. 
The daughterless (da) gene is ubiquitously expressed in somatic cells during 
embryogenesis (Vaessin, Brand, Jan, & Jan, 1994) and functions as a regulatory 
mechanism in sex determination, neurogenesis and oogenesis (Cronmiller & 
Cummings, 1993). Following germ band retraction, the expression profile of da 
becomes more specific with expression evident in the ventral side of the developing 
ventral cord of the CNS (Vaessin et al., 1994). An increase in da expression can also be 
seen in the salivary glands, gut and muscle until cuticle formation. Expression can also 
be seen in the parasympathetic nervous system (PSNS) and is evident in the imaginal 
discs in a similar intensity to that of the CNS (Vaessin et al., 1994). The da-GAL4 
driver is a driver in which GAL4 has been inserted within the da enhancer and is thus 
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under the control of the regulatory elements that drive expression of da. da-GAL4 will 
be useful in determining the global effect of a transgene in Drosophila. 
Due to the strong expression profile of da, it was decided that armadillo (arm) would be 
used as it is a weaker ubiquitous driver. arm is expressed throughout Drosophila 
embryogenesis (Akiyoshi et al., 2014; Peifer et al., 1991; Riggleman et al., 1989). 
Expression of arm-GAL4 is evident throughout development with highest levels 
occurring during the early to mid-embryogenesis and also during early pupal stages 
(Akiyoshi et al., 2014; Riggleman et al., 1989). arm is uniformly expressed and is also 
one of the more abundant transcripts present in the cell (Riggleman et al., 1989). Due to 
the broad and constant expression of arm-GAL4, it was decided to use it as a weaker 
ubiquitous driver (Rewitz, Yamanaka, & O'Connor, 2010). 
The embryonic lethal abnormal visual system (elav) is located on the X-chromosome in 
Drosophila (Campos et al., 1987) and is expressed during development in the 
embryonic nervous system (Robinow & White, 1988), the salivary glands (Campos et 
al., 1987) and in all post-mitotic neurons (Rewitz et al., 2010).  
The fluorescent reporter Apoliner was used in conjunction with elav-GAL4 to aid in the 
detection of early apoptotic events. Apoliner is a fluorescent reporter that is capable of 
detecting caspase activity which is evident during apoptosis (Bardet et al., 2008). 
Apoliner is a sensor that is composed of two fluorescent proteins, monomeric red 
fluorescent protein (mRFP) and enhanced green fluorescent protein (eGFP), which are 
fused together by a caspase cleavage site (Bardet et al., 2008). The mRFP fluorophore 
contains a transmembrane domain while the eGFP fluorophore contains a nuclear 
targeting signal. Caspases cleave the fluorophores at the caspase-sensitive linker site 
resulting in the fluorophores separating from each other. This results in eGFP 
translocating to the nucleus while mRFP is left at the membranes (Bardet et al., 2008). 
Therefore, upon caspase activation eGFP will be present in the nucleus while mRFP is 
present at the membranes.  
As the human COQ8A mutant phenotype involves motor dysfunction (such as gait 
ataxia), D42-GAL4 was used to drive expression in motor neurons. D42 is expressed in 
the peripheral nervous system (PNS), the ventral nerve cord, the brain, sensory neurons 
and the motor neurons in Drosophila (Pilling, Horiuchi, Lively, & Saxton, 2006; 
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Sanyal, 2009; Schroll et al., 2006; Yeh, Gustafson, & Boulianne, 1995). D42 expression 
is also present in the central brain and ventral ganglia (Parkes et al., 1998). 
The glass multiple reporter (GMR)-GAL4 driver is commonly used to drive expression 
of a transgene in the developing eye (Li, Li, Zheng, Zhang, & Xue, 2012) specifically in 
the post-mitotic cells posterior to the morphogenetic furrow (Freeman, 1996). However, 
it was later identified that the expression of GMR-GAL4 was also present in the 
developing wing, the larval brain, the leg and the trachea (Li et al., 2012). For this 
study, we will be focusing on the expression of transgenes in the developing eye to 
examine any neurological involvement of the transgenes. 
The eyeless (ey) gene plays a vital role in eye development not only in Drosophila but 
throughout the animal kingdom (Hauck, Gehring, & Walldorf, 1999). ey is expressed in 
the developing nervous system and the eye during morphogenesis (Halder, Callaerts, & 
Gehring, 1995). ey is known as a master control gene as it is responsible for the initial 
activation of the eye development pathway (Halder et al., 1995). Initially, ey is 
expressed in the embryonic ventral nerve cord before being expressed in the larval 
developing imaginal discs and eye discs which is anterior to the morphogenetic furrow 
(Halder et al., 1995). Expression of ey mutants can result in a decrease or complete 
absence of the Drosophila compound eye. However even with the loss of the compound 
eye due to ey mutants the simple Drosophila eye is still present (Halder et al., 1995). 
The use of the ey-GAL4 driver line will enable a quantitative measure based on the size 
of the resulting compound eye. ey-GAL4 is expressed earlier in eye development to that 
of GMR-GAL4 and will highlight the importance of the gene function in these earlier 
stages. 
1.8.3 RNAi-mediated knockdown of target gene expression 
RNA interference (RNAi) (Figure 1.7) is a natural defence mechanism that is present in 
all living organisms. This mechanism enables protection from viral infection via the 
introduction of double-stranded RNA (dsRNA). Introduction of long dsRNA into an 
organism results in activation of the endonuclease Dicer which cuts the dsRNA into 
smaller 19-21 nucleotide segments known as small interfering RNA (siRNA). These 
siRNAs are then bound by the RNA-induced silencing complex (RISC) which separates 
the siRNA into two separate single-stranded RNA (ssRNA) molecules with one known 
as the guide strand acting as a template for gene silencing and the other the passenger 
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strand which is degraded. The RISC bound guide strand then forms a complex with 
Argonaute proteins. The Argonaute complex containing the guide strand binds to the 
target messenger RNA (mRNA) and cleaves the mRNA. The target mRNA is then 
degraded preventing expression of the target gene. This process ultimately results in a 
decrease in expression of the target gene (Fire et al., 1998) and aids in characterising the 
function of a gene. The VDRC has developed a library of fly lines harbouring RNAi 
constructs that target most genes in Drosophila. RNAi can be used in conjunction with 






While each RNAi construct was bioinformatically designed to target only one gene, a 
potential limitation is off-target effects which could result in a mutant phenotype that is 
not specific to RNAi silencing of the target gene. When ordering RNAi lines from 
VDRC, it is often beneficial to order two or more RNAi lines targeted to a gene as some 
RNAi lines are less effective or reliable than others (Dietzl et al., 2007). Some fly lines 
may also require RNAi enhancers to increase the expression of an RNAi line. In 
Drosophila, Dicer-2 binds to siRNA to enhance RNAi expression (Dietzl et al., 2007).  
Figure 1.7 RNA interference mechanism. RNAi is a natural mechanism used to silence foreign dsRNA in 
an organism. 1. Long double-stranded RNA (dsRNA), also known as a hairpin, is introduced into the 
target organism/cell. Dicer, an endonuclease protein, binds to the dsRNA and cleaves it into 19-25 
nucleotide segments of small-interfering RNA (siRNA). 2. The multi-protein complex RISC binds to siRNA 
and unwinds the small dsRNA fragments into single-stranded RNA (ssRNA). 3. ssRNA separates into two 
strands known as a guide strand, which binds to RISC and Argonaut, and the passenger stand which is 
degraded. 4. RISC and Argonaut bind to the guide stand. 5. The target mRNA is then cleaved by the RISC 
and Argonaut complex. Degradation of the target mRNA occurs after cleavage resulting in the silencing 
of gene expression. 
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2 Aims of this Thesis 
With the increased number of genetic mutations being identified by whole genome 
and/or exome sequencing, a model system is needed to characterise these mutations 
functionally. Drosophila is a highly functional model organism that can be used to 
study learning and memory, neuronal development and neurodegeneration. The Minds 
for Minds research network in New Zealand (Jacobsen et al., 2017) identified two 
COQ8A SNPs in two human siblings. Compound heterozygous inheritance of COQ8A 
mutations resulted in a heterogeneous disease state that included cerebellar ataxia, 
cerebellar atrophy, and CoQ deficiency.  
This project aimed to characterise the phenotypes resulting from the reduction of coq8 
in Drosophila to develop a model of coq8 deficiency. This model could be used to 
functionally characterise the impact of the mutations on coq8 function. 
I hypothesise knockdown of Drosophila coq8 results in a degenerative phenotype and 
that this degenerative phenotype can be rescued by reintroduction of wild-type coq8, but 
not the two mutants. 
The specific objectives are as follows: 
1. Characterisation of the phenotypes resulting from RNAi knockdown of coq8 in 
Drosophila 
2. Generation and characterisation of flies that overexpress wild-type and mutant 
forms of coq8 
3. Determination of whether wild-type or mutant coq8 can rescue RNAi 
knockdown 
4. Generation and characterisation of flies that overexpress wild-type and mutant 
forms of human COQ8A 





3.1 Maintenance of Drosophila melanogaster strains 
Flies were housed in 30 mL v-bottomed vials (Labserv) or 100 mL glass bottles 
containing eight mL or 40 mL of standard fly food, respectively (per L: cornmeal, yeast, 
sugar, agar, molasses, methyl 4-hydroxybenzoate and ethanol. Flies were raised at 18℃, 
22℃ or 25℃, depending on experimental parameters as described in the results section. 
Flies were kept on a 12-hour light-dark cycle. Flies were anesthetised using CO2 when 
setting crosses or collecting virgin females or FlyNap® (Carolina Biological Supply 
Company) when anaesthesia was required for longer than 2-3 minutes, such as when 
imaging whole flies or fly heads. Drosophila strains used during this study are listed in 
appendix 9.1, 9.2 and 9.3. 
3.2 Genetic Crosses 
Ten males and ten females of each appropriate genotype were placed in bottles and 
allowed to mate for one week before being removed from the bottles. Approximately 12 
days later adult progeny began to emerge. Bottles were cleared in the morning and any 
females that emerged within eight hours were considered virgin as females do not reach 
sexual maturity until at least ten hours post-eclosion. Virgin females were housed in 
vials for five days to verify virginity, as evidenced by the lack of fertilised eggs in the 
vial. Virgin females were then crossed to the appropriate males with the desired 
genotype. For initial characterisation experiments, flies were raised in vials. Rescue 
experiments, where vast quantities of progeny were needed, were carried out in bottles. 
Seven days after crosses were set the adult flies were removed, and the bottles were 
incubated at the appropriate temperatures until most of the adult flies had emerged. 
Progeny were then assessed for fundamental experimental purposes which could have 
included progeny counts, imaging or further analysis. 
3.3 Assessment of larval survival and phenotypes 
Flies of the appropriate genotypes were housed in vials and allowed to mate for seven 
days before they were removed. The fly food containing the larvae was emptied into a 
petri dish and washed in dH2O and larvae were isolated. The number of larvae at each 
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developmental stage (1st 2nd and 3rd instar) were counted. Comparisons were made 
between the coq8 RNAi lines and the control. Representative larvae from each genotype 
were placed at -20℃ until they were incapacitated and then imaged as described in 
section 3.5. 
3.4 Assessment of pupal and adult survival 
Flies of the appropriate genotypes were housed in vials and allowed to mate for seven 
days before they were removed. Progeny counts were carried out once most adults had 
emerged from the control cross. This was approximately 20 days after setting the cross 
but varied depending on incubation temperature and genotype. Flies were anesthetised 
with FlyNap® then the number of adults of each sex were counted. Pupal counts were 
carried out once all adults had been removed from the fly bottles by counting the 
number of empty pupae on the sides of the bottles. 
For crosses that contained a balancer chromosome, pupae were not counted as their 
genotype could not be determined until the adult stage (i.e. whether they contained the 
balancer chromosome or the chromosome carrying the transgene). 
3.5 Imaging of larvae and adult flies 
Flies and larvae were anesthetised using FlyNap® and placed on a piece of white card 
for imaging. The Olympus SZX12 microscope and an Olympus LG-PS2 bifurcated light 
source combined with DP controller imaging software were used to capture images. 
Composite images were then generated in Adobe Photoshop CC 19.0 release and/or 
Affinity Photo version 1.5.1.54. For the detection of fluorophores, the Olympus U-RFL-
T mercury burner was used in conjunction with the microscope described above. 
3.6 Brain dissection 
Brain dissections were carried out on adult flies. Adult flies were anesthetised with CO2 
then placed in PFAT fixative (4% paraformaldehyde, 1X PBS, 0.1% Triton-X and 5% 
DMSO). Adult flies were fixed for 2 hours at room temperature before being washed in 
PBST (1X PBS, 0.5% Triton-X). Flies were then transferred to a petri dish containing 
ice-cold PBST. Using the Olympus VMZ 1X-4X Japan stereoscope and two sharp 
tweezers, heads were detached from bodies and the hard-outer head capsule was 
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removed to isolate the brain. The trachea and air-sacs were then removed from the outer 
surface of the brain. Freshly dissected brains were placed in fresh PBST on ice for up to 
20-30 minutes until dissections were complete. Fly debris was then removed from 
brains by incubating in PBST with 3.7% formaldehyde and heptane by inverting the 
tube ten times. After the brains settled at the bottom of the tube, the upper heptane 
phase was discarded. The brains were then further fixed and cryoprotected in PBST 
with 3.7% formaldehyde and 5% DMSO for 20 minutes. After two 5-minute washes 
with methanol, brains were stored in methanol at -20℃ until processing for 
immunofluorescence. 
3.7 Immunofluorescence 
Brains were rehydrated in 50% methanol and 50% PBST for 5 minutes. They were then 
washed four times with PBST before blocking for 2 hours with immunobuffer (5% 
Normal Goat Serum (NGS) in PBST). The immunobuffer was then removed before the 
addition of primary antibodies (Table 3.1). Antibodies were diluted in immunobuffer, 
added to fly brains and placed on an orbital rocker overnight at room temperature. 
Primary antibody was removed, and brains were washed twice with PBST before three 
longer washes (>20 minutes) in PBST. PBST was removed then brains were incubated 
in the appropriate secondary antibodies (Table 3.2) diluted in immunobuffer, and left 
overnight shaking on an orbital shaker at 4℃. Secondary antibodies were then removed 
and brains washed in PBST before being mounted in Antifade (PBS+ 4% N-propyl 
gallate). For mounting the brains, two coverslips were affixed approximately 5 mm 
apart with nail polish to create a channel for the brains to be placed in which prevented 
the brains from being flattened by the top coverslip. The coverslip edges were sealed 









Table 3.1 List of primary antibodies used for immunohistochemistry on whole mount brains. 
Antigen Clone Class Host Source Dilution 
Nc82 AB_231486
6 
Monoclonal Mouse DSHB 1:50 




c-Myc 9E10 Monoclonal Mouse DSHB 1:50 
Elav 9F8A9 Monoclonal Mouse DSHB 1:100 
Cytochrom
e c 
7H8.2C12 Monoclonal Mouse ThermoFish
er 
1:100 
GFP Ab290 Polyclonal Rabbit Abcam 1:5000 
GFP 12A6 Monoclonal Mouse DSHB 1:50 
COQ8A ab221193 Polyclonal Rabbit Abcam 1:500 
Rpd3 Ab1767 Polyclonal Rabbit Abcam 1:10,000 
 
Table 3.2 Secondary antibodies used for immunohistochemistry on whole mount brains. All secondary 
antibodies were obtained from ThermoFisher Scientific. These secondary antibodies were used to detect 
the primary antibodies from Table 3.1 via fluorescent detection. 
Name Fluorophore Dilution 
Goat anti-mouse IgG AlexaFluor® 488 1:500 
Goat anti-rabbit IgG AlexaFluor® 488 1:500 
Goat anti-mouse IgG AlexaFluor® 555 1:500 
Goat anti-rabbit IgG AlexaFluor® 555 1:500 
Goat anti-mouse IgG AlexaFluor® 647 1:500 
Goat anti-rabbit IgG AlexaFluor® 647 1:500 
 
3.8 Confocal Microscopy 
Confocal microscopy was carried out at the Manawatu Microscopy & Imaging Centre 
(MMIC) at Massey University with a Leica SP5 DM6000B Scanning Confocal 
Microscope. Processing of confocal images was carried out using ImageJ and Adobe 
Photoshop CC 19.0 release editing software. 
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3.9 Scanning Electron Microscopy 
Two days before processing, flies were removed from food containing vials and placed 
in vials containing a Kimwipe soaked with a 1% sucrose solution and left for two days 
to allow them to clean their eyes. After two days flies were anesthetised using FlyNap® 
and placed in fixative (1˚ EMFix, 3% glutaraldehyde, 2% formaldehyde in 0.1M 
phosphate buffer, pH 7.2). Flies were then taken down to MMIC for processing using 
the FEI Quanta 200 Environmental Scanning Electron Microscope. Karnovsky fixative 
(3% glutaraldehyde, 2% formaldehyde in 0.1 M phosphate buffer, pH 7.2 plus Triton X-
100). Flies were fully emerged before being taken down to MMIC for processing. 
Samples were fixed for an additional eight hours at room temperature before being 
washed with phosphate butter (0.1M, pH7.2). Samples were then dehydrated using a 
graded ethanol series (25%, 50%, 75%, 95% and 100%). The Polaron E3000 series II 
critical point drying apparatus was used to dry the samples using liquid CO2. Samples 
were then mounted on to aluminium stubs and coated with gold (Baltec SCD 050 putter 
coater). Samples were then viewed and imaged using the FEI Quanta 200 
Environmental Scanning Electron Microscope at an accelerating voltage of 20 kV. This 
process was carried out by Ms Niki Minards at the Massey Microscopy and Imaging 
Center (MMIC), Institute of Fundamental Sciences, Palmerston North. 
3.10 Preparation of whole cell lysates 
Lysates using adult flies: Flies were anesthetised in FlyNap® and heads removed with 
a razor blade. Heads were placed in an Eppendorf tube that was kept on ice. Twenty 
heads were isolated per genotype and 100 L Radioimmunoprecipitation assay (RIPA) 
buffer (10 mM Tris-Cl - pH 8.0, 1 mM EDTA, 0.5 mM EGTA, 1% Triton X-100, 0.1% 
sodium deoxycholate, 0.1% SDS, 140mM NaCl. Before use, add: 1 mM PMSF) + 1X 
Complete Mini protease inhibitors (Roche) was added to the tube. Heads were 
homogenised for 30-45 seconds using a motorised pestle. The tubes were incubated on 
ice for ten minutes then placed in a 4℃ centrifuge (Heraeus™ Fresco™ 21 
Microcentrifuge) and centrifuged at 13,000g for 5 minutes. The upper aqueous phase 
was transferred to a new pre-chilled Eppendorf tube and centrifuged again at 13,000g 
for 5 minutes at 4℃. The supernatant was then transferred to a new pre-chilled tube and 
stored at -80℃. 
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Lysates using larvae: Instead of using adult flies 3rd-instar larvae were used instead. 
Fifteen to twenty wandering third instar larvae were collected from the walls of the vials 
and placed in an Eppendorf tube that was kept on ice. The remaining steps were the 
same as previously described for adult flies. 
3.11 BCA Assay 
Cell lysates were removed from -80℃ and allowed to thaw in an ice bucket. The 
colourimetric protein quantitation assay (Pierce™ BCA Protein Assay Kit, Thermo 
Scientific™) was used as per manufacturer’s instructions. Samples were diluted 1:100 
in RIPA buffer and pipetted into a transparent 96 well plate (Greiner Bio-One 
CELLSTAR® 96 well transparent polystyrene plates) alongside the standards. 
Following a 30 minute incubation, the plate was read on a plate reader (BioTek 




3.12 Negative Geotaxis assay 
The Negative Geotaxis assay described by Barone and Bohmann (2013) was used to 
assess locomotor abnormalities in Drosophila. Thirty female flies from each genotype 
were anesthetised and placed in flat bottom vials without food so they were able to 
climb without the distraction of food or other stimuli that may affect their ability to 
climb. The vial was gently banged against a hard surface which resulted in the flies 
moving to the bottom of the vial, and then the number of flies that climbed above 5cm 
in 10 seconds were counted. These parameters were used as preliminary experiments 
carried out to evaluate the assay indicated that most control flies climbed above 5cm in 
10 seconds. The assay was repeated ten times on each vial of flies. As flies of some 
genotypes showed poor climbing ability and appeared to display a startle response at the 
beginning of the assay when they were banged to the bottom of the vial, and flies were 




3.13 Quantification of DNA and RNA 
The DeNovix DS-11 Spectrophotometer was used to measure concentrations of either 
DNA or RNA. Samples were purified, and 1 µL of sample was used for measuring the 
concentration. The arm was wiped with a damp Kimwipe to clear it of previous 
contaminants. 1 µL of the appropriate blank was used before measuring samples. A 
damp Kimwipe was used between each measurement. 1 µL of sample was placed on the 
arm and absorbance was measured at 260 and 280 nm. The concentration of DNA or 
RNA was calculated from the absorbance at 260 nm. The purity of the DNA was 
assessed via the 260/280 nm ratio. A ratio of >1.8 and >2.0 indicated pure DNA and 
RNA, respectively. 
3.14 Preparation of plasmid DNA 
3.14.1 Transformation 
DNA received from GenetiVision was initially centrifuged at 6,000g for 1 minute at 
4℃ to ensure all DNA was at the bottom of the tube. Distilled H2O was then added to 
the DNA and vortexed for 1 minute to resuspend. The tube was then placed in a heat 
block (Thermolyne DB28125 Dri-Bath, Marshall Scientific) at 50℃ for 15 minutes to 
dissolve the DNA. 
Competent cells (DH5α) were removed from -80℃ and placed in an ice box to thaw. 
Once thawed 40 µL of competent cells were placed in a new Eppendorf tube, and 2 µL 
of plasmid DNA was added to it. Tubes were then incubated for 30 minutes on ice then 
heat shocked in a 42℃ water bath for 30-45 seconds. Tubes were then placed back on 
ice for 2 minutes before 500 µL of Luria-Bertani (LB) media (For 1 L of LB: 500 mL 
dH2O, 10 g Bacto-tryptone, 5 g yeast extract, 10 g NaCl, adjust pH to 7.5 with NaOH, 
add dH2O to make it up to 1 L) was added and then they were incubated at 37℃ for 45 
minutes. 100 µL of the cell culture was added to the appropriately labelled LB-agar 
plate supplemented with ampicillin (amp concentration: 100 µg/mL). The remaining 
culture was spun down and the supernatant removed. The pellet was then resuspended 




3.14.2 Large-scale preparation of plasmid DNA 
A total of 5 mL of LB-media containing ampicillin (100 µg/mL) was placed in a 15 mL 
tube. A single colony was selected from the ampicillin plates and placed in the LB-amp 
media. Tubes were placed at 37℃ to allow growth. Once adequate growth had occurred 
1 mL of the cell culture was added to a flask (200 µL ampicillin:100 mL LB-media). 
Flasks were then placed on an orbital shaker at 220- 225 rpm at 37℃ overnight. The 
PureLink HiPure Plasmid Filter Purification kit (Invitrogen) was used for midi 
preparation of plasmid DNA and was used as per the manufacturer’s instructions. 
3.14.3 Small-scale preparation of plasmid DNA 
LB-media containing ampicillin (100 µg/mL) was placed in 15mL tubes. A single 
colony was selected and placed in the media. Tubes were placed on an orbital shaker at 
220 - 225 rpm at 37℃ overnight. The DNA-spin Plasmid Purification Kit (iNtRON) 
was used for mini preparation of plasmid DNA and was used as per manufacturer’s 
instructions. 
3.15 DNA precipitation 
DNA precipitation was carried out using 1 volume of DNA; 1/10 volume to 3M sodium 
acetate; the 2 volumes (DNA volume + 1/10 volume sodium acetate) of 100% absolute 
Ethanol. DNA was spun at 13,000g for 10 minutes at 4℃. The supernatant was 
removed, and the pellet was washed with 70% ethanol. The DNA was spun again at 
13,000g for 5 minutes at 4℃. The pellet was then air dried and resuspended in Tris-
EDTA (TE) buffer. 
3.16 DNA sub-cloning of coq8-myc 
3.16.1 pUASTattB vector 
The pUASTattB vector is often used for expression of transgenes in Drosophila. The 
pUASTattB vector contains the GAL4-dependent UAS which is crucial for expression 
of Drosophila transgenes. The coq8-myc construct arrived in the pUC57 vector and 




The pUASTattB vector was digested with XhoI and XbaI, so the plasmid was open and 
ready for ligation with the insert. The coq8-myc containing pUC57 was digested with 
XhoI and XbaI to release the coq8-myc insert from pCU57 for further ligation (methods 
3.16.5). 
3.16.2 Restriction Digest 
Restriction digests were carried out using plasmid DNA (appendix 9.8) and the 
appropriate restriction enzymes (appendix 9.4). For preparative digests required for 
DNA subcloning, the following reaction mixes (table 3.3) were prepared. 
 
Table 3.3 Restriction digest reaction recipe. 
Component Volume 40 µL total 
DNA 5 µg x µL 
Restriction enzyme (each) 0.5 µL 
10X Buffer 4 µL 
Water Make up to 40 µL 
 
 
For analytical restriction digests, a total volume of 10 µL was used. Up to 1 µg of DNA 
was used for each reaction which also contained 1X buffer, 0.5 µL enzyme and dH2O 
up to 10 µL. 
Samples were placed in at either 21℃ or 37℃ for 2 hours depending on the activation 
temperatures of the restriction enzyme. A 1% agarose gel containing 0.5 µg/µL 
ethidium bromide (to visualise DNA bands) in 1X TAE was poured into the gel dock. 
The appropriate comb was selected, and the gel was poured to the desired thickness. 
The gel was left to set for 30 minutes. Samples were then removed from the water bath, 
and the appropriate amount of 1X loading dye was added to each tube. Samples were 
left on ice until needed. 
3.16.3 Running an agarose gel.  
A 1% agarose gel was made with TAE and ethidium bromide. Once set was placed into 
the Mini-Sub® Cell GT Horizontal Electrophoresis System (Bio-RAD) and 1X TAE 
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containing 3 µg of ethidium bromide (EtBr), was added to the tank until the gel was just 
submerged. Samples were loaded in the appropriate lane and were run alongside the 1kb 
plus DNA ladder (Invitrogen). The gel was run at 100V using a PowerPac™ Basic 
Power Supply (BIO-RAD) until the dye front was two-thirds of the way down the gel 
(>45 minutes). If the gel was to be imaged, it was imaged on the Gel Doc™ XR+ Gel 
Documentation system. 
3.16.4 Gel purification 
Once bands had separated enough on the gel, it was placed on a UV block and bands 
removed for each appropriate construct using a sterile steel surgical blade (Swann-
Morton). The gel slices were placed in new Eppendorf tubes, and the PureLinkTM Quick 
Gel extraction kit (Life Technologies) was used as per manufacturer’s instructions to 
purify vector and insert DNA. The purified DNA was then run on a new 1% gel and the 
concentrations assessed based on the gel. Once concentrations were verified ligation 
mixtures were set up. 
3.16.5 DNA Ligation 
After purifying the plasmid DNA, ligation mixtures were set up as described in Table 
3.4. Ligation mixtures contained 100ng of vector DNA was used with a 5:1 vector to 
insert ratio which included 10X T4 DNA ligase reaction buffer and T4 DNA ligase 
(New England BioLabs). Ligation mixtures were placed at 18℃ overnight and 
transformed the next day. 
 
Table 3.4 Ligation mixtures. 
Ligation 
mixture 
pUAST 1 Ligase Buffer coq8-insert 
A 0.5 µL 1 µL 1 µL 7.5 µL 
C 0.1 µL 1 µL 1 µL 7.9 µL 
     
Ligation 
mixture 
pUAST 2 Ligase Buffer coq8-insert 
B 0.5 µL 1 µL 1 µL 7.5 µL 





3.16.6 Cloning restriction digest 
Colonies that had grown on LB-ampicillin plates from the ligation mixtures were 
isolated and transformed (methods 3.14.1), and a mini preparation (section 3.14.3) was 
carried out to determine whether cloning was successful. Each colony was placed in a 
separate tube, and transformation protocols followed (methods 3.14.1). DNA was 
purified and measured using Nanodrop (methods 3.13). Restriction digests (methods 
3.16.2) were set up for each colony and were cut with XhoI and XbaI to determine 
whether both the coq8-myc insert and the pUASTattB were present in the clones. The 
presence of bands at the appropriate size would result in successful cloning. 
3.16.7 DNA Sequencing 
The pUASTattB/coq8-myc plasmid was sequenced to confirm that there were no errors 
in the sequence. The primers are described in (Table 3.5). Sequencing was performed by 
the Massey Genome Service (Institute of Fundamental Sciences, Massey University). 
 
Table 3.5 Primer sequences used for sequencing reactions. 
Oligo Name Primer Sequence (5’-3’) Tm◦ Source 
coq8-For TCTACCGCCACGAGTTCATC 65.2 Sigma 
coq8--Rev ACTCCCTGGCGATTGTTCTC 65.4 Sigma 
 
 
3.17 Generation of transgenic flies 
3.17.1 Preparation of plasmid DNA 
Plasmid DNA was precipitated as previously described (methods 3.15). Plasmid DNA 
was resuspended in 50 µL of injection buffer (50 mM KCl, 0.1 mM sodium phosphate 
buffer, pH 6.8,) and stored at -20℃ until needed. 
3.17.2 Egg harvesting 
Two days before microinjection, three bottles of flies containing the VK37 C31 landing 
site (Table 9.1) were transferred into three small plastic beakers. Each fly containing 
beaker was then placed onto polystyrene Petri dishes (Fisher Scientific) (referred to as 
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egg plates) containing standard fly food with yeast paste spread on top to increase 
laying efficiency and housed at 25℃. The day of microinjection females were 
transferred to new egg plates for an hour enabling females to release any old eggs they 
may be harbouring. During this time a large glass Petri containing silicon beads was 
placed in a 200℃ oven. The silicon plate was used to dehydrate the embryos before 
injection. Once the hour had elapsed, the silicon beads were removed from the oven and 
the lid placed on top. The egg plates were replaced and left for 20-30 minutes. After this 
time, eggs were collected with a fine paintbrush and brushed onto a slide containing a 
strip of double-sided tape to hold the eggs in place. Once eggs were secured, two blunt 
tweezers were used to dechorionate the embryos. Tweezers were used to gently pierce 
the chorion and then the embryo was gently removed from the casing and placed on a 
separate piece of double-sided tape affixed to a microscope slide with the posterior end 
oriented to the right edge of the tape. Dechorionation continued for 5-10 minutes before 
the slide was placed on the silicon beads for 5-7 minutes to dehydrate the embryos so 
they would not burst during microinjection. The embryos were then covered in 
halocarbon oil 700 (Sigma-Aldrich) to prevent further dehydration and reduce 
cytoplasmic leakage once injected. 
3.17.3 Microinjection 
A very sharp microfilament (A-M Systems), which was pulled by a laser-based 
micropipette puller (P-2000, Sutter Instrument®) was used to inject plasmid DNA into 
the posterior end of the embryo. 2 µL of coq8-myc DNA was loaded into the very tip of 
the microfilament using a 20 µL Eppendorf MicroloaderTM tip. The microfilament was 
then placed into a micro-manipulator (Leica) and lowered into the slide containing the 
dechorionated embryos and submerged into the halocarbon oil. Microinjections were 
carried out on the Olympus CKZ inverted compound microscope which was attached to 
the Femto jet express Eppendorf microinjector which utilised pressurised nitrogen gas. 
A tiny amount of DNA was injected into the embryos. Once a sufficient number of 
embryos had been injected the slides were placed in a humidity chamber (QNA 
international MIC-101) with approximately 2 atmospheres of oxygen added to the 
vessel and the vessel was placed at 18℃ overnight. The next day more oxygen was 
added to the vessel, and it was placed at 21℃ overnight. 
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3.17.4 Larval collections 
On the third day after injections, any larvae that were alive and had developed to the 
first instar larval stage were collected and placed on a small piece of Kimwipe 
(Kimberly-Clarke Kimwipe). Once there were 10-20 larvae on a piece of Kimwipe, it 
was placed in a 30 mL vial containing standard fly food. The Kimwipe was moistened, 
so it was in contact with the fly food enabling larvae to move and eat. Vials were 
labelled and placed at 25℃ until adults emerged. It was important that the Kimwipe was 
moistened each day to prevent larvae from drying out. 
3.17.5 Establishing a transgenic fly line 
Flies that emerged following microinjection (G0), all had white eyes and were crossed 
to CyO virgin females or males which contained the curly balancer chromosome on the 
second chromosome. Progeny produced from these crosses were either white eyed or 
orange eyed. Those that were curly winged and orange eyed (G1) contained the coq8-
myc construct and the balancer chromosome which prevented recombination in females. 
Males and females were crossed together to produce homozygous progeny. Males and 
virgin females that had wild-type wings and orange eyes (G2) were selfed to generate a 
stable homozygous line. 
3.18 ATP Assay 
The ATP assay was carried out using the ATP Bioluminescence Assay Kit CLS II 
(Sigma-Aldrich) as per manufacturer’s instructions. 
3.19 Statistical analysis 
Experiments were carried out in triplicate to determine statistical significance for 
progeny counts. The data was then subjected to a one-way ANOVA test followed by 
post hoc analysis using the Tukey HSD test with a significance level of p<0.05. Means 
+/- standard errors were then graphed and significance levels indicated as either * = 
p<0.05 or ** = p<0.01. 
Negative geotaxis assays were carried out on 30 females flies per genotype and trials 
were repeated ten times per genotype. The number of flies that passed the 5cm mark 
were divided by the total number of flies in the vial (n=30). A one-way ANOVA was 
carried out on the data followed by post hoc analysis using the Tukey HSD test. Means 
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+/- standard error were then graphed, and significance levels indicated as either * = 
p<0.05 or ** = p<0.01. 
3.20 Mitochondrial Targeting Sequence software 
The amino acid sequence was run through each program to determine the presence of a 
MTS on Drosophila coq8. 
 
Table 3.6 Software used to determine the presence of a mitochondrial targeting sequence. 
Website Name Description Website address 







TargetP 1.1 Server Predicts the subcellular 




TPpred 2.0 Prediction of cleavage 





iPSORT Subcellular localisation 
sire predictor for N-







In humans, ARCA2 is homozygous recessive, and thus usually occurs via compound 
heterozygous inheritance in which both parents carry a single pathogenic mutation but 
present no symptoms. As an additional diagnostic approach whole genome and whole 
exome sequencing are often implemented clinically to determine the genetic mutations 
associated with the phenotype. What is not clear is whether the identified genetic 
mutations are responsible for the phenotype. Functional characterisation aids in our 
understanding of how the gene works and what mutant phenotypes these mutations 
induce. Drosophila, with its set of genetic tools for gene manipulation, provide the 
means to functionally characterise COQ8A mutations in a rapid and inexpensive 
manner. The initial objective of this project was to knock down the Drosophila 
homologue of human COQ8A via the UAS/GAL4 system and characterise the resulting 
phenotypes.  
The UAS/GAL4 system is a powerful binary system used in Drosophila to turn genes 
on or off in a cell and/or tissue specific manner. GAL4 is not endogenously expressed in 
Drosophila providing a highly specific system that functions with high fidelity. 
Targeting gene expression in this way allows for in-depth investigations into cellular 
and molecular function in individual subsets of cells and/or tissues. 
Mutations in coq8, the Drosophila homologue of COQ8A and COQ8B, are 
homozygous lethal. Therefore we expected that a robust RNAi-mediated knockdown of 
coq8 should also be lethal. To that end, the da-GAL4 driver was selected. da is 
expressed ubiquitously throughout Drosophila during most stages of development 
(Vaessin et al., 1994), thus when placed under control of the da promoter, GAL4 drives 
a high level of ubiquitous expression. A second ubiquitous driver, arm-GAL4 was also 
selected. arm is ubiquitously expressed through most stages of development but at a 
weaker level than da (Rewitz et al., 2010). The rationale for using arm-GAL4 was to 
confirm the results obtained with da-GAL4. If a lower level of knockdown of coq8 
allowed survival to a later developmental stage, these larval and/or adults could be 
phenotypically characterised. As the clinical presentations seen in those individuals 
affected with COQ8A mutations included neuronal phenotypes together with cerebellar 
atrophy and motor dysfunction, it was also desirable to select a brain-specific driver to 
characterise the neuronal phenotypes resulting from knockdown of coq8. elav is 
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essential for development in the embryonic nervous system (Robinow & White, 1988), 
and is expressed in all post-mitotic neurons of the CNS and the PNS as well as in post-
mitotic neurons (Jiménez & Campos-ortega, 1987; Rewitz et al., 2010). Following 
selection of these drivers, the first task was to confirm the expression patterns 
associated with each of the core driver lines used in this project by examining the 
expression of GFP. CD8::GFP is a plasma membrane-targeted GFP which is ideal for 
visualisation of neuronal processes.  
4.1 Characterisation of the expression pattern associated 
with the three main GAL4 driver lines 
The use of these three driver lines will provide a profile of the function of coq8 in 
Drosophila. Five virgin females from each driver line were crossed to five UAS-CD8-
GFP males (methods 3.2). The UAS-CD8-GFP flies enabled visualisation of the 
expression patterns associated with each driver line utilising GFP for visualisation. 
Representatives were selected for each larval stage and then placed at -20℃ until they 
were incapacitated. The remaining larvae were left in the vial until pupation and finally 
eclosion which was when they emerged as adult flies. Larvae and adult flies were 
imaged (methods 3.5). Adult fly brains were then dissected (methods 3.6) and imaged 
via confocal microscopy (methods 3.8). 
When driven by da-GAL4, ubiquitous expression of GFP was observed throughout all 
stages of larval development, pupation and adulthood (Figure 4.1). Please note that the 
visualisation of GFP is partially occluded in adult flies due to the head and body casing. 
Expression in the brain was concentrated in the mushroom body lobes (Anterior) and 
the calyx (Posterior). The mushroom body is essential for memory and learning 
(McGuire et al., 2001) while the calyx provides sensory input into the mushroom body 
(Heisenberg, 1998). Overall, the expression is strong. This is consistent with previous 





arm-GAL4 is lethal when homozygous, so it is maintained as a heterozygous stock over 
a balancer chromosome. The balancer chromosome contains multiple inversions which 
prevent crossing-over and recombination. Balancer chromosomes have many different 
phenotypes that are chromosome dependent which makes it effortlessly distinguishable 
from other phenotypes enabling easy detection of flies that contain the transgene and 
flies that do not. Balancer chromosomes also prevents a homozygous recessive lethal 
stock from losing the recessive phenotype. Balancer chromosomes are a unique and 
significant part of Drosophila functional studies. 
Figure 4.1. Expression patterns for the ubiquitous driver da-GAL4. Expression is 
highlighted during all stages of development from larvae to adult and throughout 
the brain. MB = mushroom body, C = Calyx, KC = Kenyon cells. 
Genotype shown was UAS-CD8::GFP/da-GAL4. 
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arm-GAL4 was used in conjunction with the TM3 balancer which results in stubbled 
(Sb) bristles and serrate wings which have a nick taken out of them. Any progeny that 
contain stubble does not contain the transgene and acts as a negative control for the 
experiment. A crossing scheme (Figure 4.3) was constructed to indicate the 
inheritability of the transgene when using the arm-GAL4 driver line. arm-GAL4 drove 
a similar expression pattern (Figure 4.2) to that seen in da-GAL4 (Figure 4.1) with GFP 
expressed ubiquitously throughout the body and during all stages of development. 




Figure 4.2 Expression patterns for the weak ubiquitous driver arm-GAL4. 
Indicating ubiquitous expression during all stages of development but weaker than 





Mutations in human COQ8A result in various neurological phenotypes including 
cerebellar degeneration and ataxia. The elav-GAL4 driver was used to knockdown coq8 
in all neurons to characterise the impact reduced coq8 expression has on neuronal 
development and function in Drosophila. Expression of CD8::GFP driven by elav-
GAL4 (Figure 4.4) indicates a more specific expression pattern. When compared to the 
ubiquitous da-GAL4 (Figure 4.1) and arm-GAL4 (Figure 4.2), elav-GAL4-driven GFP 
is expressed at a higher level in the larval brain (Figure 4.4, circles). In the adult brain 
(Figure 4.4, anterior-posterior), expression is also higher in the mushroom body 
(anterior) and the calyx (posterior). It is also worth noting that expression is seen in the 
salivary glands in larvae (outside the circles) which was previously described (Campos 
et al., 1987). 
 
 
Figure 4.3 Crossing scheme using the weak ubiquitous driver arm-GAL4. arm-GAL4 is maintained as a 
heterozygous stock over the TM3 balancer chromosome which results in a distinctive mutant phenotype 
resulting it stubbled adult progeny. Virgin females containing the arm-GAL4 driver line maintained over 
the TM3 balancer chromosome were crossed to adult males containing the UAS-CD8::GFP. Progeny 
that resulted from the cross resulted in males and females that contained UAS-CD8::GFP and arm-GAL4 
which results in expression of the transgene. Males and females were also produced that contained UAS-
CD8::GFP and the TM3 balancer chromosome. In the absence of arm-GAL4 there is no expression of the 






Expression profiles highlighted the specificity of each driver line used in this project. 
da-GAL4 (Figure 4.1) and arm-GAL4 (Figure 4.2) can be used to characterise the 
overall function of coq8 in Drosophila. Due to the clinical presentation in humans with 
COQ8A mutations the elav-GAL4 driver (Figure 4.4) will enable characterisation of the 
impact coq8 has on the neurons and more specifically the brain. By expressing coq8 in 
the brain alone, we can further characterise the function and expression patterns of 
coq8. 
Figure 4.4. Expression patterns using the pan-neuronal driver elav-GAL4. 
Expression patterns of the highly specific pan-neuronal elav-GAL4 driver using 
CD8-GFP. Genotype was UAS-CD8::GFP/elav-GAL4 
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4.2 Characterisation of the phenotypes resulting from 
RNAi knockdown of coq8 in Drosophila 
After characterising expression of the driver lines (section 4.1) the impact of ubiquitous 
knockdown of coq8 was examined. In Drosophila, gene-specific knockdown is 
achieved via the expression of an inverted repeat RNAi that is fused downstream of a 
UAS. A library of UAS-RNAi lines targeting most genes in the Drosophila genome has 
been generated by the VDRC. The RNAi library was bioinformatically designed by 
using Drosophila genome sequences that utilised explicitly targeted inverted repeats to 
known protein-coding genes (Dietzl et al., 2007). In doing so, the off-target effects were 
minimised. However, it has been previously mentioned that not all RNAi lines are 
equally efficacious in knocking down gene expression (Dietzl et al., 2007) and, for that 
reason, more than one RNAi line has been developed for a single gene, including coq8. 
Two UAS-RNAi fly lines (termed coq8 KD and coq8 KD2), each targeting a different 
sequence within coq8, were ordered from the VDRC. 
4.2.1 Assessment of survival following da-GAL4-mediated 
knockdown of coq8 
Ten da-GAL4 virgin females were crossed to either ten control, coq8 KD or coq8 KD2 
and placed at 21℃ (methods 3.2). Progeny counts were carried out 20 days post cross 
and were carried out as previously described (methods 3.2). Pupae, males and females 
(Figure 4.5) indicated a significant decrease in coq8 KD when compared to control 
(ANOVA, post hoc Tukey HSD Test, p<0.01 pupae, males and females) and a 
significant decrease in coq8 KD when compared to coq8 KD2 (ANOVA, post hoc 
Tukey HSD Test, p<0.01 for pupae, males and females). These results suggest that 
larval lethality was observed in coq8 KD progeny. A significant decrease was also seen 
between control and coq8 KD2 adult males (ANOVA, post hoc Tukey HSD Test, 
p<0.01). 
These data suggest that the decrease in the number of adult males is due to the absence 
of coq8 in both coq8 KD and coq8 KD2. It also suggests that coq8 KD is more effective 
at knocking down coq8 than coq8 KD2. The knockdown of coq8 had a more significant 
effect on survival in coq8 KD flies when compared to both control and coq8 KD2. The 
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difference in the number of adult females and the number of pupae between control and 
coq8 KD2 was not significant suggesting that coq8 KD2 may not be as capable of 
knocking down coq8 as coq8 KD. However, further investigations were needed to 
support this idea. 
Progeny counts (Figure 4.5) indicated that coq8 KD had an adverse effect on survival in 
Drosophila. To further characterise those observations larval counts were carried out 
seven days post cross to assess development and survivability. Five da-GAL4 virgin 
females were crossed to either five control, coq8 KD or coq8 KD2 males and left for 
seven days. Adults were removed, and the contents of each vial examined (methods 
3.3). Initial observations indicated a severe developmental delay in coq8 KD flies but 
not in control or coq8 KD2 (Figure 4.6) suggesting that the loss of coq8 was responsible 







Figure 4.5 Progeny counts for the characterisation of coq8 knockdown 
using the ubiquitous driver da-GAL4. Flies were raised at 21℃ and 
supplemented with normal fly food. Males, females and pupa were counted 
20 days post cross. Genotypes shown are w1118/+;daGAL4/+ (control); 
w1118/+;da-GAL4/coq8KD and w1118/+;da-GAL4/coq8KD2. Means +/- 
standard error. ANOVA, post hoc Tukey HSD Test. Statistical significance * 




To quantify these observations larvae were counted (methods 3.3) and compared 
(methods 3.5). Counts for first instar larvae were similar across all three crosses (Table 
4.1). Differences were seen for the 2nd and 3rd instar larvae with coq8 KD larvae 
showing severe developmental delay when compared to control and coq8 KD2. Again, 
this suggested that a more severe phenotype was seen in coq8 KD progeny versus coq8 
KD2 progeny. 
 
Table 4.1 Larval counts from the ubiquitous knockdown of coq8 in Drosophila. 
 
Control and coq8 KD2 larvae showed similar larval numbers across all larval stages 
with slightly less 1st instar larvae present in coq8 KD2. The results obtained with coq8 
KD are consistent with the lethal phenotype expected from the loss of coq8 expression. 
The lack of phenotype from coq8 KD2 indicated that it is not effective at knocking 
down coq8. Therefore it was decided only to use coq8 KD. Reintroduction of wild-type 
Larval Stages Control coq8 KD coq8 KD2 
1st 31 20 14 
2nd 24 3 27 
3rd 19 0 14 
Figure 4.6 Larval phenotype from the ubiquitous knockdown of coq8. Images were 
taken 7 days post egg laying. Severe developmental delay was seen in coq8 KD larvae 
but not in coq8 KD2 larvae. Genotypes shown are w1118/+;daGAL4/+ (control); 
w1118/+;da-GAL4/coq8KD (coq8 KD) and w1118/+;da-GAL4/coq8KD2 (coq8 KD2). 
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partially rescued the knockdown phenotype confirming the specificity of the RNAi for 
the target mRNA (section 4.4.3). 
4.2.2 Assessment of survival following arm-GAL4-mediated 
knockdown of coq8 
Due to the larval lethality and severe developmental delay seen with the use of the 
strong ubiquitous driver, da-GAL4 (section 4.2.1), we decided to use the weaker 
ubiquitous driver arm-GAL4. 
A similar crossing scheme to that used for the da-GAL4 experiments was implemented. 
Adult progeny of each genotype were counted 27 days post cross (methods 3.2), at 
which time all viable adults had emerged. Larval phenotypes could not be assessed 
because the stubble phenotype is only evident in adults. Therefore larvae cannot be 
correctly identified as to whether they contain the chromosome harbouring coq8 KD or 
the balancer chromosome (in which case no knockdown can occur). In the control cross, 
approximately equal numbers of males and females with and without stubble phenotype 
emerged, as expected (Figure 4.7). This indicates that the presence of the arm-GAL4 
driver (in the absence of coq8 KD) does not affect viability. However, no non-stubble 
adults emerged from the coq8 KD cross. Therefore, an expression of coq8 KD was 
100% lethal. There were significantly less coq8 KD progeny when compared to the 
control (ANOVA, post hoc Tukey HSD Test, p<0.05) and arm-GAL4 progeny (in the 
















Figure 4.7 Progeny counts for the characterisation of coq8 knockdown 
using the ubiquitous driver arm-GAL4. Flies were raised at 21℃ and 
supplemented with normal fly food. Males and females were counted 27 days 
post cross. Genotypes shown are w1118/+;arm-GAL4/+ (control); and 
w1118/+;coq8KD/+; arm-GAL4/+ (coq8 KD). Means +/- standard error, 




4.2.3 Assessment of phenotypes following elav-GAL4-
mediated knockdown of coq8 
Due to the lethality associated with the ubiquitous knockdown on coq8 in Drosophila 
and therefore the inability to produce viable progeny for behavioural analysis it was 
necessary to isolate the knockdown of coq8 to the neurons. The pan-neuronal driver, 
elav-GAL4, was used to assess the neurological impact of coq8 knockdown in 
Drosophila. 
4.2.3.1 Analysis of the impact pan-neuronal knockdown of 
coq8 had on survival 
Ten elav-GAL4 virgin females were crossed to ten males from either control or coq8 
KD genotypes (methods 3.2). Progeny was counted 24 days post cross (methods 3.4). 
There was no statistical significance for pupal or female progeny counts (Figure 4.8) 
between control and coq8 KD flies. However, male progeny counts showed a 
significant decrease in the number of coq8 KD males when compared to control males 
(ANOVA, post hoc Tukey HSD Test, p<0.01).  
These results suggest that the absence of coq8 in the neurons of Drosophila resulted in 
male lethality but had no effect on female survival or overall pupal production. This 

















Figure 4.8 Progeny counts for the knockdown of coq8 in Drosophila 
using the pan neuronal driver elav-GAL4. Flies were raised at 21℃ 
and supplemented with normal fly food. Progeny were counted 24 
days post cross. Genotypes shown are w1118/+;elav-GAL4/+ (control) 
and w1118/+;elav-GAL4/coq8KD. Means +/- standard error, ANOVA, 
post hoc Tukey HSD Test. Statistical significance * = p<0.05 and ** 
= p<0.01. Crosses were carried out in triplicate. 
49 
 
4.2.3.2 Characterisation of the expression patterns 
associated with the pan-neuronal knockdown of 
coq8 
Mutations in human COQ8A result in various neurological phenotypes including 
cerebellar degeneration and ataxia. To characterise the impact of reduced coq8 
expression has on neuronal development and function in Drosophila, the elav-GAL4 
driver was used to knockdown coq8 in all neurons. elav-GAL4 females were crossed to 
either control or coq8 KD male flies (methods 3.2). Flies were raised at 21℃ in vials. 
Once adults emerged, brains were dissected (methods 3.6) and subjected to 
immunohistological analyses (methods 3.7 and 3.8).  
Initial immunofluorescence was carried out using the anti-nc82 antibody to mark and 
highlight the gross structure of the brain and an anti-caspase, Dcp-1, antibody that 
detects the early markers of caspase activity in Drosophila (Foo, Song, & Cohen, 2017). 
Nc82 is a marker of presynaptic active zones in the brain (Wagh et al., 2006). Anti-nc82 
binds Bruchpilot, a marker of active zones and thus highlights the neuropil, the 
synaptically dense region of the brain to allow an assessment of overall brain 
architecture.  
There were no anatomical differences seen between coq8 KD and the control as 
observed by anti-nc82 immunofluorescence (Figure 4.9). 1 µm sections were taken via 
confocal microscopy and showed no apparent vacuoles or anomalies in the structure of 
the brain (cross-section). The anti-caspase antibody showed no specific staining so gave 
no indication of apoptosis or caspase activity in the brain. The use of Apoliner 








Figure 4.9 Analysis of the gross structure of the Drosophila brain and the impact coq8 KD has 
on apoptosis. The gross structure of the Drosophila brain was highlighted using the α-nc82 
antibody to stain the neuropil. In order to assess caspase activity, the Dcp1 antibody was used. 





4.2.3.3 Analysis of the impact the loss of coq8 had on 
apoptosis in the Drosophila brain  
Apoliner is a fluorescent reporter that can detect early caspase activity. Apoliner is 
composed of two fluorescent reporters, enhanced green fluorescent protein (eGFP) and 
monomeric red fluorescent protein (mRPF) which are tethered to each other by a 
caspase sensitive cleavage site (Bardet et al., 2008). mRPF contains a transmembrane 
domain while eGFP contains a nuclear targeting signal. Upon caspase activation, the 
caspase-sensitive cleavage site is cleaved, and eGFP translocates into the nucleus while 
mRPF maintains at the membranes. (Bardet et al., 2008). A new fly line was generated 
that contained both elav-GAL4 and Apoliner. Elav-GAL4 female virgin flies were 
crossed to Apoliner males to create a homozygous stock for this assay (methods 9.5). 
The resulting elav-GAL4;Apoliner virgin females were crossed to the control and coq8 
KD males (methods 3.2), and brains of the resulting progeny were analysed via confocal 
microscopy (methods 3.6 and 3.8). No differences in nuclear GFP localisation was 
observed between control and coq8 knockdown brains (Figure 4.10). Zooming in on the 
glomeruli, which are involved in olfactory learning (Semmelhack & Wang, 2009), 
showed that there was no detectable apoptosis present in the brain (Figure 4.10). This 
was the second mechanism used to assess the presence of apoptosis in the brain and the 





4.2.3.4 Negative Geotaxis assay to assess locomotor ability 
in flies lacking coq8 
Viable coq8 KD progeny were produced when expressed using the pan-neuronal driver, 
elav-GAL4. Viable progeny enabled further analysis to be carried out on coq8 KD adult 
flies. Locomotor ability is often reduced in people afflicted with COQ8A mutations, so 
the progeny produced from elav-GAL4 crosses were used to characterise this mutant 
phenotype in Drosophila. 
Pan-neuronal knockdown of coq8 was semi-lethal in Drosophila (section 4.2.3) which 
enabled the survival of female progeny, but lethality was present in coq8 KD males. 
Female survivors displayed locomotor impairment which was characterised by a 
delayed ability or inability to climb. To further characterise this, negative geotaxis 
assays were carried out. Negative geotaxis assays utilised the flies natural ability to 
climb once startled. A standard distance was determined by the capacity of most control 
Figure 4.10 Analysis of apoptosis using Apoliner and elav-GAL4. In the absence of coq8, brains 
show no increase in apoptosis in the brain. Indicating that in the absence of coq8 there is no 
change in apoptotic activity. Genotypes shown are w1118/elav-GAL4; (control) and w1118/elav-
GAL4;coq8 KD/Apoliner; (coq8 KD). 
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flies to climb up the sides of the test vial. This distance was 5cm in 10 seconds. Due to 
the locomotor impairment seen in the coq8 KD flies, flies were assessed again at 30 
seconds to see if an increase in recovery time would allow for an increase in climbing 
ability for coq8 KD flies. Flies were collected 27 days post cross and assayed. 
 
Negative geotaxis assays (methods 3.12) indicated that at both the 10 second and 30 
second trials (Figure 4.11) control flies performed significantly better than coq8 KD 
flies (ANOVA, post hoc Tukey HSD Test, p<0.01). At 10 seconds no coq8 KD flies had 
crossed the line whereas almost all control flies had. At 30 seconds only 10% of coq8 
KD flies had crossed the line whereas most control flies had crossed the line. This 
indicates that increasing the recovery time enabled coq8 KD progeny to recover enough 
to cross the 5cm mark. However, at 30 seconds, control flies were beginning to wander 
Figure 4.11 Negative geotaxis assays used to determine locomotor ability. The assay was carried 
out using progeny from the elav-GAL4 crosses in (section 4.2.3.1). Control and coq8 KD flies 
were used. Means have been normalised by dividing the number of flies that passed the 5cm line 
by the total number of flies for each trial (n=30). Flies were initially assayed at 10 seconds to 
assess locomotor ability before being assessed at 30 seconds to assess recovery in coq8 
knockdown flies. Genotypes shown are w1118/elav-GAL4; (control) and w1118/elav-
GAL4;coq8KD/+; (coq8KD). Means +/- standard error. ANOVA, post hoc Tukey HSD test. 
Statistical significance * = p<0.05 and ** = p<0.01. 
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back down the vial. These results indicated that pan-neuronal knockdown of coq8 in 
Drosophila pan-neurons resulted in a significant decrease in locomotor ability. 
4.2.4 Characterisation resulting from the knockdown of coq8 
in the Drosophila compound eye  
In humans, COQ8A mutations often result in cerebellar atrophy and neurodegeneration 
in affected individuals (Barca et al., 2014; Blumkin et al., 2014; Gerards et al., 2010). 
This phenotype is associated with the loss of COQ8A function in the brain. The 
compound eye was used to characterise this phenotype in Drosophila. 
 
 
The highly elaborate structure of the Drosophila compound eye is composed of a 
remarkably orchestrated and logical arrangement of over 800 ommatidia (Kumar, 2012). 
The cell-to-cell interactions and organisation of this structure are critical for proper 
development and function. The compound eye can be used to assess neurological 
disorders due to the retina and optic lobe being a part of the CNS. This means the retina 
and the optic lobe can be used to assess the impact a gene may have in neuronal or 
Figure 4.12 Assessment of apoptosis and neurodegeneration in the compound eye.  
GMR-GAL4 expression of control and coq8 KD flies. Control flies show normal 
development of the Drosophila compound eye. In the absence of coq8 necrosis is 
present. The top down view of the eye showed a necrotic tumour protruding from the 
compound eye. Genotypes shown are w1118/+;GMR-GAL4/+ (control); and GMR-
GAL4/coq8KD (coq8 KD). 
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neurodegenerative disorders (Johnson & Cagan, 2009) The GMR-GAL4 driver can be 
used to drive expression of a transgene during the later stages of eye development (Li et 
al., 2012).  
 
 
Five virgin GMR-GAL4 females were crossed to five coq8 KD or control males 
(methods 3.2). Flies were raised at 25℃ in vials and housed for 30 days before imaging 
(methods 3.5). Control flies showed normal eye development with a regular array of 
ommatidia (Figure 4.12) and (Figure 4.13) whereas coq8 KD presented with black 
necrotic patches (coq8 KD). The necrotic patches varied in size and intensity but were 
never observed in control eyes. Over time the necrotic patches worsened which was 
Figure 4.13 Neurodegeneration in the Drosophila eye. The use of the eye specific driver, GMR-
GAL4, enabled the detection of neurodegeneration in the photoreceptors of the compound eye. 
Control flies contain a regular array of ommatidia with bristles spaced accordingly throughout 
the eye. coq8 KD eyes contain necrotic patches and a loss of overall integrity of the eye. 
Genotypes shown are w1118/+;GMR-GAL4/+ (control); and GMR-GAL4/coq8 KD (coq8 KD). 
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indicative of neurodegeneration due to the loss of coq8. In the severest cases, tumours 
protruded from the eye (Figure 4.12 coq8 KD). Scanning electron microscopy (SEM) 
(methods 3.9)  revealed a breakdown in the gross structure of the coq8 KD eye (Figure 
4.13) with a complete loss of adhesion between ommatidia. Bristles were in disarray 
and often missing. This suggests that coq8 is required for maintenance of ommatidia 
structure and cell survival in the eye. 
4.2.4.1 Characterisation resulting from the knockdown of 
coq8 in the photoreceptors of the eye during all 
stages of development  
The presence of necrosis in the compound eye using the GMR-GAL4 driver indicated 
that the knockdown of coq8 results in neurodegeneration in this structure. Next, we 
wanted to determine the effect the knockdown of coq8 has on the eye during all stages 
of eye development. The GMR-GAL4 driver is only active from the later larval stages 
so to characterise the effect coq8 has during all stages of eye development the ey-GAL4 
driver was chosen. The ey driver, like the arm-GAL4 driver, is lethal as a homozygous 
stock, so it is maintained over a CyO balancer chromosome which displays a curly wing 
phenotype.  
Five virgin ey-GAL4 females were crossed to five male flies from either control or coq8 
KD flies (methods 3.2). Flies were raised at 21℃ and 18℃. The knockdown of coq8 
had a very severe impact on survival as no coq8 KD containing progeny survived to 
eclosion. Pupae could not be counted due to the presence of the balancer chromosome. 
As there were no survivors, the impact on eye development could not be assessed with 
this driver. However, ey is also expressed in the developing nervous system (Halder et 
al., 1995) suggesting that coq8 may be critical for development in other ey-GAL4 
expressing regions of the body. 
4.2.5 Characterisation of the influence coq8 had on ATP 
production in Drosophila 
Human CoQ functions in the mitochondria as an electron transporter from complex I 
and complex II to complex III in the MRC (Crane et al., 1957; Lagier-Tourenne et al., 
2008; Turunen et al., 2004). The MRC is responsible for the production to ATP in the 
mitochondria of eukaryotes. In patients with mutations to COQ8A, which can include a 
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decrease in CoQ biosynthesis, there was also a correlation with the decrease in ATP 
levels in cells and tissues in the body. Some cells and/or tissues are more responsive to 
the decrease in ATP due to their reliability on CoQ to function (Lester & Crane, 1959). 
To assess ATP levels for this project, control and coq8 KD flies were used in 
conjunction with the ATP Bioluminescence Assay Kit CLS II (Roche Applied Science). 
Examination of the impact of ubiquitous knockdown of coq8 had on ATP levels in 
Drosophila was vital in determining whether the knockdown of coq8 would result in a 
similar phenotype to that seen in humans. As the ubiquitous knockdown of coq8 in 
Drosophila resulted in the larval lethality, first instar larvae were collected and used in 
this assay. Bottles were used to house progeny to obtain more significant numbers of 
coq8 KD larvae. Ten da-GAL4 virgin flies were crossed to either control or coq8 KD 
males. They were placed in 100 mL bottles with standard fly food.  
One week post cross, wandering 3rd instar larvae were collected from control bottles 
and were placed on ice in Eppendorf tubes. From the same experimental crosses, 1st 
instar larvae were collected from coq8 KD bottles. Larvae had not progressed any 
further for coq8 KD progeny. Light emission data was normalised to the blank and 
compared (Figure 4.14). Control lysates were used as the standard and were compared 
to coq8 KD lysates. The coq8 KD ATP levels were less than the control. This was 
consistent with the decrease in ATP production often found in people with COQ8A 
mutations (Gerards et al., 2010). 
The 25℃ samples, which had an increase in coq8 KD expression, resulted in a decrease 
in ATP production. These results indicated that ATP production in coq8 KD flies is less 
than that of control flies. This is consistent with previous case studies and the 
dependence on coq8 for the production of ATP. These data are preliminary and must be 










Figure 4.14 Analysis of the ATP levels associated with the loss of coq8. Flies were raised at 
21℃ and 25℃. Heads were collected for 21℃ samples and larvae for 25℃. Samples were 
prepared as per manufacturer’s instructions. Values were normalised and compared. Samples 
were carried out in duplicated and normalised to the control. Genotypes shown are w1118/+;elav-
GAL4/+ (control) and w1118/+;elav-GAL4/coq8 KD (coq8 KD). 
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4.3 Generation and characterisation of flies that 
overexpress wild-type and mutant forms of Drosophila 
coq8 
Ubiquitous knockdown of coq8 in Drosophila resulted in larval lethality and severe 
developmental delay (section 4.2.1 and 4.2.2), whereas pan-neuronal knockdown had no 
visible impact on brain development but did impair climbing ability (section 4.2.3). 
Also, knockdown of coq8 in the compound eye resulted in the loss of ommatidial 
integrity, necrosis and neurodegeneration (section 4.2.4) and finally, the loss of coq8 
resulted in a decrease in ATP production (section 4.2.5). Together, these phenotypes 
indicated that coq8 is an essential gene for survival and locomotor ability in Drosophila. 
These measurable phenotypes allowed RNAi-mediated knockdown of coq8 to be used 
as a model for the knockdown of coq8 in Drosophila. Based on this model, it is 
expected that reintroduction of wild-type coq8 will alleviate the loss of coq8. However, 
the introduction of a mutant form of coq8 with an impaired function would not. To 
functionally characterise the mutations found by Jacobsen et al. (2017), the appropriate 
DNA constructs corresponding to the Drosophila variants of these COQ8A mutations 
were generated. 
4.3.1 Generation of fly stocks that overexpress wild-type and 
mutant forms of Drosophila coq8 
The yeast homologue COQ8 has been widely characterised and is essential for CoQ 
biosynthesis (He et al., 2014). Sequence alignments between yeast, human and 
Drosophila (appendix 9.6, Figure 4.15) were used to determine the variants needed for 
this project. 
The alignment of human COQ8A, yeast COQ8 and Drosophila coq8 (annotation 
symbol CG32649) showed 53% amino acid identity and 70% similarity between human 
COQ8A and Drosophila coq8, 42% amino acid identity and 61% similarity between 
human COQ8A and yeast COQ8, 43% amino acid identity and 64% similarity between 
yeast COQ8 and Drosophila coq8. The paternally derived human SNP was 
characterised by as a non-synonymous missense change from Leucine to Proline 
(c.830T>C, p.Leu277Pro) (Jacobsen et al., 2017). This amino acid change is predicted 
to disrupt the highly conserved KxGQ domain that is found in the N-terminal of 
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COQ8A. In humans, the amino acid sequence at the motif is KLGQ (L277P) while the 
corresponding mutation in Drosophila is I295P which is an isoleucine change to proline 
at position 295. The KxGQ domain contains an invariant KxGQ motif which folds and 
occludes the active site of the enzyme Stefely et al. (2015). 
 
 
The maternally-inherited mutation disrupts a canonical splice site donor in exon 12 
(c.1506+1G>A) and is predicted to result in translation through an intron for 19 amino 
acids until it reaches a premature STOP codon resulting in a truncated protein product. 
The last amino acid of the wild-type sequence before the intron is K502. The splice site 
mutation cannot be modelled as the introns are not conserved in Drosophila. Therefore 
the Drosophila sequence was truncated at the corresponding amino acid, L520, to 
model the truncation of the C-terminal domain. As there was no available antibody for 
Drosophila coq8, a myc-tag was placed on the N-terminal of each Drosophila coq8 
construct to enable detection via immunohistochemistry. The myc-tagged wild-type 
coq8 (from here on referred to as myc-coq8) I295P and L520* sequences were 
produced by GenScript® and cloned into the pUASTattB transformation vector for 
Figure 4.15 Sequence alignment to identify the COQ8A mutants found by Jacobsen et al. 
(2017). The blue box highlights the human L277P mutation/Drosophila I295P with the black box 
indicating the presence of the highly conserved KxGQ motif. The pink box highlights the human 
K502*/Drosophila L520* mutants that result in a truncated protein product. The sequence 
alignment was carried out using Clustal Omega https://www.ebi.ac.uk/Tools/msa/clustalo/  
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generation of transgenic Drosophila (Groth, Fish, Nusse, & Calos, 2004). This was also 
performed by Genscript®, pUASTattB contains multiple cloning sites upstream of a 
UAS which, when used in conjunction with GAL4 driver lines, drives expression of the 
transgene. It also contains a mini-white gene for selection of transgenic Drosophila and 
an attB site for PhiC31-mediated transgenesis. High-quality plasmid DNA was prepared 
(section 3.14.2) and sent to GenetiVision for production of transgenic flies.  
4.3.2 Characterisation of survival resulting from the strong 
ubiquitous expression of wild-type and mutant forms of 
coq8 in a wild-type background 
Before investigating whether any of the transgenes could rescue the knockdown 
phenotype, it was imperative to determine whether overexpression of myc-coq8, I295P 
or L520* affected survival when expressed in a wild-type background. As coq8 
functions as a dimer, it was possible that introduction of the mutant forms could 
interfere with normal function even when expressed in a wild-type background. Flies 
containing myc-coq8, I295P or L520* variants of coq8 were crossed to the strong 
ubiquitous driver da-GAL4 (methods 3.2). Control flies and coq8 KD flies were 
included in these experiments as reference points for wild-type and lethal phenotypes. 
Progeny counts were carried out 23 days post cross (methods 3.4). 
While the results are preliminary, progeny counts (Figure 4.16) indicated that, while 
similar numbers of pupae were produced for control, myc-coq8, I295P and L520* 
genotypes, there was a decrease in the number of adult males and females produced by 
L520* flies. There was also a slight decrease in the number of adult progeny for myc-
coq8. In these experiments, progeny were not produced for the coq8 KD cross which 
was consistent with previous findings (section 4.2.1). These experiments must be 




Figure 4.16 Progeny counts to assess the impact of the strong 
ubiquitous expression of coq8 variants on survival. Only one cross 
was carried out for these experiments so in order to reach statistical 
significance more crosses are necessary. Genotypes shown are 
w1118/+;daGAL4/+ (control); w1118/+;da-GAL4/coq8 KD (coq8 KD) 
and w1118/+;da-GAL4/myc-coq8 (myc-coq8), 




4.3.3 Characterisation of survival resulting from the highly 
specific pan-neuronal expression of wild-type and 
mutant forms of coq8 in a wild-type background 
Knockdown of coq8 using the highly specific pan-neuronal driver elav-GAL4 was 
semi-lethal in Drosophila (section 4.2.3.1). Some female coq8 KD survivors presented 
with locomotor impairment (section 4.2.3.3) which was of interest due to the human 
mutant phenotype which results in gait ataxia and uncontrolled movements (Jacobsen et 
al., 2017).  
Five elav-GAL4 virgin females were crossed to five males of either control, coq8 KD, 
myc-coq8, I295P or L520* genotypes (methods 3.2). Flies were raised in 30 mL vials. 
Progeny was counted 24 days post cross (methods 3.4). 
Progeny counts (Figure 4.17) indicated that knockdown of coq8 in the neurons was 
lethal in both males and females in these experiments. However, previous experiments 
in which there were female survivors, had been carried out in glass bottles, whereas this 
experiment was carried out in smaller plastic vials. The difference in containers, plus 
fluctuations in air conditioning temperature, which was not holding a consistent 
temperature at this time, were thought to be contributing factors during these 
experiments. If the temperature within the vials were slightly higher, this would result in 
increased GAL4 activity and therefore increased RNAi expression which is likely to 
increase female lethality. Pan-neuronal expression of myc-coq8 or the coq8 mutants did 




Figure 4.17 Analysis of the impact of pan-neuronal expression of 
coq8 variants on survival. Only one cross was carried out for these 
experiments so in order to reach statistical significance more crosses 
are necessary. Genotypes are w1118/+; elav-GAL4/+ (control); 
w1118/+; elav-GAL4/coq8 KD (coq8 KD) and w1118/+; elav-
GAL4/myc-coq8 (myc-coq8). w1118/+; elav-GAL4/I295P (I295P), 
w1118/+; elav-GAL4/L520* (L520*). 
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4.3.4 Negative Geotaxis assay to assess locomotor ability in 
flies expressing wild-type or mutant forms of coq8 in a 
wild-type background 
In humans, clinical presentation can include cerebellar atrophy and a decrease in motor 
skills (Barca et al., 2014; Jacobsen et al., 2017; Stefely et al., 2016), therefore in order 
to determine whether pan-neuronal overexpression of myc-coq8 or mutant coq8 altered 
locomotor activity in a wild-type fly, a negative geotaxis assay was performed (methods 
3.12).  
Five elav-GAL4 virgin females were crossed to each Drosophila variant and raised at 
21℃ in 30 mL vials (methods 3.2). After 25 days adult female survivors were collected, 
and locomotor ability assessed using the negative geotaxis assay (section 3.12). Control 
flies were used as the positive reference sample, and all data was normalised to the total 
number of flies per trial (n=30). 
It was evident that there were some defects present in the coq8 KD progeny. They were 
a lot slower in their movements and not as quick to respond after being startled but did 
attempt to climb. Upon closer inspection, they were holding their wings in an unusual 
position and would often flick them. When the assay was carried out it was clear that 
coq8 KD progeny were not able to climb after being startled. Initial runs suggested that 
the banging on the bench was preventing the flies from recovering quick enough to 
climb. Therefore flies were given an extra 20 seconds (for a total of 30 seconds) to 
climb up the vial to allow them time to recover. 
Negative geotaxis assays (Figure 4.18) determined that across both time trials control, 
myc-coq8 and I295P flies exhibited normal climbing ability. However, coq8 KD and 
L520* flies had a significant decrease in climbing ability when compared to all other 
genotypes at both time points (ANOVA, post hoc Tukey HSD Test, p<0.01) indicating 
that the loss of coq8 results in a decrease in climbing ability. This also suggests that 




4.3.5 Characterisation resulting from the expression of wild-
type or mutant forms of coq8 in the Drosophila 
compound eye 
The compound Drosophila eye is a highly elaborate structure that requires a number of 
cellular processes for proper development. The retina of the Drosophila eye is often 
used to assess neuronal degeneration (London et al., 2013) due to the retina and optic 
nerve being derived from the CNS (Johnson & Cagan, 2009). The knockdown of coq8 
in the Drosophila compound eye resulted in a loss of integrity of the lattice structure of 
the eye, necrosis and neurodegeneration (section 4.2.4). In order to characterise the 
impact the Drosophila variants, myc-coq8, I295P and L520*, had on eye development 
when expressed in a wild-type background eye morphology was analysed here. 
Figure 4.18 Negative geotaxis assay using the pan-neuronal elav-GAL4 
driver. Flies raised at 21℃. Trials were run for 30 seconds each and 
successful climbers were counted once they crossed the 5cm line. 
Genotypes are w1118/+; elav-GAL4/+ (control); w1118/+;elav-
GAL4/coq8KD (coq8 KD) and w1118/+;elav-GAL4/myc-coq8 (myc-coq8), . 
w1118/+; elav-GAL4/I295P (I295P), w1118/+; elav-GAL4/L520* (L520*). 
Means +/- standard error. ANOVA, post hoc Tukey HSD Test. Statistical 
significance * = p<0.05 and ** = p<0.01.  
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Five virgin GMR-GAL4 females were crossed to five male flies from either control, 
coq8 KD, myc-coq8, I295P or L520* (methods 3.2). Flies were raised at 25℃ in vials 
and housed for 30 days before imaging (methods 3.5). By raising flies at 25℃ a more 
severe knockdown of the transgene occurred. Control flies showed normal eye 
development (Figure 4.19) with a healthy array of ommatidia, bristles and a consistent 
shape to the eye. The eyes of coq8 KD flies showed the irregular ommatidia 
arrangement and disrupted bristle formation as well as black necrotic patches and a 
break down in the integrity of the eye. The black necrotic patches observed were of 
varying sizes and intensities but were only present in coq8 KD fly eyes. The remaining 
coq8 variants, myc-coq8, I295P and L520*, had normal ommatidia and eye 
development which was similar to the control. 
 
Overexpression of myc- coq8 or the I295P mutant did not appear to alter survival, 
climbing ability or eye development, however pan-neuronal expression of L520* in a 
wild-type background resulted in a semi-lethal phenotype in Drosophila at the pupal 
stage and also resulted in severe defects in locomotor activity as measured by the 
negative geotaxis assay, indicating that it may be acting as a dominant negative effect. 
 
Figure 4.19 GMR-GAL4 characterisation experiments to assess the involvement Drosophila coq8 
variants have on the compound eye. Genotypes shown are w1118/+;GMR-GAL4/+ (control); GMR-




4.4 Determination of whether wild-type or mutant 
Drosophila coq8 could rescue the coq8 knockdown 
phenotype 
A model of coq8 deficiency was characterised in section 4.2. Ubiquitous knockdown of 
coq8 using both the strong da-GAL4 and weak arm-GAL4 drivers resulted in larval 
lethality and severe developmental delay, pan-neuronal knockdown of coq8 under the 
control of the highly specific elav-GAL4 driver resulted in a semi-lethal phenotype and 
reduced locomotor function, and knockdown of coq8 in the post-mitotic eye with GMR-
GAL4 resulted in disruption to ommatidial development, necrosis, and 
neurodegeneration. 
4.4.1 Generation of Drosophila fly lines that express wild-
type or mutant forms of coq8 in a knockdown 
background 
To assess whether the myc-coq8, I295P or L520* transgenes could rescue the 
knockdown phenotypes described above, they were first recombined into the same fly 
line containing the UAS-coq8 inverted repeat RNAi construct, such that when crossed 
to the appropriate GAL4 driver, the transgene would be expressed concurrently with 
coq8 RNAi. The sequence alignment (Figure 4.15) depicts the three variants that were 
generated for these rescue experiments. A crossing scheme can be found in appendix 
9.5. 
4.4.2 Characterisation of the phenotypes resulting from 
ubiquitous expression of wild-type or mutant coq8 in 
coq8 KD flies when raised at 21℃ 
Ten adult male flies of each genotype, described above, were crossed to ten da-GAL4 
virgin flies and raised at 21℃ (methods 3.2). Once the adult progeny had emerged adult 
flies, pupae and dead larvae were counted (methods 3.4). Images of the fly bottles were 
taken at the end of each week to provide a visual representation of pupal development 
between the genotypes (Figure 4.20). 
Control flies developed normally and were used as a positive control for developmental 
progress. It was evident in week one that lethality and/or severe developmental delay 
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was present in all genotypes lacking coq8. By week three most control flies had 
emerged. While a small number of pupae were present in KD;myc-coq8 bottles, there 
were no pupae present in coq8 KD, KD;I295P or KD;L520*. This suggested that 
reintroduction of wild-type coq8 resulted in a partial rescue. 
Progeny from these crosses were counted and compared (Figure 4.21). Dead larvae 
were counted for these experiments to quantify the lethality associated with coq8 
expression in Drosophila. Dead larvae containing the coq8 KD RNAi were small and 
immature which indicated that lethality occurred early in larval development. There was 
a significant increase in the number of dead larvae in KD;L520* (ANOVA, post hoc 
Tukey HSD Test, <0.05) when compared to the all other genotypes. Larval lethality was 
evident in coq8 KD progeny as larvae did not reach pupation. However, a small number 
of pupae were present in KD;myc-coq8 and KD;I295P bottles suggesting that 
reintroduction of wild-type coq8 or I295P partially rescued larval lethality. Adult 
progeny counts showed normal development for control flies but a complete absence of 
adults in all other genotypes (ANOVA, post hoc Tukey HSD Test, p<0.01 for males, 
p<0.05 for females). These results indicated that reintroduction of wild-type coq8 and 
I295P were able to partially rescue larval lethality resulting in pupation in a small 




Figure 4.20 Photos of the fly bottles from da-GAL4 crosses taken 
at 1, 2 and 3 weeks post cross. Images indicate the difference seen 
in the development of Drosophila under the strong ubiquitous 
driver. Genotypes shown are w1118/+;daGAL4/+ (control); 
w1118/+;da-GAL4/coq8KD (coq8 KD) and w1118/+;da-GAL4/ 
coq8KD;myc-coq8 (KD;myc-coq8), w1118/+;daGAL4/ coq8KD 





Figure 4.21 Progeny counts from rescue experiments using the 
strong ubiquitous driver da-GAL4. Flies were raised at 21℃ and 
housed in 100 ml glass bottles. Progeny were counted 26 days post 
cross. Genotypes shown are w1118/+;daGAL4/+ (control); w1118/+;da-
GAL4/coq8KD (coq8 KD) and w1118/+;da-GAL4/ coq8KD;myc-coq8 
(KD;myc-coq8), . w1118/+;daGAL4/ coq8KD ;I295P (KD;I295P), 
w1118/+, daGAL4/ coq8KD/L520* (KD;L520*). Means +/- standard 
error. ANOVA, post hoc Tukey HSD Test. Statistical significance * = 
p<0.05 and ** = p<0.01. Crosses carried out in triplicate. 
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4.4.3 Characterisation of the phenotypes resulting from 
ubiquitous expression of wild-type or mutant coq8 in 
coq8 KD flies when raised at 18℃  
GAL4 activity is temperature sensitive; at lower temperatures, GAL4 activity is lower, 
which results in reduced transgene expression, whereas an increase in temperature 
results in increased GAL4 activity and subsequently an increase in transgene expression 
(Duffy, 2002). For this reason, it was decided that a decrease in temperature may lead to 
an increase in survival. Due to the inability to rescue the knockdown phenotype at 21°C, 
it was decided to repeat the experiments at 18°C to determine whether rescue might be 
improved when coq8 RNAi expression was reduced. 
Crosses were set up as previously described (section 3.2) but were raised at 18°C. 
Progeny were counted 26 days post cross (section 3.4). No significant differences were 
seen in the dead larval counts for any of the genotypes (Figure 4.22). A partial rescue 
was seen in KD;myc-coq8 pupae which had significantly more pupae than all other 
coq8 KD containing flies (ANOVA, post hoc Tukey HSD Test, p<0.01). A minimal 
amount of KD;myc-coq8 adult males emerged and did not appear to have any 
noticeable defects. As expected, there was significantly more control adult flies when 
compared to all coq8 KD containing flies (ANOVA, post hoc Tukey HSD Test, 
p<0.01). To partially rescue the knockdown phenotype wild-type coq8 was reintroduced 
and resulted in the emergence of a small number of viable male offspring. 
Raising flies at a lower temperature increased the number of pupae produced by 
KD;myc-coq8 flies and also the emergence of a small number of viable males. This 
suggests that decreasing coq8 RNAi expression in Drosophila resulted in partial rescue 




Figure 4.22 Progeny counts for the rescue experiments at 18℃ 
using the strong ubiquitous driver da-GAL4. Flies were raised at 
18℃ and dead larvae counted to determine the effect Drosophila 
variants have on survival. Genotypes shown are 
w1118/+;daGAL4/+ (control); w1118/+;da-GAL4/coq8KD (coq8 
KD) and w1118/+;da-GAL4/ coq8KD;myc-coq8 (KD;myc-coq8), . 
w1118/+;daGAL4/ coq8KD ;I295P (KD;I295P), w1118/+, daGAL4/ 
coq8KD/L520*(KD;L520*). Means +/- standard error. ANOVA, 
post hoc Tukey HSD Test. Statistical significance * = p<0.05 and 
** = p<0.01. Crosses carried out in triplicate. 
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4.4.4 Characterisation of the phenotypes resulting from the 
weak ubiquitous expression of wild-type or mutant coq8 
in coq8 KD flies raised at 21℃ 
Due to the inability to rescue lethality using the strong ubiquitous driver da-GAL4 at 
21°C, the arm-GAL4 driver was used with the rationale that weaker RNAi expression 
could result in an increase in rescue with the reintroduction of wild-type coq8.  
Ten arm-GAL4 virgin females were crossed to ten males from either control, coq8 KD, 
KD;myc-coq8, KD;I295P or KD:L520*. Flies were crossed and raised at 21℃ 
(methods 3.2). Adult flies were counted 26 days post cross (methods 3.4). For these 
experiments, pupae were not counted as the pupal genotype could not be determined 
due to the presence of a balancer chromosome. For these crosses, flies that contained the 
Sb balancer chromosome did not contain the driver line needed for the successful 
expression of the transgene (Figure 4.3). Any flies that emerged with standard wild-type 
bristles contained the driver and the transgene. The presence of the balancer 
chromosome in these crosses provide an internal control for the experiment as those 
flies did not express the transgene.  
The Sb in vial controls showed no significant differences in males or females (Figure 
4.23). A partial rescue in adult males expressing both the driver and the transgenes, 
KD;myc-coq8, was seen with the absence of males in all other coq8 KD containing 
flies. While there was no significant difference seen between control males and 
KD;myc-coq8 there was with all other genotypes (ANOVA, post hoc Tukey HSD Test, 
p<0.01). Lethality was evident in females expressing the driver and the transgene for all 
coq8 KD containing flies with a significant decrease in progeny when compared to the 
control (ANOVA, post hoc Tukey HSD Test, p<0.01). The knockdown phenotype in 
female flies was partially rescued by the reintroduction of wild-type coq8. However, 
rescue was not seen in any other genotypes that contained coq8 KD (ANOVA, post hoc 
Tukey HSD Test, p<0.01). 
A partial rescue was seen with the reintroduction of wild-type coq8 in male progeny for 
KD;myc-coq8 crosses. This indicates that the lethality associated with coq8 KD flies is 




Figure 4.23 Progeny counts for rescue experiments using the weak 
ubiquitous driver arm-GAL4. Sb=no transgene. Genotypes shown are 
w1118/+;arm-GAL4/+ (control); w1118/+;coq8KD/+; arm-GAL4/+ 
(coq8 KD)  and w1118/+; coq8KD;myc-coq8/+; arm-
GAL4/+(KD;myc-coq8), w1118/+; coq8KD;I295P/+; arm-
GAL4/+(KD;I295P), w1118/+; coq8KD;L520*/+; arm-
GAL4/+(KD;L520*). Means +/- standard error. ANOVA, post hoc 
Tukey HSD Test. Statistical significance * = p<0.05 and ** = p<0.01. 
Crosses were carried out in triplicate. 
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4.4.5 Characterisation of the phenotypes resulting from the 
pan-neuronal reintroduction of wild-type or mutant coq8 
into a knockdown background raised at 21℃ 
Pan-neuronal knockdown of coq8 resulted in a semi-lethal phenotype (section 4.2.3.1) 
and impaired locomotor ability (section 4.2.3.4). The following rescue experiments 
assessed the ability for coq8 variants to rescue the previously characterised coq8 
knockdown phenotype. As previously described (section 4.4.1) the coq8 inverted repeat 
was recombined into the same fly line as either myc-coq8, I295P or L520* in order co-
express the coq8 variants in a knockdown background. Ten males from each fly 
construct were then crossed to ten virgin elav-GAL4 females (methods 3.2). 
Initial observations revealed a developmental delay present in coq8 KD flies (Figure 
4.24) week one saw a similar phenotype across all crosses with development occurring 
sooner in control flies. By the end of week two, control flies had begun to emerge while 
all coq8 KD containing flies had not. This developmental delay was worse in 
KD;L520* flies with a large number of pupae still occupied by the time progeny counts 






Figure 4.24 Photos of fly bottles for elav-GAL4 rescue 
experiments. Images were taken 1 and 2 weeks post cross. 
Genotypes shown are w1118/+; elav-GAL4/+ (control); 
w1118/+;elav-GAL4/coq8KD (coq8 KD) and w1118/+;elav-
GAL4/ coq8KD ;myc-coq8, .(KD;myc-coq8) w1118/+; elav-




Progeny counts (Figure 4.25) indicated a significant decrease in the number of adult 
males between control and coq8 KD (ANOVA, post hoc Tukey HSD Test, p<0.01), 
KD;myc-coq8 (ANOVA, post hoc Tukey HSD Test, p<0.05), KD;I295P (ANOVA, post 
hoc Tukey HSD Test, p<0.01) and KD;L520* (ANOVA, post hoc Tukey HSD Test, 
p<0.01). A significant increase in adult males was seen in KD;myc-coq8 when 
compared to coq8 KD (ANOVA, post hoc Tukey HSD Test, p<0.01), KD;I295P 
(ANOVA, post hoc Tukey HSD Test, p<0.05) and KD;K502* (ANOVA, post hoc 
Tukey HSD Test, p<0.01) suggesting that the reintroduction of wild-type coq8 was able 
to partially rescue the knockdown phenotype. The introduction of the mutants into the 
knockdown background, KD;I295P and KD;L520*, saw a worsening of the knockdown 
phenotype in males. There was a significant decrease between KD;myc-coq8 and both 
KD;I295P (ANOVA, post hoc Tukey HSD Test, p<0.05) and KD;L520* (ANOVA, 
post hoc Tukey HSD Test, p<0.01) suggesting that in the presence of the coq8 mutants 
survival is reduced. 
Adult female progeny counts showed a significant derease between control females and 
both KD;I295P (ANOVA, post hoc Tukey HSD Test, p<0.05) and KD;L520* 
(ANOVA, post hoc Tukey HSD Test, p<0.01). This suggests that expression of the 
mutant variants in the knockdown background does not rescue the coq8 knockdown 
phenotype. There were no significant differences seen between control, coq8 KD and 
KD;myc-coq8. However, there was a significant decrease in the number of adult 
females between KD;myc-coq8 and both KD;I295P (ANOVA, post hoc Tukey HSD 
Test, p<0.01) and KD;L520* (ANOVA, post hoc Tukey HSD Test, p<0.01). These 
results suggest that the introduction of either mutant variant to the knockdown 
background resulted in a significant decrease in the number of adult females  
Pan-neuronal knockdown of coq8 was lethal in males and semi-lethal in females. There 
was no effect on pupal development in these crosses indicating that lethality occurs 
during the pupal stage. Reintroduction of wild-type coq8 into the knockdown 
background rescued male lethality but the reintroduction of the coq8 mutants did not. 
L520* reduced survival in coq8 KD females similarly to what was seen when coq8 








Figure 4.25 Progeny counts for rescue experiments using the pan-
neuronal driver elav-GAL4. Flies were raised at. 21℃. Genotypes 
shown are w1118/+; elav-GAL4/+ (control); w1118/+;elav-
GAL4/coq8KD (coq8 KD) and w1118/+;elav-GAL4/ coq8KD ;myc-
coq8, .(KD;myc-coq8) w1118/+; elav-GAL4/ coq8KD;I295P 
(KD;I295P), w1118/+; elav-GAL4/ coq8KD;L520* (KD;L520*). Means 
+/- standard error. ANOVA, post hoc Tukey HSD Test. Statistical 




4.4.6 Negative Geotaxis assay to assess locomotor ability 
resulting from the reintroduction of wild-type or mutant 
coq8 into a knockdown background raised at 21℃ 
In section 4.2.3.4, it was demonstrated that knockdown of coq8 resulted in impaired 
locomotor function in the negative geotaxis assay, indicating that expression of coq8 in 
neurons could be essential for normal locomotor function in Drosophila. This result was 
consistent with the clinical presentation exhibited in patients with COQ8A mutations 
where deficiencies can include the loss of fine motor skills or gait ataxia (Barca et al., 
2016; Jacobsen et al., 2017). 
Flies of the appropriate genotypes were assessed via the negative geotaxis assay 
(methods 3.12) to examine whether wild-type or mutant variants of coq8 could rescue 
the impaired locomotor function resulting from knockdown of coq8. 
During both 10 second and 30 second trials (Figure 4.26), most control flies and 
KD;myc-coq8 flies had crossed the 5cm line and were not significantly different from 
each other. Control flies and KD;myc-coq8 climbed significantly better than coq8 KD, 
KD;I295P and KD;L520* flies (ANOVA, post hoc Tukey HSD Test, p<0.01) 
suggesting a full rescue of locomotor ability with the reintroduction of wild-type coq8. 
Additionally KD;L520* flies performed worse than coq8 KD flies indicating that 
introduction of the L520* mutant resulted in a worsening in locomotor ability. 
The negative geotaxis assay was also repeated with flies that were raised at 18℃. The 
10 second trials indicated that control flies had significantly better locomotor ability 
than all other genotypes (ANOVA, post hoc Tukey HSD Test, p<0.01). However, the 
locomotor ability of KD;myc-coq8 flies was still significantly better than coq8 KD and 
KD;L520* flies (ANOVA, post hoc Tukey HSD Test, p<0.01). This indicates that while 
KD;myc-coq8 locomotor ability was not restored to that of the control, it was still 
significantly better than coq8 KD and KD;L520* flies. 
The 30 second trials showed no statistical significance between the control flies and 
KD;myc-coq8 suggesting that reintroduction of the wild-type, myc-coq8, into the 
knockdown background resulted in the full rescue of locomotor ability. There was a 
significant decrease between the control and both KD;I295P and KD;L520* suggesting 
that while the rescue was seen in KD;myc-coq8 introduction of the mutants into the 
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knockdown background had an adverse effect on locomotor ability. In contrast of the 
climbing data at 21℃ (Figure 4.26) KD;L520* flies performed similarly to that of coq8 
KD flies suggesting that expression of KD;L520* may have decreased when flies are 
raised at 18℃. Reintroduction of wild-type coq8 was able to rescue the loss of 
locomotor ability due to the loss of coq8. Partial rescue was seen with KD;I295P, 






Figure 4.26 Negative geotaxis assay to assess locomotor ability in 
rescue experiments. Flies were raised at 18℃. Genotypes shown are 
w1118/+; elav-GAL4/+ (control); w1118/+;elav-GAL4/coq8KD (coq8 
KD) and w1118/+;elav-GAL4/ coq8KD ;myc-coq8, .(KD;myc-coq8) 
w1118/+; elav-GAL4/ coq8KD;I295P (KD;I295P), w1118/+; elav-GAL4/ 
coq8KD;L520* (KD;L520*). Means +/- standard error. ANOVA, post 




4.4.7 Characterisation of the phenotypes resulting from the 
expression of wild-type or mutant coq8 in the compound 
eye of coq8 KD flies 
4.4.7.1 Characterisation of the compound eye using light 
microscopy 
It was previously established that knockdown of coq8 under the control of the eye-
specific driver GMR-GAL4 resulted in black necrotic patches and neurodegeneration in 
the Drosophila eye (section 4.2.4). Moreover, SEM images indicated a loss of cohesion 
and overall structure of the ommatidia suggesting that coq8 plays a vital role in the 
proper development of the Drosophila compound eye.  
Flies containing the appropriate genotype were crossed to GMR-GAL4 (methods 3.2) to 
determine whether the introduction of wild-type or mutant variants of coq8 could rescue 
the deficits in ommatidia development and reduce neurodegeneration (as observed by 
necrotic patches) resulting from knockdown of coq8. Flies were raised in vials and 
placed at either 25℃, 21℃ or 18℃ until imaged 30-60 days post cross (methods 3.5). 
Representative images from an analysis of 50 pairs of eyes were shown for each 
genotype at each temperature. Control males and females across all three temperatures 
showed normal development and ommatidia arrangement (Figure 4.27). coq8 KD flies 
presented with black necrotic patches at all three temperatures. Females presented with 
a more severe phenotype than males. Reintroduction of wild-type coq8, KD;myc-coq8, 
resulted in smaller necrotic patches (21℃) if not a complete lack of necrosis in the eye 
(18℃). KD;I295P fly eyes displayed a phenotype that was worse than KD;myc-coq8 
but not as severe as coq8 KD alone which was evident across all temperatures. Of all 
the genotypes KD;L520* had the most severe mutant phenotype suggesting that 
introduction of L520* into the knockdown background caused a worsening of the 
previously described knockdown phenotype (section 4.2.4). KD;L520* flies raised at 
25℃ presented with the worst mutant phenotype of all as the casing surrounding the eye 




Figure 4.27 Analysis of the impact rescue experiments have on the compound eye. GMR-
GAL4 rescue experiments carried out at 25℃, 21℃, and 18℃. The eye specific driver is a 
good indicator of neurodegeneration in the compound eye. Genotypes shown are 
w1118/+;GMR-GAL4/+ (control), GMR-GAL4/coq8KD, GMR-GAL4/ coq8KD ;myc-coq8, 
GMR-GAL4/ coq8KD ;I295P, and GMR-GAL4/ coq8KD ;L520*. 
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4.4.7.2 Characterisation of the compound eye using 
scanning electron microscopy at 21℃ 
Scanning electron microscopy images provided higher resolution of the Drosophila eye 
which enabled further analysis of the lattice structure of the compound eye. Flies were 
raised at 21℃ and prepared as previously described before being sent to MMIC for 
SEM processing (methods 3.9). 
Control flies (Figure 4.28) displayed normal eyes with a regular array of plump 
ommatidia and bristles. By knocking down, coq8 in the eye necrosis was evident in 
coq8 KD flies with ommatidia fused together and a loss of most bristles. Reintroduction 
of wild-type coq8 (KD;myc-coq8) presented with necrosis, mostly absent bristles and 
an irregular array of ommatidia. KD;I295P flies had necrosis in the eye, fused and 
misshapen ommatidia, and a loss of bristles cells. KD;L520* eyes had a more 
significant loss of ommatidia arrangement with a loss of bristles and necrosis present in 
the eye. While reintroduction of wild-type coq8 did not rescue the knockdown 







Figure 4.28 Determination of the impact reintroduction of wild-type coq8 has in coq8 KD eyes.   
Flies were raised at 21℃ and images taken via SEM. Genotypes shown are w1118/+;GMR-GAL4/+ 
(control); GMR-GAL4/coq8KD, GMR-GAL4/ coq8KD ;myc-coq8, GMR-GAL4/ coq8KD ;I295P, 




4.4.8 Characterisation of the phenotypes resulting from the 
expression of wild-type or mutant coq8 in the compound 
eye of coq8 KD flies 
Knocking down coq8 in the developing Drosophila eye using the ey-GAL4 driver 
expectedly resulted in lethality which was likely due to the decrease in ey-GAL4 
expression elsewhere in the body. ey-GAL4 is also expressed in the developing 
embryonic nervous system (section 4.2.4.1) (Halder et al., 1995). To determine whether 
expression of coq8 could rescue lethality, ey-GAL4. Females were crossed to males 
from either control, coq8 KD, KD;myc-coq8, KD;I295P or KD;L520* genotypes and 
raised at 21℃ (methods 3.2). From these crosses survivors were only present in 
KD;myc-coq8 crosses (Figure 4.29). This suggested that reintroduction of wild-type 
coq8 enabled rescue of lethality. However, a severe mutant phenotype remained which 
varied considerably between individuals. Due to the absence of coq8 in these rescue 
experiments, it indicated that, for standard development of the compound eye, coq8 
must function in a wild-type capacity. KD;myc-coq8 flies presented with either the 
complete absence of a compound eye or at best a fraction of the full sized compound 
eye. 
Figure 4.29 ey rescue experiments with flies raised at 21℃. Only 




4.5 Characterisation of the expression patterns associated 
with the wild-type and mutant forms of Drosophila 
coq8 
After completing the characterisation experiments using the Drosophila coq8 variants, it 
was vital to characterise the expression patterns of wild-type and mutant Drosophila 
coq8 transgenes. To do so elav-GAL4 virgin females were crossed to each Drosophila 
variant (methods 3.2). Brains were used to visualise the expression of coq8 via 
immunohistochemistry. 
4.5.1 Characterisation of coq8 expression patterns in the 
Drosophila brain 
An N-terminal myc tag was added to each construct to visualise the expression patterns 
associated with wild-type and mutant coq8. Five elav-GAL4 virgin females were 
crossed to five males of either EGFP-KASH (negative control), myc-MEF2-VP16 
(positive control) or myc-coq8 genotypes (methods 3.2) to characterise expression in 
the fly brain. Fly brains were dissected (methods 3.6) from adult flies then 
immunohistochemistry (methods 3.7) was carried out before detection via confocal 
microscopy (methods 3.8). 
Myc expression (Figure 4.30) was absent in EGFP-KASH (negative control) 
highlighting the specificity of α-myc staining in the brain. MEF2-VP16 is a 
transcription factor, and myc-MEF2-VP16 was detected in neuronal nuclei (MEF2-
VP16). The myc-coq8 expression was cytosolic and evident as halos present in the 






Figure 4.30 Analysis of myc expression in wild-type coq8 fly brains. 
Immunohistochemistry was carried out on positive control (myc-MEF2-VP16) and 
myc coq8. The negative control EGFP-KASH showed no myc expression, MEF2-
VP16 showed expression in nuclei. myc expression for myc-coq8 showing cytosolic 
localisation Genotypes shown are w1118/+; elav-GAL4/+ (control); w1118/+;elav-
GAL4/myc-coq8 (myc-coq8) and w1118/+;elav-GAL4/myc-MEF2-VP19, .(MEF2-
VP16) w1118/+; elav-GAL4/EGFP-KASH (negative control). 
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Further analysis of subcellular distribution was examined by co-labelling with α-Rpd3. 
Rpd3 is a histone deacetylase and thus could be used as a nuclear marker to confirm that 
the expression of myc-coq8 was in the cytoplasm surrounding the nuclei. The 
expression profile for Drosophila coq8 variants varied in intensity (Figure 4.31) with 
myc-coq8 having the highest α-myc expression which also appeared to be more 
widespread. I295P was expressed at a lower level and had a more variable expression 
pattern. It would be advisable to repeat the experiments to see whether there is a 
difference between I295P expression and myc-coq8. L520* expression was present in a 
minimal amount around the optic lobes but not in the antennal lobes like myc-coq8. 
Wild-type coq8 expression was predominantly seen in the antennal lobes located in the 




Figure 4.31 Neuronal expression of the Drosophila variants under the control of elav-GAL4. anti-myc 
was used to visualise expression of the Drosophila coq8 variants. anti-Rpd3 is a marker of the neuropil 
Genotypes shown are w1118/+; elav-GAL4/+ (control); /+;elav-GAL4/myc-coq8, .(myc-coq8) w1118/+; 




High magnification of the area surrounding the antennal lobe of myc-coq8 brains 
(Figure 4.32) indicated Rpd3 expression (green) was localised in the nuclei whereas 
myc expression (magenta) was cytosolic. Colocalisation between Rpd3 and myc did not 
occur in the merged image highlighting the fact that myc-coq8 expression was present 
in the cytosol and not in the nuclei. These results showed that myc-coq8 was expressed 
in the cytosol and that the level of coq8 expression decreased in the I295P and L520* 
variants. This could suggest that due to the coq8 mutations there could be a decrease in 
protein production and possibly degradation of coq8 mRNA. 
 
 
4.5.2 Characterisation of coq8 expression patterns in the 
mitochondria of the Drosophila brain 
After determining the cytosolic localisation of wild-type coq8 (section 4.5.1), it was 
necessary to determine whether myc-coq8 localised to mitochondria using mitoGFP, 
which consists of GFP fused to a mitochondrial matrix targeting domain (LaJeunesse et 
al., 2004). A fly line harbouring both the D42-GAL4 driver, which drives strong 
expression in motor neurons, and UAS-mitoGFP, a mitochondrial localised GFP, were 
crossed to wild-type coq8. 
 
Figure 4.32 High magnification of an optical slice through the Kenyon cell layer of the brain to 
characterise myc-coq8 expression. 1 µm thick slices were imaged. Rpd3 (green) and myc (magenta) 
expressed in myc-coq8 fly brain. Genotypes shown are w1118/+; elav-GAL4/+ (control); /+;elav-




Immunofluorescent detection in the brain indicated that coq8 and mito-GFP appeared 
adjacent to each other but lacked colocalisation in mitochondria as indicated by a lack 
of white in the merged channel (Figure 4.33). myc-coq8 staining appeared diffuse in 
comparison to mito-GFP expression. 
 
 
High magnification captures were taken (Figure 4.34) and showed a lack of 
colocalisation between mito-GFP and myc-coq8. As myc-coq8 colocalisation was not 
seen in these experiments, it was imperative to determine the reasoning for it. A study 
by Cullen et al. (2016) identified a mitochondrial targeting sequence present on the N-
terminal of human COQ8A. In the study, COQ8A was FLAG-tagged on both the N- 
and C-terminus to determine colocalisation using Mito-tracker. Although both 
constructs were functional, colocalisation in mitochondria was absent in N-terminally 
Figure 4.33 Mitochondrial localisation of Drosophila coq8 variants via immunofluorescent detection 
in the neurons. Genotypes shown are w1118/D42-GAL4;myc-coq8/+; UAS-mito-GFP, .(myc-coq8) 
Figure 4.34 High magnification images of mitochondrial localisation in the brain of myc-coq8 flies. 
Genotypes shown are w1118/D42-GAL4;myc-coq8/+; UAS-mito-GFP, .(myc-coq8). 
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tagged COQ8A, but present in C-terminally tagged COQ8A.  
When the N-terminally myc-tagged results obtained here were compared to Cullen et al. 
(2016) the staining patterns were similar suggesting that functional coq8 is being 
produced (as observed by rescue of the coq8 KD phenotype) and that the N terminal is 
likely being cleaved and the functional portion of the protein that is localised to 
mitochondria is not being detected Due to this it was determined that a second coq8 
expressing fly, coq8-myc, with the myc tag on the C-terminal would be produced to 
assess mitochondrial expression. 
 
4.6 Subcloning of coq8-myc and generation of transgenic 
flies 
To further investigate the mitochondrial localisation of coq8, a second Drosophila coq8 
construct was created that contained a myc-tag placed on the C-terminus of the protein, 
which was referred to as coq8-myc. The DNA construct was synthesised by GenScript® 
and provided in the plasmid cloning vector pUC57 (appendix 9.8). Therefore it was 
necessary to subclone coq8-myc into pUASTattB (appendix 9.8) for germline 
transformation of Drosophila. 
4.6.1 Cloning coq8-myc 
The pUASTattB and pUC57/coq8-myc plasmids were both digested with XhoI and 
XbaI (methods 3.16.1). The pUASTattB vector was then treated with 1 µL of calf 
intestinal alkaline phosphatase (CIP) to prevent self-ligation. Both digests were run on 
an agarose gel (methods 3.16.3) (Figure 4.36 Gel A), and the 2,034 bp coq8-myc 
fragment and 8,489 bp linearised pUASTattB vector were gel purified (methods 3.16.4), 
(Figure 4.36 Gel B) then ligated (Table 3.4) (methods 3.16.5) and transformed into 
E.coli (methods 3.14.1). 
Following transformation, mini preparation (methods 3.14.3) of plasmid DNA was 
performed on eleven individual clones. These were digested with XhoI and XbaI 
(Figure 4.35) to identify recombinant clones. Clones 1 and 4 released the expected 




Figure 4.36 Cloning gels. Gel A: Lanes:1. 1kb plus ladder; 2 and 3, pUAST vector 
digested with XhoI and Xba; 4. pUC57/coq8-myc digested with XhoI and XbaI. Size 
is in base pairs. 
Gel B: Gel purified fragments for DNA ligation. Lanes: 1. Kb plus ladder, 2. 
pUAST, 3. coq8-myc; 4. pUAST. Size in base pairs. 
 
Figure 4.35 Restriction digests of plasmid clones. Each clone was 
digested with XhoI and XbaI to determine if the vector and insert were 




Clone 1 was selected, and further restriction digests were carried out to confirm the 
presence of the coq8-myc insert (Figure 4.37). The correct fragment sizes were obtained 
indicating that coq8-myc had been successfully cloned into pUASTattB. The insert was 
sequenced with forward and reverse primers (methods 3.16.7) which confirmed the 













Figure 4.37 Analytical restriction digests of pUAST/coq8-myc 















4.6.2 Generation of transgenic coq8-myc flies 
Midi preparations of pUAST/coq8-myc were performed (methods 3.14.2) to obtain 
high-quality DNA for microinjection. The plasmid was precipitated and resuspended in 
injection buffer (methods 3.15) and then microinjected into Drosophila embryos which 
carried a PhiC31 attP landing site at position VK37 (methods 3.17.3). A transgenic line 
was successfully obtained, and genetic crosses were then performed to obtain a stable 
homozygous line (methods 3.17.15). 
4.6.3  Characterisation of the mitochondrial localisation of N- 
and C-terminally tagged coq8 in the Drosophila brain 
Due to the possibility of an MTS present on the N-terminal of Drosophila myc-coq8, a 
second construct was made with the myc tag on the C-terminal (section 4.6). It was 
previously determined (section 4.5.2) that colocalisation was absent in N-terminally 
tagged wild-type coq8 with similar results reported in human COQ8A (Cullen et al., 
2016). 
Five D42 -GAL4;mito-GFP virgin females were crossed to five males that contained 








Uncut 10,523 37℃ 
XhoI/XbaI 8,489 37℃ 
 2,034  
SmaI 5,253 25℃ 
 3,615  
 1,655  
BamHI 7,380  
 3,165  
PstI 8,835 37℃ 
 849  
 372  
 243  
 151  
 56  
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coq8-myc and myc-coq8 had very similar expression profiles for mitoGFP (green) and 
myc (magenta) which suggested that both coq8 constructs were present at similar levels 
in the brain. High magnification optical slices (Figure 4.40) that were 1 µm thick 
showed that coq8-myc colocalised with mitoGFP (white) whereas myc-coq8 did not.  
 
 
Figure 4.38 Mitochondrial localisation of N- and C-terminally tagged Drosophila coq8. 
Immunofluorescent detection using mito-GFP and anti-myc in the neurons. Genotypes shown are 
w1118/D42-GAL4;myc-coq8/+; UAS-mito-GFP, .(myc-coq8) and w1118/D42-GAL4;coq8-myc/+; UAS-
mito-GFP, .(coq8-myc). 
 
These results suggest, similar to that of Cullen et al. (2016), the possibility of an MTS 
present on the N-terminal of coq8 which prevented myc-coq8 from colocalising with 
mitoGFP as it was cleaved before entry into the mitochondria. 
4.6.4 Using software to predict MTS present on Drosophila 
coq8 
Due to the differences that were seen in the mitochondrial localisation experiments 
(section 4.6.3) the following software was used to predict the presence of an MTS. Two 
of the four websites (Table 4.3) identified a 56 aa targeting sequence which was 
consistent with the findings by Cullen et al. (2016) where a mitochondrial targeting 
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sequence was present on the N-terminal of COQ8A. To further characterise this in 
Drosophila further experiments will be needed. 
 
Table 4.3 Websites used to determine the possibility of an MTS present on Drosophila coq8 
Website Protein ID Protein length MTS length 
















4.7 Generation and characterisation of flies that 
overexpress wild-type and mutant forms of human 
COQ8A 
The initial rescue experiments were performed using Drosophila wild-type and mutant 
coq8. The next logical step was to determine whether wild-type human COQ8A was 
able to rescue the coq8 KD phenotype. Human COQ8A and Drosophila coq8 are 
functionally conserved thus Drosophila could be used as a model for testing the impact 
of mutations on human COQ8A function. 
In humans, there are two forms of COQ8, COQ8A and COQ8B. Mutations to these 
genes result in very different mutant phenotypes. Patients with mutations in COQ8A 
present with cerebellar atrophy and gait ataxia with a decrease in CoQ levels (Horvath 
et al., 2012; Jacobsen et al., 2017; Lagier-Tourenne et al., 2008) while patients that 
present with COQ8B mutations have nephrotic conditions (Ashraf et al., 2013). It is 
unknown whether Drosophila coq8 or human COQ8A have similar functions in 
Drosophila so these and subsequent experiments will provide a better understanding of 
this. Sequences can be found in appendix 9.7 with plasmid maps in appendix 9.8. 
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4.7.1 Generation of fly stocks that overexpress wild-type or 
mutant forms of human COQ8A 
Wild-type human COQ8A and constructs corresponding to the maternal and paternal 
mutations were generated to characterise the expression of the human COQ8A variants 
(section 1.6 and Figure 4.15). L277P was generated via the incorporation of the point 
mutation into the wild-type open reading frame (ORF). The splice site mutation could 
not be modelled as if all the introns were included, the construct (appendix 9.7) was too 
large to synthesise, therefore the wild-type sequence was included up until the last 
amino acid prior to the splice site (L520*) and then the following sequence was 
included that was predicted to be expressed if the splice site was mutated. This 
corresponded to 29 amino acids until a stop codon was reached. The constructs were 
made as previously described (section 4.3.1) and were carried out by Dr Helen 
Fitzsimons. A crossing scheme can be found in appendix 9.5. 
4.7.2 Characterisation of survival resulting from the strong 
ubiquitous expression of wild-type and mutant forms of 
human COQ8A in a wild-type background 
Before determining whether overexpression of the wild-type human COQ8A, L277P or 
K502* human variants could rescue the coq8 knockdown phenotype (section 4.2) 
expression of each variant was assessed to determine the impact on development and 
survival in a wild-type background. 
Five virgin da-GAL4 virgins were crossed to five males from either control, coq8 KD, 
COQ8A, L277P, or K502* genotypes. Ubiquitous knockdown of Drosophila coq8 was 
previously characterised (section 4.2.1) and indicated larval lethality before pupation as 
well as severe developmental delay. Two independent crosses were counted for these 
experiments. Progeny was counted 24 days post cross (methods 3.4). 
Progeny counts (Figure 4.39) showed similar pupal development across all genotypes 
with 100% lethality seen in the coq8 KD pupae. While the number of COQ8A pupae 
was similar to the control, it appeared that in both males and females only around half 
the number eclosed when compared to the other genotypes, suggesting that human 
COQ8A might be causing lethality at the pupal stage. These observations are interesting 







Figure 4.39 Progeny counts for human COQ8A using the strong 
ubiquitous driver da-GAL4 at 21℃. Progeny were counted 22 
days post cross. The human COQ8A variants were expressed in 
the wild-type background to see the effects these mutations had on 
fly survival. Genotypes shown are w1118/+;daGAL4/+ (control); 
w1118/+;da-GAL4/coq8KD (coq8 KD) and w1118/+;da-




4.7.3 Characterisation of human COQ8A expression patterns 
in the Drosophila brain 
To examine whether wild-type and mutant variants of COQ8A localised to 
mitochondria, D42;UAS-mito-GFP flies were crossed to either COQ8A, L277P or 
K502* and brains dissected (methods 3.6) and processed for immunofluorescence as 
previously described (methods 3.7 and 3.8). An anti-COQ8A (anti-ADCK3) antibody 
was used to detect COQ8A (Table 3.1). 
Expression in control fly brains (Figure 4.40) showed nonspecific staining for both 
mito-GFP (green) and COQ8A (magenta) indicating a lack of human COQ8A 
expression, which was expected, however, mitoGFP expression was unusually low in 
these brains, and this experiment will need to be repeated. COQ8A brains showed 
specific COQ8A staining with a similar cytosolic expression profile to that seen in 
Drosophila coq8 (section 4.6.3). A similar pattern of expression was observed in α-
COQ8A expression was highest in L277P brains. COQ8A expression was absent in 
K502* brains which suggested that there was no expression of COQ8A in these flies 
consistent with the introduction of a premature stop codon resulting in the absence of 
COQ8A expression in the brain via nonsense-mediated decay of mRNA or protein 
degradation. While the expression pattern for the human variants is similar to that seen 
in the Drosophila variants (section 4.5.2) the amount of expression is somewhat 
different with wild-type COQ8A having less expression than L277P which was 
unexpected. High magnification optical slices were captured (Figure 4.41) to visualise 
the colocalisation of both mito-GFP and COQ8A in the fly brain. The mitochondrial 
localisation was observed for both wild-type COQ8A and L277P suggesting that human 







Figure 4.40 Immunohistochemistry of whole mount brains to characterise the expression of 
human COQ8A in Drosophila. Brains are labelled with anti-COQ8A and anti-GFP to determine 
localisation of COQ8A expression. Control (top) indicated that expression of COQ8A was absent 
in the Drosophila brain. Boxes indicated the areas in which the zoom captures were taken in the 
following figure. Anterior view of the brain. Genotypes shown are w1118/D42-GAL4; UAS-mito-
GFP/+ (control); w1118/D42-GAL4;COQ8A/+; UAS-mito-GFP, .(COQ8A), w1118/D42-






4.7.4 Characterisation resulting from the expression of wild-
type or mutant forms of human COQ8A in the 
Drosophila compound eye 
The impact of expression of wild-type COQ8A on the developing eye was examined. 
Crosses were carried out as previously described (methods 3.2) with flies being raised at 
 C for 30 days. Flies were then anesthetised and imaged (methods 3.5). As previously﮲25
observed, coq8 KD flies displayed black necrotic patches with the surface of the 
ommatidia somewhat smoothed showing a loss in cell shape and function. Expression of 
wild-type COQ8A, L277P and K502* did not affect normal eye development. 
 
 
Figure 4.41 High magnification of optic slices to assess expression of human COQ8A and 
L277P. Immunohistochemistry using mito-GFP and anti-COQ8A. Genotypes shown are 
w1118/D42-GAL4; UAS-mito-GFP/+ (control); w1118/D42-GAL4;COQ8A/+; UAS-mito-GFP, 






4.8 Determination of whether wild-type or mutant human 
COQ8A could rescue the coq8 knockdown phenotype 
The ubiquitous knockdown of Drosophila coq8 resulted in larval lethality and severe 
developmental delay (section 4.2.1). Reintroduction of wild-type Drosophila coq8 into 
the knockdown background rescued larval lethality (section 4.4.3). 
4.8.1 Generation of Drosophila fly lines that express wild-
type or mutant forms of human COQ8A in a knockdown 
background 
To assess whether the COQ8A, L277P or K502* transgenes could rescue the coq8 KD 
phenotypes, they were first recombined into the same fly line as coq8 KD. 
Unfortunately, due to time constrictions the only rescue experiment conducted was 
using the eye driver GMR-GAL4 with wild-type COQ8A and L277P. 
4.8.2 Characterisation of the phenotypes resulting from the 
reintroduction of wild-type or mutant human COQ8A 
into a knockdown background expressed in the 
Drosophila compound eye 
To determine whether the expression of wild-type COQ8A or L277P could rescue the 
necrotic phenotype resulting from knockdown of coq8, KD;COQ8A and KD;L277P 
Figure 4.42 GMR-GAL4 characterisation experiments to determine the effect COQ8A variants 
have in the compound eye of Drosophila. Necrosis is evident in the KD eye but is absent in the 
others. Genotypes shown are w1118/+;GMR-GAL4/+ (control); GMR-GAL4/CG32649KD, (coq8 
KD) GMR-GAL4/ COQ8A (COQ8A), GMR-GAL4/ L277P (L277P), GMR-GAL4/ K502* (K502*). 
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flies were crossed to GMR-GAL4 flies as previously described (methods 3.4). Imaging 
took place 30 days post cross (methods 3.5). 
 
 
Control and coq8 KD flies presented with a similar phenotype to that seen in the initial 
characterisation experiments (Figure 4.13). Control flies displayed normal development 
in the eye while coq8 KD flies contained black necrotic patches. Flies that expressed 
KD;COQ8A presented with an unanticipated glossy eye. This mutant phenotype was 
similar to the glossy eye phenotype seen in (Yarosh et al., 2008) resulting from loss of 
expression of the Drosophila optic atrophy 1 (dOpa1) gene, which is a homologue of 
human OPA1 a gene most commonly mutated in optic atrophy cases in humans. The 
dOpa1 gene is an essential gene in mitochondrial function (Yarosh et al., 2008). This 
could suggest that COQ8A is impairing normal mitochondrial function. In flies that 
expressed KD;L277P flies present with small spots of necrosis in the eye. This 
phenotype is more consistent with a rescue phenotype seen previously (section 4.4.7.1). 
While these results are preliminary due to the absence of the KD;K502* construct to use 
as a comparison in these human rescue experiments, it was evident that wild-type 
Figure 4.43 Rescue experiments using the highly specific eye driver GMR-GAL4 at 25℃. Genotypes 
shown are w1118/+;GMR-GAL4/+ (control); GMR-GAL4/coq8KD, (coq8 KD) GMR-GAL4/ 
coq8KD;COQ8A (KD;COQ8A), and GMR-GAL4/coq8KD; L277P (KD;L277P). 
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COQ8A may have a different or additional function in Drosophila than COQ8A and 
furthermore, human COQ8A expression appears to enhance the deleterious phenotype 
resulting from coq8 KD, suggesting it may be further impairing mitochondrial function. 
These experiments will need to be explored further to gain a better understanding of the 




Whole exome sequencing is increasingly being used to identify genetic mutations which 
may be responsible for a disease state. With many of these mutations currently 
uncharacterised, functional studies provide the means to characterise these mutations 
and determine whether the genetic mutations are responsible for the mutant phenotype. 
It has been previously determined that human COQ8A mutations can result in cerebellar 
atrophy, gait ataxia and CoQ10 deficiency. Mutations to COQ8A can occur in a number 
of different places in the gene resulting in highly variable disease phenotypes (Barca et 
al., 2016; Blumkin et al., 2014; Cullen et al., 2016; Gerards et al., 2010; Hikmat et al., 
2016). Therefore, a model system such as Drosophila was needed to functionally 
characterise individual mutations. The project involved using, developing and 
characterising a model of coq8 deficiency and then introducing both wild-type and 
variant forms of Drosophila coq8 and human COQ8A to mimic the mutations found by 
Jacobsen et al. (2017) to determine whether they had impaired coq8 function. 
5.1 Ubiquitous knockdown of coq8 is lethal 
The ubiquitous knockdown of coq8 in Drosophila resulted in severe developmental 
delay and larval lethality (section 4.2.1) when driven by da-GAL4 and the weaker arm-
GAL4 driver line (section 4.2.2). The results suggested that coq8 is a crucial gene for 
survival in Drosophila which is consistent with the role coq8 plays in mitochondrial 
function (Barca et al., 2014). Reintroduction of wild-type coq8 (myc-coq8) resulted in a 
partial rescue of the knockdown phenotype where an increase in the number of pupae 
was seen when compared to coq8 KD (section 4.4.3). This was also the first indication 
that the knockdown phenotype was due to the loss of coq8 and not an off-target effect 
due to RNAi expression. While it did not rescue the knockdown phenotype enough to 
result in viable adult progeny, progression to pupations was evident. Based on the loss 
of locomotor ability seen in the climbing assays (section 4.2.3.4, 4.3.4 and 4.4.6) it is 
possible that a decrease in coordination and muscle tone prevented adults from 
emerging from their pupal casings. In some instances, the pupal casings were opened, 
and heads were visible, but adult flies had died while emerging. However, most pupae 
had reached P12 which is the final stage of pupation. 
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5.2 Pan-neuronal knockdown of coq8 was lethal in males 
and impaired locomotor activity in females 
On restriction of the knockdown of coq8 to neurons, a semi-lethal phenotype was 
observed which resulted in the pupal death of male progeny, again the pupae reached 
P12, suggesting that impaired neuronal function resulted in the inability to emerge 
(section 4.2.3). Having viable female progeny enabled the detection of a decrease in 
locomotor ability in coq8 KD flies (section 4.2.3.4). This decrease in locomotor ability 
was reminiscent of the gait ataxia seen in humans afflicted with COQ8A mutations 
(Barca et al., 2014; Gerards et al., 2010; Jacobsen et al., 2017; Liu et al., 2014). 
Reintroduction of the wild-type coq8 (myc-coq8) variant resulted in a partial rescue of 
the knockdown phenotype (section 4.4.6). 
It is not clear why elav-driven expression of coq8 RNAi was only lethal in males, but it 
is possible that it may have been a result of dosage compensation. Dosage compensation 
in Drosophila occurs on the male X chromosome (Gelbart & Kuroda, 2009; Lucchesi & 
Kuroda, 2015). Drosophila males transcribe their X chromosome genes two-fold to 
express X chromosome genes to a similar level as females who contain two X 
chromosomes. Drosophila coq8 is located on the X chromosome 
(http://flybase.org/reports/FBgn0052649.html) as is elav-GAL4. If the level of 
expression of GAL4 or coq8 RNAi differs between males and females, it is possible that 
the level of knockdown also differs, leading to an increase in male lethality. It has also 
been noted that some X chromosome genes are dosage-sensitive and that sensitivity is 
more likely to affect genes that are a part of a multiprotein complex (Pessia, Makino, 
Bailly-Bechet, McLysaght, & Marais, 2012) and this could be the case with Drosophila 
coq8 as human COQ8A is thought to function in a regulatory capacity in the CoQ 
biosynthetic pathway(Quinzii & Hirano, 2010). 
5.3 A reduction in coq8 results in decreased ATP 
production but no noticeable effect on neuronal 
integrity or survival 
ATP production, which occurs in the mitochondria of eukaryotes, was also assessed to 
determine whether the loss of coq8 would affect ATP levels. It had been previously 
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determined that COQ8A was involved in electron shuttling from complex I and 
complex II to complex III in the MRC (Grant et al., 2010; Lagier-Tourenne et al., 2008; 
Stefely et al., 2015). Results indicated that in the absence of coq8 in Drosophila there 
was a decrease in ATP production (section 4.2.5). This indicated that coq8 is necessary 
for the production of ATP in Drosophila. As these experiments were carried out on one 
set of larvae and flies, it is necessary to repeat the experiment to determine reliability in 
the current results. 
It was expected that coq8 KD fly brains would exhibit some defects that would be easily 
distinguishable from those of wild-type flies. This idea was based on the assumption 
that human COQ8A results in cerebellar ataxia which often results in a 
neurodegenerative phenotype (Horvath et al., 2012; Jacobsen et al., 2017; Lagier-
Tourenne et al., 2008; Mollet et al., 2008). Initial experiments looked at the gross 
anatomical structure of the brain (section 4.2.3.2), but no developmental nor 
neurodegenerative abnormalities (such as vacuoles) were seen. Due to the 
neurodegenerative phenotype evident in humans, apoptosis was assessed via analysis of 
caspase activation. This was with an anti-cleaved Dcp1 antibody (section 4.2.3.2) and 
Apoliner. (section 4.2.3.3). When compared to the severe phenotype seen in the eye, 
this suggests the brain is far more resistant to the effects of reduced CoQ production. 
5.4 I295P substitution impairs coq8 function within the 
KxGQ motif 
The mutations of KxGQ, in the case of Drosophila I295P and human L277P, may affect 
the autoinhibitory function of the KxGQ domain which folds and occludes the substrate 
binding pocket in COQ8A (Stefely et al., 2015). As well as affecting the autoinhibitory 
function of KxGQ, the KxGQ residues are also a part of the QKE triad which aids in 
inhibiting protein kinase activity (Stefely et al., 2015). If the autoinhibitory function of 
KxGQ and the QKE triad are absent, due to the presence of the I295P and L277P 
mutations, the substrate binding pocket is able to bind substrates, and activation of 
protein kinase activity could occur. It has been previously determined that the QKE 
triad is essential for CoQ biosynthesis (Stefely et al., 2015). In addition to this 
Drosophila L520* mutation is located in regions that are capable of having active 
kinase function (Stefely et al., 2015). A salt bridge is present between K358 and E411 
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while cation-binding is present between N493 and D507. The L520* mutation results in 
a truncated protein product lacking a portion of the protein kinase domain. Due to the 
decrease in myc expression seen in L520* (section 4.5.1), it is possible that the loss of 
the C-terminus, due to the truncation at L520*, may be responsible for the decrease in 
expression. This could suggest that the C-terminus could be responsible for either 
mRNA or protein stability. As a result, mRNA could be degraded via nonsense-
mediated decay. The G549S and E552K mutations mentioned previously (Table 1.2) 
result in decreased protein stability (Lagier-Tourenne et al., 2008) As this is integral for 
proper function of coq8 L520* was non-functional (section 4.5). In addition, the results 
from these experiments suggest that the loss of the protein kinase domain in the L520* 
and K502 mutants is vital for coq8 stability vs the loss of the autoinhibitory function of 
the KxGQ domain and the QKE triad as mutants harbouring the I295P and L277P 
mutations were present in similar patterns to those seen in the wild-type variants and 
also expressed to a greater extent than to that of the truncated protein products.  
5.5 coq8 is required for eye development 
Knockdown of coq8 in the Drosophila eye resulted in severe necrosis and 
neurodegeneration, resulting in a worsening phenotype over time (section 4.2.4). When 
the wild-type coq8 was expressed in coq8 KD eyes, there was an almost complete 
rescue of the necrotic phenotype with a small patch or a complete lack of necrosis. 
There also appeared to be some rescue in I295P which suggests it may retain some 
activity. However, there was a worsening of the knockdown phenotype in the presence 
of the L520* variant. The L520* mutant resulted in a truncated protein product and 
possibly the degradation of mRNA. This loss of protein production leads to a worsening 
of the coq8 knockdown phenotype suggesting that coq8 production is essential for the 
proper development of the Drosophila compound eye. 
5.6 Human COQ8A exacerbated the coq8 KD eye 
phenotype 
The glossy eye phenotype present in KD;COQ8A flies (section 4.8.2) was unexpected 
and could be because human COQ8 is present in two isoforms, COQ8A and COQ8B, 
whereas Drosophila only has one isoform coq8. COQ8B mutations often result in 
nephrotic conditions and disruption of CoQ biosynthesis in humans (Ashraf et al., 2013) 
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and may be integral for proper function in Drosophila. The glossy eye phenotype was 
previously reported by Yarosh et al., (2008) where the Drosophila optic atrophy 1 
(dOpa1) gene was mutated. It was determined that the dOpa1 is essential for 
mitochondrial function and could suggest human COQ8A functions in a similar 
capacity in Drosophila. However, due to the inability for COQ8A to rescue the mutant 
phenotype and also the presence of a more severe mutant phenotype, it is possible that 
COQ8A may impair eye function due to a dominant adverse effect.  
5.7 Mitochondrial localisation of wild-type coq8 and 
COQ8A 
It is well known that COQ8A functions in the MRC and is located in the inner 
mitochondria membrane (Jacobsen et al., 2017; Lagier-Tourenne et al., 2008; Liu et al., 
2014). Cullen et al. (2016) determined that there was an MTS present on the N-terminal 
of COQ8A. Similar experiments were carried out in this project where adult fly brains 
expressing each Drosophila coq8 or human COQ8A variant were stained using primary 
antibodies targeted to either COQ8A (human) or myc (Drosophila). Mito-GFP was also 
expressed in the brains to determine Drosophila coq8 or human COQ8A localisation. 
Confocal microscopy determined colocalisation in most cases with the intensity of 
staining extremely faint in the L520* and K502* variants (section 4.5.2 and 4.7.3). 
Colocalisation occurred in human COQ8A, L277P and Drosophila coq8-myc. 
Colocalisation was not seen in Drosophila myc-coq8 due to the myc tag being present 
on the N-terminal of the protein. This indicated that similar to the findings of Cullen et 
al. (2016) there may be an MTS present on the N-terminal of Drosophila coq8. When 
the amino acid sequence for Drosophila coq8 was run through a number of websites to 
identify the presence of an MTS the results indicated a possibility that there may be a 
targeting sequence present, but there were mixed results (section 4.6.4). For two of the 
five websites used it was predicted that there was a 56 aa sequence that is likely to be a 
MTS. Further assays will need to be conducted in Drosophila to determine whether this 
is true. 
6 Future work 
The rescue of lethality, climbing ability and necrotic eye phenotype by wild-type coq8 
suggests that the coq8 RNAi was explicitly targeting coq8 mRNA. However, RT-qPCR 
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should be performed to confirm that there is a significant decrease in the expression 
levels of coq8 in coq8 KD flies. It would be beneficial to compare the expression levels 
of coq8 KD and coq8 KD2 to ensure that coq8 KD did indeed have a stronger 
knockdown than coq8 KD2 as suspected in section 4.2.1. It may also be beneficial to do 
qRT-PCR on flies expressing wild-type and mutant forms of Drosophila coq8 and 
human COQ8A as well as all KD;coq8 variants and KD;COQ8A variants this is 
particularly important for the L520* mutant in order to determine whether the lack of 
protein expression is a result of the loss of mRNA or protein instability. Expression 
levels would give a quantitative measure for the knockdown phenotypes seen during the 
project. Barca et al. (2016) determined that a mutation (c.1511_1512delCT) in COQ8A, 
although it showed no change in mRNA levels, saw a severe decrease in protein 
stability suggesting that post-translational degradation occurred in the mutant. 
Due to the possibility of an MTS present in Drosophila coq8 using MTS prediction 
websites, it may be helpful to perform western blotting for both myc-coq8 and coq8-
myc to determine the presence or absence of the myc-tag. In the presence of a MTS, it 
would be expected that myc-coq8 would not appear when using an anti-myc antibody 
due to the N-terminal cleavage of the MTS. In contrast, it would be expected that a band 
would be present for coq8-myc which would occur at the appropriate band size of that 
for coq8. 
Preliminary results were obtained during the characterisation experiments for both 
Drosophila coq8 (section 4.3) and human COQ8A (section 4.7) variants when 
expressed in a wild-type background. More experiments are needed to obtain statistical 
significance. Once these are obtained an interpretation of the results will be supported 
statistically. 
It is necessary to complete the characterisation experiments for the climbing assays and 
all of the rescue experiments for the human COQ8A variants in Drosophila (section 
4.8) to assess whether the knockdown phenotype can be rescued by either wild-type 
COQ8A or either mutant variant. The difference in COQ8A expression in the wild-type 
background (section 4.7.2) is of interest as a more severe mutant phenotype emerged 
(section 4.8.2) suggesting that COQ8A has a different function to Drosophila coq8. 
Human COQ8 exists as two isoforms COQ8A (also known as ADCK3) and COQ8B 
(ADCK4) (Ashraf et al., 2013) both resulting in very distinctive mutant phenotypes. 
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The KD;K502* rescue construct must be completed for characterisation. Once all three 
constructs, KD;COQ8A, KD;L277P and KD;K502*, are completed rescue experiments 
can be completed as done so for the Drosophila variants (section 4.4). 
Expression of the wild-type and mutant forms of Drosophila coq8 in a wild-type 
background indicated that both myc-coq8 (wild-type) and I295P did not have a negative 
impact of Drosophila survival while L520* resulted in a decrease in progeny numbers, 
and decreased locomotor ability (section 4.3.4). To mimic the mutant phenotype seen in 
the case study by Jacobsen et al. (2016) it would be interesting to combine both 
Drosophila mutant variants into the same fly line and characterise the effects of 
compound heterozygous inheritance in Drosophila. This would aid in the understanding 
of the working model that Drosophila provided in this project and also shed some light 
on the homology and efficacy associated with Drosophila as a functional model for 
human disease. 
Loss of coq8 in the eye resulted in impaired formation of the ommatidial lattice (section 
4.2.4) it may be beneficial to delve deeper into the eye by looking at individual 
ommatidia, which contain secreting cone cells, photoreceptor neurons, and bristle cells 
in order to determine the effect the loss of coq8 has on the compound eye. Both adult 
and larval eye dissections (Williamson & Hiesinger, 2010) would be able to further 
characterise the role coq8 plays eye development. Immunohistochemistry could be 
implemented to determine the presence or absence of specific cells present in each 
ommatidium (Hsiao et al., 2012). As ommatidia are arranged in a regular and consistent 
array, any changes would be due to the presence of absence of Drosophila coq8 or 
human COQ8A in Drosophila. Another possibility would be the use of antibodies 
targeting to specific caspase initiators and effectors to determine the role coq8 plays in 
the eye (Yu et al., 2002). 
An additional parameter that could be introduced into the project could be the impact 
age has on climbing ability and survival in flies expressing coq8 RNAi. As there was a 
noticeable disparity seen in climbing ability of flies expressing coq8 RNAi and the 
mutant variants (section 4.2.3.4, 4.3.4, and 4.4.6) it may be beneficial to conduct 
climbing assays at specified time points to see if age influences climbing ability over 
time. Morbidity experiments could also be conducted to assess the impact coq8 RNAi 
has on lifespan in Drosophila. In flies that are heterozygous for the small boy (sbo) 
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gene, which is the Drosophila homologue of human COQ2, a 12.5% increase in male 
lifespans and a 30.8% increase in females was observed (Liu et al., 2011). 
It has been previously described that an increase in oxidative stress and a decrease in 
ATP production is correlated with the decrease of CoQ biosynthesis (Quinzii et al., 
2010). During this project, it was established that there was a decrease in ATP 
production due to the loss of coq8 in Drosophila (section 4.2.5). It would be beneficial 
to assess the levels of reactive oxygen species (ROS) in the Drosophila brain. 
Dihydroethidium (Thermo-Fisher), which is a superoxide detection mechanism, could 
be used to assess the presence of ROS in the brain. Blue fluorescence is present in the 
cytosol of the cell until it is oxidised, at this point the stain intercalates with DNA and 
results in the presence of a red stain in the nucleus. In the presence of ROS, there would 
be an increase red fluorescence seen in the cells. 
While Drosophila coq8 rescue experiments were able to partially rescue some of the 
knockdown phenotypes (section 4.4) CoQ levels were not evaluated. The most common 
and also most treatable phenotypes in human COQ8A mutations is a decrease in CoQ 
levels. To determine the effect, the loss of coq8 had in Drosophila it would be 
beneficial to determine the CoQ levels of CoQ8 (5%), CoQ9 (89%), CoQ10 (13%) which 
are the most common forms of CoQ in Drosophila, via HPLC. By identifying the 
amount of CoQ present in coq8 KD flies, CoQ supplementation amounts could be 
determined and administered. 
7 Conclusion 
Drosophila is an excellent model for biomedical research due to its genetic tractability 
and the ability to use a number of genetic tools to investigate the inner working of a 
disorder that is often not possible in humans. Whole exome sequencing can determine 
the identity of genetic mutations responsible for a disease state. As the output of this 
information increases, a model system is needed to functionally characterise them. 
Drosophila provides the means to characterise the effects of Drosophila coq8 variants, 
and human COQ8A variants had on Drosophila. The loss of Drosophila coq8 resulted 
in larval lethality, developmental delay, a decrease in locomotor ability, a decrease in 
ATP production as well as necrosis and neurodegeneration. Reintroduction of wild-type 
Drosophila coq8 resulted in a rescue in locomotor ability and partial rescue in necrosis 
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in the eye. This indicated that the loss of coq8 was responsible for the knockdown 
phenotype. Reintroduction of I295P and L520* did not rescue the knockdown 
phenotypes, although there was a slight improvement with I295P indicating it may 
retain some function. Reintroduction of COQ8A into the knockdown background 
resulted in a new phenotype in the compound eye. The glossy eye phenotype was 
previously described in the dOpa1gene which is involved in mitochondrial function. 
This suggests that human COQ8A impairs mitochondrial function. 
Here, we have shown that Drosophila can be used to investigate and functionally 
characterise the effects of the loss of coq8 on a range of neuronal phenotypes by aiding 
in the understanding of coq8 function in humans. Due to the highly conserved nature of 
essential genes Drosophila aid in our understanding of how a gene functions and in 
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9.1 Fly lines 
Table 9.1 Transgenic fly lines used during the project. 
Name Genotype Phenotype Source 









3B}VK37, UAS-coq8 WT Insert 
into VK37(2L) 22A3 
Red eyes Genetivision 
I295P y[1]w[67c23]; PBac{y+-attP-
3B}VK37, UAS-coq8 I295P 
Insert into VK37(2L) 22A3 
Red eyes Genetivision 
L520* y[1]w[67c23]; PBac{y+-attP-
3B}VK37, UAS-coq8 L520* 
Insert into VK37(2L) 22A3 
Red eyes Genetivision 
coq8-myc y[1]w[67c23]; PBac{y+-attP-
3B}VK37, UAS-coq8-myc WT. 
Insert into VK37(2L) 22A3 
Red eyes Helen 
Fitzsimmons 
COQ8A y[1]w[67c23]; PBac{y+-attP-
3B}VK37, UAS-hCOA8A WT* 





3B}VK37, UAS-hCOQ8A L277P 
Insert into VK37(2L) 22A3 
Orange eyes Genetivision 
K502 y[1]w[67c23]; PBac{y+-attP-
3B}VK37, UAS-hCOQ8A 













VP16. Insert into VK37(2L) 
22A3 
Red eyes Genetivision 





3B}VK00037 22A3 2L 
White eyes BDSC 
24872 
 
9.2 RNAi lines 
Table 9.2 RNAi lines obtained from VDRC to reduce Drosophila coq8 expression in order to 
characterise the knockdown phenotype. 
RNAi Name Genotype Phenotype Source 
coq8 RNAi 1 w[1118];P[GD113
06]v26534 
CG32649 
Red eyes VDRC 
coq8 RNAi 2 y,w[1118];P[attP,y[
+],w[3’],KK10796
6 CG32649 




9.3 Driver lines 
Table 9.3 GAL4 driver lines used to drive transgenic expression in Drosophila. 
Driver 
Lines 


























































9.4 Restriction enxymes 
Table 9.4 List of restriction enzymes used during this cloning experiments including the restriction 
cutting sequences, the buffer used for each restriction enzyme, the incubations and deactivation 









XhoI C/TCGAG Cutsmart 37℃ 65℃ BioLabs 
XbaI T/CTAGA Cutsmart 37℃ 65℃ BioLabs 
BamHI G/GATCC 3.1 37℃ No BioLabs 
SalI G/TCGAC 3.1 21℃ 65℃ BioLabs 
PstI CTGCA/G 3.1 37℃ 80℃ BioLabs 
SmaI CCC/GGG Cutsmart 25℃ 65℃ BioLabs 
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9.5 Crossing schemes 
Figure 9.1 Crossing scheme used to create the elav-GAL4/Apoliner driver line for 
the visualisation of apoptosis in Drosophila. 
The pairs of horizontal lines represent pairs of chromosomes in Drosophila. 
Females are displayed on the left with males on the right. The male Y chromosome 
is depicted as a half arrow. Each cross begins with a virgin female crossed to a 
male of the appropriate genotype.  
elav-GAL4 virgin females are crossed to UAS-Apoliner males. 
Male progeny produced from cross 1 are crossed to virgin females that contain the 
Cyo/Sco balancer chromosome on the 2nd chromosome. 
Curly progeny produced from cross 2 that contain elav-GAL4;UAS-Apoliner 
(glowing under fluorescent microscope) were crossed together to create a 
homozygous stock. Progeny that emerge from this cross with normal wings are 




Figure 9.2 Crossing scheme for the generation of Drosophila coq8 variants expressed in a 
knockdown background. Flies of the desired genotype from each cross (boxed), were selected for 
the following cross. All fly lines are in a w- (white) genetic background. Both coq8 KD and each 
coq8 transgene construct also contain the w+ minigene which confers orange eyes, allowing flies 
carrying the transgenes to be selected. The presence of both coq8 KD and the coq8 transgene 
results in red eyes, which allows for selection of male flies in which both constructs have 
recombined onto the same chromosome in cross #2. The balancer chromosome CyO prevents 
recombination in females. Cy is a dominant mutation resulting in curly wings. After cross #3, red 




9.6 Sequence Alignment 
Figure 9.3 sequence alignment between yeast COQ8, Drosophila coq8 and human 
COQ8A with mutants identified by Jacobsen et al. (2017) highlighted. The KxGQ 
motif is also highlighted (outlined) to indicate the highly conserved nature the motif. 





9.7 Sequences for fly lines created during the project 
Wild-type myc-coq8 
Myc tag is highlighted in bold 
 
atggagcagaagctgattagtgaggaggacctgggaacaagccgcagtgcccaggaggcc 
 M  E  Q  K  L  I  S  E  E  D  L  G  T  S  R  S  A  Q  E  A  
gccgccctgctgcgcggactgcgcattctgctggaggcctgcggacgcgagcacctggcc 
 A  A  L  L  R  G  L  R  I  L  L  E  A  C  G  R  E  H  L  A  
cacggccgccacctgtggagcaacagctccatccgcgagctgatcgccgagaatgtggcc 
 H  G  R  H  L  W  S  N  S  S  I  R  E  L  I  A  E  N  V  A  
cacacccagcagctggtgcgcagcagcagccagaacccaaccgaggagctgaagaagctg 
 H  T  Q  Q  L  V  R  S  S  S  Q  N  P  T  E  E  L  K  K  L  
cagcagaccgtgaaggagacgggagagcgcggatacgtggtggccaagggcatctgcagc 
 Q  Q  T  V  K  E  T  G  E  R  G  Y  V  V  A  K  G  I  C  S  
ctgctggagacgaagatcaagatgagccgcgaggagtcggccatctcggagccagcccag 
 L  L  E  T  K  I  K  M  S  R  E  E  S  A  I  S  E  P  A  Q  
gtgtcgagcatccgcaagtccacccccaccgcccagaaccccgcctcgtgggacgccgcc 
 V  S  S  I  R  K  S  T  P  T  A  Q  N  P  A  S  W  D  A  A  
aacctggacatcagcagcatcaccctgcaggagttcgaggagatcctgtcccgccgcaat 
 N  L  D  I  S  S  I  T  L  Q  E  F  E  E  I  L  S  R  R  N  
aaggaccgcagcgtgtccctgcgcacccccgccaccaagagcaaccagaccatgcccaag 
 K  D  R  S  V  S  L  R  T  P  A  T  K  S  N  Q  T  M  P  K  
aaggagacgagcaccaatccaggcatcatcacccaggataccgagtacgtgaacaatgtg 
 K  E  T  S  T  N  P  G  I  I  T  Q  D  T  E  Y  V  N  N  V  
ctgcgcttcgtggccggagccaaggtggaggagcagcccccagatgcccagcccaagaag 
 L  R  F  V  A  G  A  K  V  E  E  Q  P  P  D  A  Q  P  K  K  
aagagcgatcagccagccatcgaggtgcccgagctgtcgaaggtggccaagcagcgcaag 
 K  S  D  Q  P  A  I  E  V  P  E  L  S  K  V  A  K  Q  R  K  
gtgccaagctcccgcattggacgcatggcctcgttcggcggcctgttcgccggcctgggc 
 V  P  S  S  R  I  G  R  M  A  S  F  G  G  L  F  A  G  L  G  
ctgggcaccctgaacgagctgaccaagggcgccctgggcctgggcggctcgacctccatg 
 L  G  T  L  N  E  L  T  K  G  A  L  G  L  G  G  S  T  S  M  
cgcgaggccctgctgtcccccgccaatgccgagcgcatcgtggacaccctgtgcaaggtg 
 R  E  A  L  L  S  P  A  N  A  E  R  I  V  D  T  L  C  K  V  
cgcggcgccgccctgaagattggacagatcctgtccatccaggattcgagcgtggtgtcg 
 R  G  A  A  L  K  I  G  Q  I  L  S  I  Q  D  S  S  V  V  S  
ccacagctggccaaggccttcgagcgcgtgcgccaggccgccgactacatgcccgattgg 
 P  Q  L  A  K  A  F  E  R  V  R  Q  A  A  D  Y  M  P  D  W  
caggtggagcgcgtgatgaacacccagctgggagccgactggcgccagcgcctgaagtcg 
 Q  V  E  R  V  M  N  T  Q  L  G  A  D  W  R  Q  R  L  K  S  
ttcgaggataagcccttcgccgccgccagcattggacaggtgcaccgcgccaccctgtcc 
 F  E  D  K  P  F  A  A  A  S  I  G  Q  V  H  R  A  T  L  S  
gacggcatggatgtggccatcaagatccagtacccgggagtggcccagagcattgagtcc 
 D  G  M  D  V  A  I  K  I  Q  Y  P  G  V  A  Q  S  I  E  S  
gacatcgacaacctggtgggcatgctgaaagtgtgggacgtgttcccgcagggcttcttc 
 D  I  D  N  L  V  G  M  L  K  V  W  D  V  F  P  Q  G  F  F  
atcgataatgtggtgcgcgtggccaagcgcgagctgcagtgggaggtggattacgaccgc 
 I  D  N  V  V  R  V  A  K  R  E  L  Q  W  E  V  D  Y  D  R  
gaggccgagtacaccgagaagttccgcgagatgatcgccccatacccggagtactacgtg 
 E  A  E  Y  T  E  K  F  R  E  M  I  A  P  Y  P  E  Y  Y  V  
ccgcgcgtggtgcgcgacctgaccacctcctcggtgctgaccaccgagctggtgccgggc 
 P  R  V  V  R  D  L  T  T  S  S  V  L  T  T  E  L  V  P  G  
gtgccactggacaagtgcttcgatctgtcgtacgagcaccgccgccacattgccgccagc 




 V  L  K  L  C  L  R  E  L  F  E  I  E  C  M  Q  T  D  P  N  
tggagcaatttcctgtacgatgccccgtcccgccgcctgatgctgattgacttcggcagc 
 W  S  N  F  L  Y  D  A  P  S  R  R  L  M  L  I  D  F  G  S  
acccgcttctaccgccacgagttcatccgcaactaccgccgcgtgatcatgtcggccgcc 
 T  R  F  Y  R  H  E  F  I  R  N  Y  R  R  V  I  M  S  A  A  
gagaacaatcgccagggagtgctggagatgtcccgcgagatgggcttcctgaccggctac 
 E  N  N  R  Q  G  V  L  E  M  S  R  E  M  G  F  L  T  G  Y  
gagacgaagcagatggagcaggcccacgtggatgccgtgatgatcctgggcgagattttc 
 E  T  K  Q  M  E  Q  A  H  V  D  A  V  M  I  L  G  E  I  F  
cgctacgatggcgacttcgatttcggccgccagaataccaccgagcgcctggccgccctg 
 R  Y  D  G  D  F  D  F  G  R  Q  N  T  T  E  R  L  A  A  L  
gtgcccacgatggtggcccaccgcctgtgcccacccccggaggagatttactcgatccac 
 V  P  T  M  V  A  H  R  L  C  P  P  P  E  E  I  Y  S  I  H  
cgcaagctgagcggcatcttcctgctgtgcgcccgcctgaatgtgcgcatgaattgcgtg 
 R  K  L  S  G  I  F  L  L  C  A  R  L  N  V  R  M  N  C  V  
ccgttttacaaggacatcgtgctgggaaagtttaaggattaa 





Myc tag is highlighted in bold 
I295P mutation is highlighted in red 
 
atggagcagaagctgattagtgaggaggacctgggaacaagccgcagtgcccaggaggcc 
 M  E  Q  K  L  I  S  E  E  D  L  G  T  S  R  S  A  Q  E  A  
gccgccctgctgcgcggactgcgcattctgctggaggcctgcggacgcgagcacctggcc 
 A  A  L  L  R  G  L  R  I  L  L  E  A  C  G  R  E  H  L  A  
cacggccgccacctgtggagcaacagctccatccgcgagctgatcgccgagaatgtggcc 
 H  G  R  H  L  W  S  N  S  S  I  R  E  L  I  A  E  N  V  A  
cacacccagcagctggtgcgcagcagcagccagaacccaaccgaggagctgaagaagctg 
 H  T  Q  Q  L  V  R  S  S  S  Q  N  P  T  E  E  L  K  K  L  
cagcagaccgtgaaggagacgggagagcgcggatacgtggtggccaagggcatctgcagc 
 Q  Q  T  V  K  E  T  G  E  R  G  Y  V  V  A  K  G  I  C  S  
ctgctggagacgaagatcaagatgagccgcgaggagtcggccatctcggagccagcccag 
 L  L  E  T  K  I  K  M  S  R  E  E  S  A  I  S  E  P  A  Q  
gtgtcgagcatccgcaagtccacccccaccgcccagaaccccgcctcgtgggacgccgcc 
 V  S  S  I  R  K  S  T  P  T  A  Q  N  P  A  S  W  D  A  A  
aacctggacatcagcagcatcaccctgcaggagttcgaggagatcctgtcccgccgcaat 
 N  L  D  I  S  S  I  T  L  Q  E  F  E  E  I  L  S  R  R  N  
aaggaccgcagcgtgtccctgcgcacccccgccaccaagagcaaccagaccatgcccaag 
 K  D  R  S  V  S  L  R  T  P  A  T  K  S  N  Q  T  M  P  K  
aaggagacgagcaccaatccaggcatcatcacccaggataccgagtacgtgaacaatgtg 
 K  E  T  S  T  N  P  G  I  I  T  Q  D  T  E  Y  V  N  N  V  
ctgcgcttcgtggccggagccaaggtggaggagcagcccccagatgcccagcccaagaag 
 L  R  F  V  A  G  A  K  V  E  E  Q  P  P  D  A  Q  P  K  K  
aagagcgatcagccagccatcgaggtgcccgagctgtcgaaggtggccaagcagcgcaag 
 K  S  D  Q  P  A  I  E  V  P  E  L  S  K  V  A  K  Q  R  K  
gtgccaagctcccgcattggacgcatggcctcgttcggcggcctgttcgccggcctgggc 
 V  P  S  S  R  I  G  R  M  A  S  F  G  G  L  F  A  G  L  G  
ctgggcaccctgaacgagctgaccaagggcgccctgggcctgggcggctcgacctccatg 
 L  G  T  L  N  E  L  T  K  G  A  L  G  L  G  G  S  T  S  M  
cgcgaggccctgctgtcccccgccaatgccgagcgcatcgtggacaccctgtgcaaggtg 
 R  E  A  L  L  S  P  A  N  A  E  R  I  V  D  T  L  C  K  V  
cgcggcgccgccctgaagcccggacagatcttgtccatccaggattcgagcgtggtgtcg 
 R  G  A  A  L  K  P  G  Q  I  L  S  I  Q  D  S  S  V  V  S  
ccacagctggccaaggccttcgagcgcgtgcgccaggccgccgactacatgcccgattgg 
 P  Q  L  A  K  A  F  E  R  V  R  Q  A  A  D  Y  M  P  D  W  
caggtggagcgcgtgatgaacacccagctgggagccgactggcgccagcgcctgaagtcg 
 Q  V  E  R  V  M  N  T  Q  L  G  A  D  W  R  Q  R  L  K  S  
ttcgaggataagcccttcgccgccgccagcattggacaggtgcaccgcgccaccctgtcc 
 F  E  D  K  P  F  A  A  A  S  I  G  Q  V  H  R  A  T  L  S  
gacggcatggatgtggccatcaagatccagtacccgggagtggcccagagcattgagtcc 
 D  G  M  D  V  A  I  K  I  Q  Y  P  G  V  A  Q  S  I  E  S  
gacatcgacaacctggtgggcatgctgaaagtgtgggacgtgttcccgcagggcttcttc 
 D  I  D  N  L  V  G  M  L  K  V  W  D  V  F  P  Q  G  F  F  
atcgataatgtggtgcgcgtggccaagcgcgagctgcagtgggaggtggattacgaccgc 
 I  D  N  V  V  R  V  A  K  R  E  L  Q  W  E  V  D  Y  D  R  
gaggccgagtacaccgagaagttccgcgagatgatcgccccatacccggagtactacgtg 
 E  A  E  Y  T  E  K  F  R  E  M  I  A  P  Y  P  E  Y  Y  V  
ccgcgcgtggtgcgcgacctgaccacctcctcggtgctgaccaccgagctggtgccgggc 
 P  R  V  V  R  D  L  T  T  S  S  V  L  T  T  E  L  V  P  G  
gtgccactggacaagtgcttcgatctgtcgtacgagcaccgccgccacattgccgccagc 




 V  L  K  L  C  L  R  E  L  F  E  I  E  C  M  Q  T  D  P  N  
tggagcaatttcctgtacgatgccccgtcccgccgcctgatgctgattgacttcggcagc 
 W  S  N  F  L  Y  D  A  P  S  R  R  L  M  L  I  D  F  G  S  
acccgcttctaccgccacgagttcatccgcaactaccgccgcgtgatcatgtcggccgcc 
 T  R  F  Y  R  H  E  F  I  R  N  Y  R  R  V  I  M  S  A  A  
gagaacaatcgccagggagtgctggagatgtcccgcgagatgggcttcctgaccggctac 
 E  N  N  R  Q  G  V  L  E  M  S  R  E  M  G  F  L  T  G  Y  
gagacgaagcagatggagcaggcccacgtggatgccgtgatgatcctgggcgagattttc 
 E  T  K  Q  M  E  Q  A  H  V  D  A  V  M  I  L  G  E  I  F  
cgctacgatggcgacttcgatttcggccgccagaataccaccgagcgcctggccgccctg 
 R  Y  D  G  D  F  D  F  G  R  Q  N  T  T  E  R  L  A  A  L  
gtgcccacgatggtggcccaccgcctgtgcccacccccggaggagatttactcgatccac 
 V  P  T  M  V  A  H  R  L  C  P  P  P  E  E  I  Y  S  I  H  
cgcaagctgagcggcatcttcctgctgtgcgcccgcctgaatgtgcgcatgaattgcgtg 
 R  K  L  S  G  I  F  L  L  C  A  R  L  N  V  R  M  N  C  V  
ccgttttacaaggacatcgtgctgggaaagtttaaggattaa 




Myc tag is highlighted in bold 
L520* mutation is highlighted in red 
 
atggagcagaagctgattagtgaggaggacctgggaacaagccgcagtgcccaggaggcc 
 M  E  Q  K  L  I  S  E  E  D  L  G  T  S  R  S  A  Q  E  A  
gccgccctgctgcgcggactgcgcattctgctggaggcctgcggacgcgagcacctggcc 
 A  A  L  L  R  G  L  R  I  L  L  E  A  C  G  R  E  H  L  A  
cacggccgccacctgtggagcaacagctccatccgcgagctgatcgccgagaatgtggcc 
 H  G  R  H  L  W  S  N  S  S  I  R  E  L  I  A  E  N  V  A  
cacacccagcagctggtgcgcagcagcagccagaacccaaccgaggagctgaagaagctg 
 H  T  Q  Q  L  V  R  S  S  S  Q  N  P  T  E  E  L  K  K  L  
cagcagaccgtgaaggagacgggagagcgcggatacgtggtggccaagggcatctgcagc 
 Q  Q  T  V  K  E  T  G  E  R  G  Y  V  V  A  K  G  I  C  S  
ctgctggagacgaagatcaagatgagccgcgaggagtcggccatctcggagccagcccag 
 L  L  E  T  K  I  K  M  S  R  E  E  S  A  I  S  E  P  A  Q  
gtgtcgagcatccgcaagtccacccccaccgcccagaaccccgcctcgtgggacgccgcc 
 V  S  S  I  R  K  S  T  P  T  A  Q  N  P  A  S  W  D  A  A  
aacctggacatcagcagcatcaccctgcaggagttcgaggagatcctgtcccgccgcaat 
 N  L  D  I  S  S  I  T  L  Q  E  F  E  E  I  L  S  R  R  N  
aaggaccgcagcgtgtccctgcgcacccccgccaccaagagcaaccagaccatgcccaag 
 K  D  R  S  V  S  L  R  T  P  A  T  K  S  N  Q  T  M  P  K  
aaggagacgagcaccaatccaggcatcatcacccaggataccgagtacgtgaacaatgtg 
 K  E  T  S  T  N  P  G  I  I  T  Q  D  T  E  Y  V  N  N  V  
ctgcgcttcgtggccggagccaaggtggaggagcagcccccagatgcccagcccaagaag 
 L  R  F  V  A  G  A  K  V  E  E  Q  P  P  D  A  Q  P  K  K  
aagagcgatcagccagccatcgaggtgcccgagctgtcgaaggtggccaagcagcgcaag 
 K  S  D  Q  P  A  I  E  V  P  E  L  S  K  V  A  K  Q  R  K  
gtgccaagctcccgcattggacgcatggcctcgttcggcggcctgttcgccggcctgggc 
 V  P  S  S  R  I  G  R  M  A  S  F  G  G  L  F  A  G  L  G  
ctgggcaccctgaacgagctgaccaagggcgccctgggcctgggcggctcgacctccatg 
 L  G  T  L  N  E  L  T  K  G  A  L  G  L  G  G  S  T  S  M  
cgcgaggccctgctgtcccccgccaatgccgagcgcatcgtggacaccctgtgcaaggtg 
 R  E  A  L  L  S  P  A  N  A  E  R  I  V  D  T  L  C  K  V  
cgcggcgccgccctgaagattggacagatcctgtccatccaggattcgagcgtggtgtcg 
 R  G  A  A  L  K  I  G  Q  I  L  S  I  Q  D  S  S  V  V  S  
ccacagctggccaaggccttcgagcgcgtgcgccaggccgccgactacatgcccgattgg 
 P  Q  L  A  K  A  F  E  R  V  R  Q  A  A  D  Y  M  P  D  W  
caggtggagcgcgtgatgaacacccagctgggagccgactggcgccagcgcctgaagtcg 
 Q  V  E  R  V  M  N  T  Q  L  G  A  D  W  R  Q  R  L  K  S  
ttcgaggataagcccttcgccgccgccagcattggacaggtgcaccgcgccaccctgtcc 
 F  E  D  K  P  F  A  A  A  S  I  G  Q  V  H  R  A  T  L  S  
gacggcatggatgtggccatcaagatccagtacccgggagtggcccagagcattgagtcc 
 D  G  M  D  V  A  I  K  I  Q  Y  P  G  V  A  Q  S  I  E  S  
gacatcgacaacctggtgggcatgctgaaagtgtgggacgtgttcccgcagggcttcttc 
 D  I  D  N  L  V  G  M  L  K  V  W  D  V  F  P  Q  G  F  F  
atcgataatgtggtgcgcgtggccaagcgcgagctgcagtgggaggtggattacgaccgc 
 I  D  N  V  V  R  V  A  K  R  E  L  Q  W  E  V  D  Y  D  R  
gaggccgagtacaccgagaagttccgcgagatgatcgccccatacccggagtactacgtg 
 E  A  E  Y  T  E  K  F  R  E  M  I  A  P  Y  P  E  Y  Y  V  
ccgcgcgtggtgcgcgacctgaccacctcctcggtgctgaccaccgagctggtgccgggc 
 P  R  V  V  R  D  L  T  T  S  S  V  L  T  T  E  L  V  P  G  
gtgccactggacaagtgcttcgatctgtcgtacgagcaccgccgccacattgccgccagc 
 V  P  L  D  K  C  F  D  L  S  Y  E  H  R  R  H  I  A  A  S  
gtgctgaagctgtgcctgcgcgagctgttcgagatcgagtgcatgcagaccgaccccaac 




















Wild-type coq8-myc  
Myc tag is highlighted in bold 
atgagccgcagtgcccaggaggccgccgccctgctgcgcggactgcgcattctgctggag 
 M  S  R  S  A  Q  E  A  A  A  L  L  R  G  L  R  I  L  L  E  
gcctgcggacgcgagcacctggcccacggccgccacctgtggagcaacagctccatccgc 
 A  C  G  R  E  H  L  A  H  G  R  H  L  W  S  N  S  S  I  R  
gagctgatcgccgagaatgtggcccacacccagcagctggtgcgcagcagcagccagaac 
 E  L  I  A  E  N  V  A  H  T  Q  Q  L  V  R  S  S  S  Q  N  
ccaaccgaggagctgaagaagctgcagcagaccgtgaaggagacgggagagcgcggatac 
 P  T  E  E  L  K  K  L  Q  Q  T  V  K  E  T  G  E  R  G  Y  
gtggtggccaagggcatctgcagcctgctggagacgaagatcaagatgagccgcgaggag 
 V  V  A  K  G  I  C  S  L  L  E  T  K  I  K  M  S  R  E  E  
tcggccatctcggagccagcccaggtgtcgagcatccgcaagtccacccccaccgcccag 
 S  A  I  S  E  P  A  Q  V  S  S  I  R  K  S  T  P  T  A  Q  
aaccccgcctcgtgggacgccgccaacctggacatcagcagcatcaccctgcaggagttc 
 N  P  A  S  W  D  A  A  N  L  D  I  S  S  I  T  L  Q  E  F  
gaggagatcctgtcccgccgcaataaggaccgcagcgtgtccctgcgcacccccgccacc 
 E  E  I  L  S  R  R  N  K  D  R  S  V  S  L  R  T  P  A  T  
aagagcaaccagaccatgcccaagaaggagacgagcaccaatccaggcatcatcacccag 
 K  S  N  Q  T  M  P  K  K  E  T  S  T  N  P  G  I  I  T  Q  
gataccgagtacgtgaacaatgtgctgcgcttcgtggccggagccaaggtggaggagcag 
 D  T  E  Y  V  N  N  V  L  R  F  V  A  G  A  K  V  E  E  Q  
cccccagatgcccagcccaagaagaagagcgatcagccagccatcgaggtgcccgagctg 
 P  P  D  A  Q  P  K  K  K  S  D  Q  P  A  I  E  V  P  E  L  
tcgaaggtggccaagcagcgcaaggtgccaagctcccgcattggacgcatggcctcgttc 
 S  K  V  A  K  Q  R  K  V  P  S  S  R  I  G  R  M  A  S  F  
ggcggcctgttcgccggcctgggcctgggcaccctgaacgagctgaccaagggcgccctg 
 G  G  L  F  A  G  L  G  L  G  T  L  N  E  L  T  K  G  A  L  
ggcctgggcggctcgacctccatgcgcgaggccctgctgtcccccgccaatgccgagcgc 
 G  L  G  G  S  T  S  M  R  E  A  L  L  S  P  A  N  A  E  R  
atcgtggacaccctgtgcaaggtgcgcggcgccgccctgaagattggacagatcctgtcc 
 I  V  D  T  L  C  K  V  R  G  A  A  L  K  I  G  Q  I  L  S  
atccaggattcgagcgtggtgtcgccacagctggccaaggccttcgagcgcgtgcgccag 
 I  Q  D  S  S  V  V  S  P  Q  L  A  K  A  F  E  R  V  R  Q  
gccgccgactacatgcccgattggcaggtggagcgcgtgatgaacacccagctgggagcc 
 A  A  D  Y  M  P  D  W  Q  V  E  R  V  M  N  T  Q  L  G  A  
gactggcgccagcgcctgaagtcgttcgaggataagcccttcgccgccgccagcattgga 
 D  W  R  Q  R  L  K  S  F  E  D  K  P  F  A  A  A  S  I  G  
caggtgcaccgcgccaccctgtccgacggcatggatgtggccatcaagatccagtacccg 
 Q  V  H  R  A  T  L  S  D  G  M  D  V  A  I  K  I  Q  Y  P  
ggagtggcccagagcattgagtccgacatcgacaacctggtgggcatgctgaaagtgtgg 
 G  V  A  Q  S  I  E  S  D  I  D  N  L  V  G  M  L  K  V  W  
gacgtgttcccgcagggcttcttcatcgataatgtggtgcgcgtggccaagcgcgagctg 
 D  V  F  P  Q  G  F  F  I  D  N  V  V  R  V  A  K  R  E  L  
cagtgggaggtggattacgaccgcgaggccgagtacaccgagaagttccgcgagatgatc 
 Q  W  E  V  D  Y  D  R  E  A  E  Y  T  E  K  F  R  E  M  I  
gccccatacccggagtactacgtgccgcgcgtggtgcgcgacctgaccacctcctcggtg 
 A  P  Y  P  E  Y  Y  V  P  R  V  V  R  D  L  T  T  S  S  V  
ctgaccaccgagctggtgccgggcgtgccactggacaagtgcttcgatctgtcgtacgag 
 L  T  T  E  L  V  P  G  V  P  L  D  K  C  F  D  L  S  Y  E  
caccgccgccacattgccgccagcgtgctgaagctgtgcctgcgcgagctgttcgagatc 
 H  R  R  H  I  A  A  S  V  L  K  L  C  L  R  E  L  F  E  I  
gagtgcatgcagaccgaccccaactggagcaatttcctgtacgatgccccgtcccgccgc 
 E  C  M  Q  T  D  P  N  W  S  N  F  L  Y  D  A  P  S  R  R  
ctgatgctgattgacttcggcagcacccgcttctaccgccacgagttcatccgcaactac 
 L  M  L  I  D  F  G  S  T  R  F  Y  R  H  E  F  I  R  N  Y  
cgccgcgtgatcatgtcggccgccgagaacaatcgccagggagtgctggagatgtcccgc 




 E  M  G  F  L  T  G  Y  E  T  K  Q  M  E  Q  A  H  V  D  A  
gtgatgatcctgggcgagattttccgctacgatggcgacttcgatttcggccgccagaat 
 V  M  I  L  G  E  I  F  R  Y  D  G  D  F  D  F  G  R  Q  N  
accaccgagcgcctggccgccctggtgcccacgatggtggcccaccgcctgtgcccaccc 
 T  T  E  R  L  A  A  L  V  P  T  M  V  A  H  R  L  C  P  P  
ccggaggagatttactcgatccaccgcaagctgagcggcatcttcctgctgtgcgcccgc 
 P  E  E  I  Y  S  I  H  R  K  L  S  G  I  F  L  L  C  A  R  
ctgaatgtgcgcatgaattgcgtgccgttttacaaggacatcgtgctgggaaagtttaag 
 L  N  V  R  M  N  C  V  P  F  Y  K  D  I  V  L  G  K  F  K  
gatgagcagaagctgattagtgaggaggacctgtaa 
 D  E  Q  K  L  I  S  E  E  D  L  -   
136 
 
Wild-type human COQ8A 
 
atggccgccattctgggagatacgattatggtggccaagggactggtgaagctgacacag 
 M  A  A  I  L  G  D  T  I  M  V  A  K  G  L  V  K  L  T  Q  
gccgccgtggagacacatctgcagcatctgggaattggcggcgagctgatcatggccgcc 
 A  A  V  E  T  H  L  Q  H  L  G  I  G  G  E  L  I  M  A  A  
cgtgccctgcagtccaccgccgtggagcagatcggcatgttcctgggcaaggtgcagggc 
 R  A  L  Q  S  T  A  V  E  Q  I  G  M  F  L  G  K  V  Q  G  
caggataagcacgaggagtacttcgccgagaacttcggcggacccgagggagagttccac 
 Q  D  K  H  E  E  Y  F  A  E  N  F  G  G  P  E  G  E  F  H  
ttctccgtgccacacgccgccggagcctcgaccgatttcagctccgcctccgccccagac 
 F  S  V  P  H  A  A  G  A  S  T  D  F  S  S  A  S  A  P  D  
cagagcgccccaccctccctgggccacgcccacagcgagggcccagcccccgcctacgtg 
 Q  S  A  P  P  S  L  G  H  A  H  S  E  G  P  A  P  A  Y  V  
gcctccggcccgttccgcgaggccggcttcccaggacaggccagcagccccctgggacgc 
 A  S  G  P  F  R  E  A  G  F  P  G  Q  A  S  S  P  L  G  R  
gccaatggacgcctgttcgccaatccccgcgacagcttctccgccatgggcttccagcgc 
 A  N  G  R  L  F  A  N  P  R  D  S  F  S  A  M  G  F  Q  R  
cgcttcttccaccaggatcagtccccggtgggcggcctgaccgccgaggacattgagaag 
 R  F  F  H  Q  D  Q  S  P  V  G  G  L  T  A  E  D  I  E  K  
gcccgccaggccaaggcccgcccagagaacaagcagcacaagcagaccctgtcggagcac 
 A  R  Q  A  K  A  R  P  E  N  K  Q  H  K  Q  T  L  S  E  H  
gcccgcgagcgcaaggtgccagtgacccgcattggacgcctggccaatttcggcggcctg 
 A  R  E  R  K  V  P  V  T  R  I  G  R  L  A  N  F  G  G  L  
gccgtgggcctgggattcggagccctggccgaggtggccaagaagtcgctgcgcagcgag 
 A  V  G  L  G  F  G  A  L  A  E  V  A  K  K  S  L  R  S  E  
gatccatcgggcaagaaggccgtgctgggctcctcgcccttcctgtcggaggccaatgcc 
 D  P  S  G  K  K  A  V  L  G  S  S  P  F  L  S  E  A  N  A  
gagcgcattgtgcgcaccctgtgcaaggtgcgcggcgccgccctgaagctgggccagatg 
 E  R  I  V  R  T  L  C  K  V  R  G  A  A  L  K  L  G  Q  M  
ctgtcgatccaggatgacgccttcatcaatccacacctggccaagatcttcgagcgcgtg 
 L  S  I  Q  D  D  A  F  I  N  P  H  L  A  K  I  F  E  R  V  
cgccagtcggccgacttcatgcccctgaagcagatgatgaagaccctgaacaatgatctg 
 R  Q  S  A  D  F  M  P  L  K  Q  M  M  K  T  L  N  N  D  L  
ggccccaactggcgcgacaagctggagtacttcgaggagcgcccgttcgccgccgccagc 
 G  P  N  W  R  D  K  L  E  Y  F  E  E  R  P  F  A  A  A  S  
atcggccaggtgcacctggcccgcatgaagggcggccgcgaggtggccatgaagatccag 
 I  G  Q  V  H  L  A  R  M  K  G  G  R  E  V  A  M  K  I  Q  
tacccgggcgtggcccagtccatcaattcggatgtgaacaatctgatggccgtgctgaac 
 Y  P  G  V  A  Q  S  I  N  S  D  V  N  N  L  M  A  V  L  N  
atgtccaatatgctgccggagggcctgttcccagagcacctgattgatgtgctgcgccgc 
 M  S  N  M  L  P  E  G  L  F  P  E  H  L  I  D  V  L  R  R  
gagctggccctggagtgcgactaccagcgcgaggccgcctgcgcccgcaagttccgcgat 
 E  L  A  L  E  C  D  Y  Q  R  E  A  A  C  A  R  K  F  R  D  
ctgctgaagggccaccccttcttctacgtgccggagatcgtggacgagctgtgctcgccg 
 L  L  K  G  H  P  F  F  Y  V  P  E  I  V  D  E  L  C  S  P  
cacgtgctgaccaccgagctggtgagcggattcccactggatcaggccgagggcctgtcc 
 H  V  L  T  T  E  L  V  S  G  F  P  L  D  Q  A  E  G  L  S  
caggagatccgcaacgagatctgctacaatatcctggtgctgtgcctgcgcgagctgttc 
 Q  E  I  R  N  E  I  C  Y  N  I  L  V  L  C  L  R  E  L  F  
gagttccacttcatgcagaccgatcccaactggagcaatttcttctacgacccgcagcag 
 E  F  H  F  M  Q  T  D  P  N  W  S  N  F  F  Y  D  P  Q  Q  
cacaaggtggccctgctggacttcggagccacccgcgagtacgatcgctccttcaccgac 
 H  K  V  A  L  L  D  F  G  A  T  R  E  Y  D  R  S  F  T  D  
ctgtacatccagatcattcgcgccgccgccgatcgcgaccgcgagacggtgcgcgccaag 
 L  Y  I  Q  I  I  R  A  A  A  D  R  D  R  E  T  V  R  A  K  
tccatcgagatgaagttcctgacaggctacgaggtgaaggtcatggaggatgcccacctg 




 D  A  I  L  I  L  G  E  A  F  A  S  D  E  P  F  D  F  G  T  
cagtcgaccaccgagaagatccacaacctgattccagtgatgctgcgccaccgcctggtg 
 Q  S  T  T  E  K  I  H  N  L  I  P  V  M  L  R  H  R  L  V  
ccacccccggaggagacgtacagcctgcaccgcaagatgggcggctcgttcctgatctgc 
 P  P  P  E  E  T  Y  S  L  H  R  K  M  G  G  S  F  L  I  C  
agcaagctgaaggcccgcttcccctgcaaggccatgtttgaggaggcctattccaactat 
 S  K  L  K  A  R  F  P  C  K  A  M  F  E  E  A  Y  S  N  Y  
tgcaagcgccaggcccagcagtag 




Human COQ8A L277P 
L277P mutation highlighted in red 
 
atggccgccattctgggagatacgattatggtggccaagggactggtgaagctgacacag 
 M  A  A  I  L  G  D  T  I  M  V  A  K  G  L  V  K  L  T  Q  
gccgccgtggagacacatctgcagcatctgggaattggcggcgagctgatcatggccgcc 
 A  A  V  E  T  H  L  Q  H  L  G  I  G  G  E  L  I  M  A  A  
cgtgccctgcagtccaccgccgtggagcagatcggcatgttcctgggcaaggtgcagggc 
 R  A  L  Q  S  T  A  V  E  Q  I  G  M  F  L  G  K  V  Q  G  
caggataagcacgaggagtacttcgccgagaacttcggcggacccgagggagagttccac 
 Q  D  K  H  E  E  Y  F  A  E  N  F  G  G  P  E  G  E  F  H  
ttctccgtgccacacgccgccggagcctcgaccgatttcagctccgcctccgccccagac 
 F  S  V  P  H  A  A  G  A  S  T  D  F  S  S  A  S  A  P  D  
cagagcgccccaccctccctgggccacgcccacagcgagggcccagcccccgcctacgtg 
 Q  S  A  P  P  S  L  G  H  A  H  S  E  G  P  A  P  A  Y  V  
gcctccggcccgttccgcgaggccggcttcccaggacaggccagcagccccctgggacgc 
 A  S  G  P  F  R  E  A  G  F  P  G  Q  A  S  S  P  L  G  R  
gccaatggacgcctgttcgccaatccccgcgacagcttctccgccatgggcttccagcgc 
 A  N  G  R  L  F  A  N  P  R  D  S  F  S  A  M  G  F  Q  R  
cgcttcttccaccaggatcagtccccggtgggcggcctgaccgccgaggacattgagaag 
 R  F  F  H  Q  D  Q  S  P  V  G  G  L  T  A  E  D  I  E  K  
gcccgccaggccaaggcccgcccagagaacaagcagcacaagcagaccctgtcggagcac 
 A  R  Q  A  K  A  R  P  E  N  K  Q  H  K  Q  T  L  S  E  H  
gcccgcgagcgcaaggtgccagtgacccgcattggacgcctggccaatttcggcggcctg 
 A  R  E  R  K  V  P  V  T  R  I  G  R  L  A  N  F  G  G  L  
gccgtgggcctgggattcggagccctggccgaggtggccaagaagtcgctgcgcagcgag 
 A  V  G  L  G  F  G  A  L  A  E  V  A  K  K  S  L  R  S  E  
gatccatcgggcaagaaggccgtgctgggctcctcgcccttcctgtcggaggccaatgcc 
 D  P  S  G  K  K  A  V  L  G  S  S  P  F  L  S  E  A  N  A  
gagcgcattgtgcgcaccctgtgcaaggtgcgcggcgccgccctgaagcccggccagatg 
 E  R  I  V  R  T  L  C  K  V  R  G  A  A  L  K  P  G  Q  M  
ctgtcgatccaggatgacgccttcatcaatccacacctggccaagatcttcgagcgcgtg 
 L  S  I  Q  D  D  A  F  I  N  P  H  L  A  K  I  F  E  R  V  
cgccagtcggccgacttcatgcccctgaagcagatgatgaagaccctgaacaatgatctg 
 R  Q  S  A  D  F  M  P  L  K  Q  M  M  K  T  L  N  N  D  L  
ggccccaactggcgcgacaagctggagtacttcgaggagcgcccgttcgccgccgccagc 
 G  P  N  W  R  D  K  L  E  Y  F  E  E  R  P  F  A  A  A  S  
atcggccaggtgcacctggcccgcatgaagggcggccgcgaggtggccatgaagatccag 
 I  G  Q  V  H  L  A  R  M  K  G  G  R  E  V  A  M  K  I  Q  
tacccgggcgtggcccagtccatcaattcggatgtgaacaatctgatggccgtgctgaac 
 Y  P  G  V  A  Q  S  I  N  S  D  V  N  N  L  M  A  V  L  N  
atgtccaatatgctgccggagggcctgttcccagagcacctgattgatgtgctgcgccgc 
 M  S  N  M  L  P  E  G  L  F  P  E  H  L  I  D  V  L  R  R  
gagctggccctggagtgcgactaccagcgcgaggccgcctgcgcccgcaagttccgcgat 
 E  L  A  L  E  C  D  Y  Q  R  E  A  A  C  A  R  K  F  R  D  
ctgctgaagggccaccccttcttctacgtgccggagatcgtggacgagctgtgctcgccg 
 L  L  K  G  H  P  F  F  Y  V  P  E  I  V  D  E  L  C  S  P  
cacgtgctgaccaccgagctggtgagcggattcccactggatcaggccgagggcctgtcc 
 H  V  L  T  T  E  L  V  S  G  F  P  L  D  Q  A  E  G  L  S  
caggagatccgcaacgagatctgctacaatatcctggtgctgtgcctgcgcgagctgttc 
 Q  E  I  R  N  E  I  C  Y  N  I  L  V  L  C  L  R  E  L  F  
gagttccacttcatgcagaccgatcccaactggagcaatttcttctacgacccgcagcag 
 E  F  H  F  M  Q  T  D  P  N  W  S  N  F  F  Y  D  P  Q  Q  
cacaaggtggccctgctggacttcggagccacccgcgagtacgatcgctccttcaccgac 
 H  K  V  A  L  L  D  F  G  A  T  R  E  Y  D  R  S  F  T  D  
ctgtacatccagatcattcgcgccgccgccgatcgcgaccgcgagacggtgcgcgccaag 




 S  I  E  M  K  F  L  T  G  Y  E  V  K  V  M  E  D  A  H  L  
gacgccatcctgattctgggagaggccttcgcctcggatgagccgttcgacttcggcacc 
 D  A  I  L  I  L  G  E  A  F  A  S  D  E  P  F  D  F  G  T  
cagtcgaccaccgagaagatccacaacctgattccagtgatgctgcgccaccgcctggtg 
 Q  S  T  T  E  K  I  H  N  L  I  P  V  M  L  R  H  R  L  V  
ccacccccggaggagacgtacagcctgcaccgcaagatgggcggctcgttcctgatctgc 
 P  P  P  E  E  T  Y  S  L  H  R  K  M  G  G  S  F  L  I  C  
agcaagctgaaggcccgcttcccctgcaaggccatgtttgaggaggcctattccaactat 
 S  K  L  K  A  R  F  P  C  K  A  M  F  E  E  A  Y  S  N  Y  
tgcaagcgccaggcccagcagtag 




Human COQ8A K502* 
The wildtype protein ends at K502 (red). Due to the mutation in the splice donor site, 60 
nucleotides in the intron are predicted to be translated (20 amino acids blue) until a stop 
codon is reached 
 
atggccgccattctgggagacacaattatggtggccaagggactggtgaagctgacacag 
 M  A  A  I  L  G  D  T  I  M  V  A  K  G  L  V  K  L  T  Q  
gccgccgtggagacgcatctgcagcacctgggaattggcggcgagctgatcatggccgcc 
 A  A  V  E  T  H  L  Q  H  L  G  I  G  G  E  L  I  M  A  A  
cgtgccctgcagtccaccgccgtggagcagatcggcatgttcctgggcaaggtgcagggc 
 R  A  L  Q  S  T  A  V  E  Q  I  G  M  F  L  G  K  V  Q  G  
caggataagcacgaggagtacttcgccgagaacttcggcggacccgagggagagttccac 
 Q  D  K  H  E  E  Y  F  A  E  N  F  G  G  P  E  G  E  F  H  
ttctccgtgccacacgccgccggagcctccaccgatttcagctccgcctcggcccccgac 
 F  S  V  P  H  A  A  G  A  S  T  D  F  S  S  A  S  A  P  D  
cagagcgccccaccctccctgggccacgcccactccgagggcccagcccccgcctacgtg 
 Q  S  A  P  P  S  L  G  H  A  H  S  E  G  P  A  P  A  Y  V  
gcctcgggcccattccgcgaggccggcttcccaggacaggccagcagccccctgggacgc 
 A  S  G  P  F  R  E  A  G  F  P  G  Q  A  S  S  P  L  G  R  
gccaatggacgcctgttcgccaatccgcgcgacagcttctccgccatgggcttccagcgc 
 A  N  G  R  L  F  A  N  P  R  D  S  F  S  A  M  G  F  Q  R  
cgcttcttccaccaggatcagtcccccgtgggcggcctgaccgccgaggacattgagaag 
 R  F  F  H  Q  D  Q  S  P  V  G  G  L  T  A  E  D  I  E  K  
gcccgccaggccaaggcccgcccagagaacaagcagcacaagcagaccctgtcggagcac 
 A  R  Q  A  K  A  R  P  E  N  K  Q  H  K  Q  T  L  S  E  H  
gcccgcgagcgcaaggtgccagtgacccgcattggacgcctggccaatttcggcggcctg 
 A  R  E  R  K  V  P  V  T  R  I  G  R  L  A  N  F  G  G  L  
gccgtgggcctgggattcggagccctggccgaggtggccaagaagtcgctgcgcagcgag 
 A  V  G  L  G  F  G  A  L  A  E  V  A  K  K  S  L  R  S  E  
gatccatccggcaagaaggccgtgctgggctcctcgcccttcctgtcggaggccaatgcc 
 D  P  S  G  K  K  A  V  L  G  S  S  P  F  L  S  E  A  N  A  
gagcgcattgtgcgcaccctgtgcaaggtgcgcggcgccgccctgaagctgggccagatg 
 E  R  I  V  R  T  L  C  K  V  R  G  A  A  L  K  L  G  Q  M  
ctgtccatccaggatgacgccttcatcaatccacacctggccaagatcttcgagcgcgtg 
 L  S  I  Q  D  D  A  F  I  N  P  H  L  A  K  I  F  E  R  V  
cgccagtccgccgacttcatgcccctgaagcagatgatgaagaccctgaacaatgatctg 
 R  Q  S  A  D  F  M  P  L  K  Q  M  M  K  T  L  N  N  D  L  
ggccccaactggcgcgacaagctggagtacttcgaggagcgcccgttcgccgccgccagc 
 G  P  N  W  R  D  K  L  E  Y  F  E  E  R  P  F  A  A  A  S  
atcggccaggtgcacctggcccgcatgaagggcggccgcgaggtggccatgaagatccag 
 I  G  Q  V  H  L  A  R  M  K  G  G  R  E  V  A  M  K  I  Q  
taccccggcgtggcccagtccatcaattcggatgtgaacaatctgatggccgtgctgaac 
 Y  P  G  V  A  Q  S  I  N  S  D  V  N  N  L  M  A  V  L  N  
atgtccaatatgctgccggagggcctgttcccagagcacctgattgatgtgctgcgccgc 
 M  S  N  M  L  P  E  G  L  F  P  E  H  L  I  D  V  L  R  R  
gagctggccctggagtgcgactaccagcgcgaggccgcctgcgcccgcaagttccgcgat 
 E  L  A  L  E  C  D  Y  Q  R  E  A  A  C  A  R  K  F  R  D  
ctgctgaagggccaccccttcttctacgtgccggagatcgtggacgagctgtgcagcccg 
 L  L  K  G  H  P  F  F  Y  V  P  E  I  V  D  E  L  C  S  P  
cacgtgctgaccaccgagctggtgtccggattcccactggaccaggccgagggcctgtcc 
 H  V  L  T  T  E  L  V  S  G  F  P  L  D  Q  A  E  G  L  S  
caggagatccgcaacgagatctgctacaatatcctggtgctgtgcctgcgcgagctgttc 
 Q  E  I  R  N  E  I  C  Y  N  I  L  V  L  C  L  R  E  L  F  
gagttccacttcatgcagaccgatcccaactggagcaatttcttctacgacccgcagcag 
 E  F  H  F  M  Q  T  D  P  N  W  S  N  F  F  Y  D  P  Q  Q  
cacaagatgtcgccccgcgtgggagcccccgccgcccgcccggagtccttctcggagtgg 
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Figure 9.4 Physical map of pUASTattB-myc-coq8 WT. 







Figure 9.6 Physical map of pUASTattB-myc-coq8 I295P. 
 







Figure 9.8 Physical map of pUAST-hCOQ8A-WT 






























Figure 9.11. PUAST cloning vector. The map indicates the multiple cloning region (MCR) 
which is susceptible to restriction digest and insertion of transgene. 
